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These studies present a series of novel roles for glucocorticoid signaling in the developing 
zebrafish embryo. The best-characterized roles of cortisol, the primary circulating corticosteroid 
in teleost fish, are known to occur by the activation of the glucocorticoid receptor (GR) in the 
post-hatch animal to mobilize energy reserves for response and recovery from stressful situations. 
For the first time, evidence is presented that GR and cortisol are key developmental regulators in 
the pre-hatch zebrafish embryo and that glucocorticoid signaling modulates multiple critical 
developmental pathways and affects embryogenesis in diverse ways. 
Prior to these experiments, very little was known regarding the developmental role of 
glucocorticoids in lower vertebrates. In mammalian models, there has been extensive study of the 
action of these steroids in late-stage organ maturation, and they have a variety of clinical and 
biomedical applications. However, in fish, there was a relative dearth of information regarding 
the basic dynamics and potential functional roles of cortisol and GR in embryogenesis. Zebrafish 
are a popular model for developmental study, with optically transparent embryos that allow for 
reliable observation. Additionally, the zebrafish genome is fully sequenced and extensively 
annotated, and a variety of molecular biology techniques are well-established in the existing 
literature. The zebrafish is also now recognized as an advantageous model for endocrine and 
stress axis studies, as it expresses a single GR gene, unique among teleosts but comparable to 
mammals. Preliminary studies published in the literature described cortisol and GR as deposited 
in the zebrafish embryo prior to fertilization, and showed their expression declining prior to 
hatch, then rising significantly as larvae approach the stage of first feeding. This dynamic 
expression of both ligand and receptor during embryogenesis, combined with knowledge from 
mammalian models, led to the hypothesis that glucocorticoid signaling may be functionally 
relevant in zebrafish development. 
A variety of techniques were used to examine the roles of cortisol and GR in the zebrafish 
embryo. Morpholino oligonucleotides were injected into one-cell embryos to block GR protein 
translation, allowing for the identification of GR-responsive developmental events and putative 
GR target genes. High-density microarray analysis of GR morphants presented numerous novel 
genes and pathways that are modulated by glucocorticoid signaling in the embryo. The ability to 
microinject molecules into a newly-fertilized zygote also allowed for other manipulations, 
including the addition of exogenous cortisol or the use of a cortisol-specific antibody to sequester 
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maternally deposited cortisol. These studies provided the first evidence regarding the functional 
importance of the maternal cortisol deposition in the zebrafish oocyte prior to fertilization. 
The detailed temporal and spatial expression of GR mRNA and protein in the developing 
embryo has been characterized for the first time. GR expression is widespread, especially in 
developing mesoderm, and de novo GR transcription in the zebrafish embryo begins within 12 
hours post fertilization. Lack of GR protein expression in the developing zebrafish embryo causes 
reduced growth, delayed somitogenesis, altered myogenesis, and severely reduces post-hatch 
survival. Additionally, GR modulates the expression of bone morphogenetic proteins, a family of 
morphogens that are involved in major developmental events including dorsoventral patterning, 
somitogenesis, myogenesis, and organogenesis. Reduction in GR protein content in the 
developing embryo is also linked to other major developmental processes including neurogenesis, 
eye formation, cellular adhesion, and development and function of the hypothalamic-pituitary-
interrenal (HPI) axis. 
Cortisol in the early embryo, which is contributed entirely by maternal deposition prior to 
fertilization, is an important regulator of cardiogenesis and development of the HPI axis. 
Modulation of cortisol content in the early embryo causes an impairment of the post-hatch 
response to a physical stressor, as larvae exposed to increased cortisol during embryogenesis 
displayed an inability to increase heart rate in response to an acute physical stress, and did not 
display the classical increase in cortisol that follows a stressor challenge. Embryos that 
experience lowered glucocorticoid signaling in development tend to have a heightened post-hatch 
response to stress, further supporting the conclusion that HPI axis development is regulated by 
glucocorticoid signaling. These studies have identified key cardiogenic and HPI axis genes that 
are GR-responsive, providing mechanistic explanations for these phenotypic changes. Together 
these findings indicate that maternal deposition of cortisol in the embryo can pattern the post-
hatch larva and has definitive impacts on performance as the offspring begin locomotion and 
approach feeding stages. 
In total, these studies demonstrate that glucocorticoid signaling is critically important to 
zebrafish embryogenesis, defining novel roles that are completely independent of the classical 
vertebrate stress response. These functions have significant effects on diverse developmental 
pathways and processes, and with the potential applicability of the zebrafish model to studies in 
higher vertebrates, may have important biomedical applications.  
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1.1 Introduction 
Activation of the vertebrate corticosteroid stress axis involves a highly conserved set of 
coordinated signaling events between various organs leading to hormonal release in response to 
stressor insult (see Table 1 for reviews). In teleosts the main circulating stress steroid is cortisol 
and this hormone binds to glucocorticoid receptor (GR) which acts as a transcription factor upon 
ligand binding to affect gene expression in target tissues (Bury and Sturm, 2007; Prunet et al., 
2008). It has recently been shown in zebrafish (Danio rerio), GR mRNA abundance is 
differentially regulated during embryogenesis (Alsop and Vijayan, 2008; 2009). Cortisol is also 
present in the newly fertilized embryo (Alsop and Vijayan, 2008), and the combined presence of 
both receptor and ligand leads to interesting questions of potential glucocorticoid signaling 
actions in development. 
 It should be noted that cortisol can also bind and activate teleost mineralocorticoid 
receptors (MR) in vitro (Prunet et al., 2006; Pippal et al., 2011). However, the extent to which it 
acts in tissues in vivo is unclear, as research has shown the co-expression of MR with the cortisol-
converting enzyme 11-hydroxysteroid dehydrogenase 2 (11hsd2) indicating that cortisol-MR 
binding may be similar to that in mammals where active cortisol is often spatially separate from 
MR expressing tissues (Edwards et al., 1988; Pascual-Le Tallec and Lombes, 2005; Sturm et al., 
2005). Teleosts do not synthesize aldosterone, and the primary ligand for MR remains unknown 
(Sturm et al., 2005; Pippal et al., 2011). As with GR, MR expression is also dynamic in the early 
embryo (Alsop and Vijayan, 2008), but without a clear understanding of basic function and 
activation, it is difficult to assess its importance. For these reasons, this introductory chapter and 
this dissertation in total will focus on the role of cortisol and its activation of the glucocorticoid 
receptor.  
 While the role of GR activation on downstream molecular responses has been explored to 
a large extent by expression analysis of targeted glucocorticoid-responsive genes and/or by 
microarrays examination of transcriptomic changes in teleosts (Mommsen et al., 1999; Vijayan et 
al., 2005; Aluru and Vijayan, 2007; Aluru and Vijayan, 2009), the role of cortisol and the GR 
signaling in developmental programming is far from clear. This introductory chapter will describe 
general zebrafish embryogenesis and some key developmental processes and regulatory 
pathways, as well as the development of the zebrafish stress axis organs and what is known about 
the role of glucocorticoid signaling in the development of a variety of animals.  
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Table 1 – Animal stress axis signaling reviews from the primary literature 
Major Subject/Animal(s) Reference 
Fish (Wendelaar Bonga, 1997) 
Fish (Mommsen et al., 1999) 
Fish (Schreck et al., 2001) 
Fish (Barton, 2002) 
Fish (Prunet et al., 2006) 
Fish (Bury and Sturm, 2007) 
Fish (Prunet et al., 2008) 
Fish (Aluru and Vijayan, 2009) 
Fish (Pankhurst, 2011) 
Amphibians (Rollins-Smith, 2001) 
Amphibians (Denver et al., 2002) 
Amphibians/reptiles (Moore and Jessop, 2003) 
Reptiles (Greenberg, 1990) 
Reptiles (Lance, 1990) 
Birds (Siegel, 1980) 
Birds (Harvey and Hall) 
Birds (Hess, 2006)   
Birds (Martin and Rubenstein, 2008) 
Mammals (Boonstra, 2005) 
Mammals (Reeder and Kramer, 2005) 
Humans (Zhou and Cidlowski, 2005) 
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Table 1 (Continued) – Animal stress axis signaling reviews from the primary literature 
Major Subject/Animal(s) Reference 
Vertebrates (Dallman et al., 1992) 
Vertebrates (Johnson et al., 1992) 
Vertebrates (Ottaviani and Franceschi, 1996) 
Vertebrates (Chrousos, 2000) 
Vertebrates (Sapolsky et al., 2000) 
Vertebrates (Tsigos and Chrousos, 2002) 
Vertebrates (Charmandari et al., 2004b) 
Vertebrates (Chrousos, 2006) 
Vertebrates (Smith and Vale, 2006) 
Vertebrates (Wada, 2008) 
Vertebrates (Denver, 2009) 
Vertebrates  (Tort and Teles) 
Molecular mechanisms (Burnstein and Cidlowski, 1989) 
Molecular mechanisms (Adcock, 2001) 
Molecular mechanisms (Schaaf and Cidlowski, 2002) 
Molecular mechanisms (Yudt and Cidlowski, 2002) 
Molecular mechanisms (Schoneveld et al., 2004) 
Molecular mechanisms (Heitzer et al., 2007) 
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1.2 The corticosteroid stress axis in teleosts 
The vertebrate stress response is highly conserved and well characterized in a variety of different 
animals (see Table 1). In general, perception of a stressor leads to the release of corticotropin-
releasing hormone (CRH) (or corticotropin-releasing factor (CRF) in fish) from the hypothalamus 
(Feist and Schreck, 2001; Tsigos and Chrousos, 2002). This neuropeptide acts on the anterior 
pituitary and stimulates the release of adrenocorticotropic hormone (ACTH), which acts on the 
adrenal gland (or interrenal tissue in fish) to release corticosteroids, including cortisol or 
corticosterone (Schmidt and Litwack, 1982; Wendelaar Bonga, 1997; Levine, 2001; Charmandari 
et al., 2004b), into circulation. Together, this interconnected network of organs is known as the 
hypothalamus-pituitary-interrenal (HPI; see Figure 1 for a schematic) axis in fish and their 
functioning is critical for evoking a cortisol stress response (Chrousos and Gold, 1992; Rehan, 
1996). A key metabolic role for corticosteroids is to mobilize energy substrate stores and produce 
glucose to cope with immediate energy demands during stressor exposure, and also to replenish 
glycogen stores during recovery (Ballard and Ballard, 1974; Chrousos and Gold, 1992; Johnson et 
al., 1992; Wendelaar Bonga, 1997; Charmandari et al., 2004b; Schreck, 2010). However, 
glucocorticoids also act on other systems, including nervous, muscle, reproductive, and immune 
systems, to affect behavior, growth, metabolism, reproduction, and/or health of the animal (see 
Table 2 for reviews). This action is mediated predominantly by binding to intracellular 
corticosteroid receptors (Funder, 1997), including GR and MR (Mommsen et al., 1999). 
Corticosteroid binding activates GR, and results in dimerization and translocation into the 
nucleus, where the activated-complex modulates target gene expression by binding to 
glucocorticoid response elements (GREs) upstream of target genes (Funder, 1993; Mommsen et 
al., 1999; Charmandari et al., 2004a) (see Figure 2 for a schematic). Mammals express a single 
GR gene, which is under variable regulation by multiple phosphorylation sites (Webster et al., 
1997). Humans express two splice variants, GRα and GRß (Bamberger et al., 1995), that exhibit 
different transcriptional activities, and GRß is activated even in the absence of ligand binding 
(Kino et al., 2009). Unlike other vertebrates, most teleost fish exhibit multiple GR genes as a 





















Figure 1 – Schematic diagram of the hypothalamic-pituitary-interrenal (HPI) axis 
The HPI axis is the coordinated stress axis in teleosts and consists of the hypothalamus which 
recognizes a stressor and produces corticotropin-releasing factor (CRF) that acts on the anterior 
pituitary to cause the release of adrenocorticotrophic hormone (ACTH), that is released into 
general circulation and causes the release of cortisol from the interrenal tissue. Cortisol then acts 
on a variety of tissues to mobilize energy stores and affect metabolic and other pathways to 
prepare for a recovery from stressor challenge. 
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Figure 2 – Schematic diagram of classical glucocorticoid receptor activation 
After the release of cortisol into circulation from the interrenal tissue, it crosses membranes 
readily due to its hydrophobic steroid structure. It then binds to the cytosolic glucocorticoid 
receptor (GR) which is thought to be bound by molecular chaperones in teleosts. Cortisol binding 
causes the shedding of these chaperones and the dimerization of the activated receptor which then 
translocates to the nucleus to act as a transcription factor and modulate target gene expression. 
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Table 2 – Reviews pertaining to stress axis interactions with major physiological systems  
Target System Reference 
Behaviour (O'Connor et al., 2000) 
Behaviour (Summers, 2002) 
Behaviour (Summers et al., 2005) 
Behaviour (Wolkowitz et al., 2009) 
Behaviour (Ellis et al., 2012) 
Feeding (Bernier and Peter, 2001) 
Immune system	   (Dohms and Metz, 1991) 
Immune system (Weyts et al., 1999) 
Immune system (Rollins-Smith, 2001) 
Immune system (Padgett and Glaser, 2003) 
Immune system (Bauer, 2005) 
Immune system (Tort, 2011) 
Metabolism (van der Boon et al., 1991) 
Metabolism (Kyrou and Tsigos, 2009) 
Metabolism/Cardiovascular (Maxwell et al., 1994) 
Metabolism/Cardiovascular (Walker, 2007) 
Metabolism/Growth (Thakore and Dinan, 1994) 
Metabolism/Growth (van Weerd and Komen, 1998) 
Osmoregulation (McCormick, 2001) 
Reproduction (Tilbrook et al., 2000) 
Reproduction (Wingfield and Sapolsky, 2003) 
Reproduction (Tetsuka, 2007) 
Reproduction (Borell et al., 2007) 
Reproduction (Milla et al., 2009) 
Reproduction (Leatherland et al., 2010) 
Reproduction (Schreck, 2010) 
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1.3 Zebrafish as a model for corticosteroid research 
Considering the depth of knowledge and study that has been focused on the role of circulating 
glucocorticoids in animals, it is surprising that detailed investigation of glucocorticoid action 
during early development has only recently been explored. Some of this is likely due to the 
relative opacity of embryogenesis in mammalian models as the early developmental events occur 
in utero limiting the accessibility of the embryo for visual observation. As an alternative to the 
primary mammalian model, the mouse, the zebrafish is a prominent model organism for 
developmental study (Lele and Krone, 1996; Grunwald and Eisen, 2002; Berman et al., 2005). 
Zebrafish embryos are optically clear and develop externally over a short period of time; they 
hatch within 2 days of fertilization and are mobile and feeding within 5 days of fertilization 
(Kimmel, 1989; Kimmel et al., 1995). The adult fish are hardy, breed readily and in large 
numbers, and there exist numerous continuing strains that allow for controlled experiments on 
genetically identical animals (Segner, 2009). In addition, the zebrafish genome is sequenced and 
well characterized and annotated, allowing the usage of advanced genetic techniques to 
investigate the effects of specific genes or proteins in developmental processes (Aleström et al., 
2006). Specifically, forward and reverse genetic techniques, such as gene or protein silencing, can 
be used readily to identify molecular mechanisms and isolate developmental roles for genes of 
interest (Nasevicius and Ekker, 2000; Löhr and Hammerschmidt, 2011).  
 Unlike most teleost species, which express multiple glucocorticoid receptor genes in their 
genome, the zebrafish has only a single GR gene, as seen in mammals (Alsop and Vijayan, 2008; 
Schaaf et al., 2008). The single zebrafish GR gene is expressed as two splice-variant isoforms 
(GRα and GRß) that are very similar in structure to those found in humans, although the role of 
the newly identified GRß variant remains unclear (Schaaf et al., 2008). The implications of this 
genomic profile are still being investigated, but it provides a promising framework to examine 
corticosteroid effects during development in humans. In addition, de novo cortisol synthesis in 
zebrafish embryos begins only around hatching (Alsop and Vijayan, 2008; 2009), meaning that 
glucocorticoid signaling during early development is due only to maternally deposited cortisol. 
This allows for easier identification of glucocorticoid-responsive developmental processes than in 
mammalian systems, where fetal glucocorticoid concentrations are more dynamic, and protection 
from maternal glucocorticoids is dependent on enzymatic degradation at the placenta (Yang, 
1997). Together, these attributes underscore the utility of zebrafish as a valuable model for 
developmental and endocrine disorders, with potentially significant application to human health 
and disease (Dooley and Zon, 2000; Schaaf et al., 2009; Schoonheim et al., 2010). 
 
  12 
1.4 Early zebrafish development 
Vertebrate development is complex, but is reasonably well conserved, with numerous patterning 
processes and morphogenic movements occurring in diverse animals, including gastrulation, 
somitogenesis, and general body axis patterning (de Robertis et al., 2000; Altmann and Brivanlou, 
2001; Yin et al., 2009; Mallo et al., 2010; Maroto et al., 2012). The zebrafish has emerged as a 
prominent model organism for developmental studies (see Table 3 for reviews) due to a number 
of useful attributes. Zebrafish are hardy fish that spawn large clutches of eggs readily in 
laboratory settings, and these eggs are optically clear allowing for ready observation of 
developmental processes (Lele and Krone, 1996; Lawrence, 2007). In this section the broad 
morphogenetic stages of pre-hatch zebrafish development will be outlined. All staging times are 
from standard incubation experiments and observations of zebrafish carried out at 28.5 C, which 
is considered the optimal temperature for zebrafish embryo incubation and development (Kimmel 
et al., 1995; Westerfield, 2007). 
 Many different factors are present in the zebrafish oocyte prior to fertilization, including 
cortisol and GR transcripts as mentioned previously, and the consensus is that they are highly 
active in early development (Pelegri, 2003; Abrams and Mullins, 2009; Fuentes and Fernández, 
2010). After fertilization, the newly-created zygote remains a single cell for approximately 40 
minutes, then the first cell division begins (Kimmel et al., 1995). The initial cell represents the 
animal pole of the cell and sits atop the yolk cell, and the yolk region most distant from the 
fertilized cell is the vegetal pole (Marlow and Mullins, 2008). The cleavage stage begins after the 
completion of first division, and cells divide synchronously every 15 minutes (Kimmel et al., 
1995). The whole mass of cells is termed the blastodisc at this stage (Kimmel and Law, 1985a). 
Zebrafish cell division is meroblastic, with dividing daughter cells (termed blastomeres) sitting 
atop the large yolk cell (Solnica-Krezel and Driever, 1994). Meroblastic division means that some 
cells remain incompletely divided, and are linked to each other by cytoplasmic connections 
(Kimmel and Law, 1985a). During these cleavage events, cytoplasmic streaming of yolk content 
into the newly formed blastomeres brings deposited factors into the developing embryo (Howley 
and Ho, 2000). This process is particularly advantageous for experiments that attempt to 
manipulate the early embryo environment, as changes in the yolk content can have functional 
action on the early embryo. The cleavage stage ends after the sixth division creating a 64-cell 
embryo, and for the first time there is more than a single layer of cells lying atop the yolk 
(Kimmel et al., 1995). 
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 As the cells begin to layer they are renamed the blastula, marking the onset of the blastula 
period at the 128-cell stage (~2 hours post fertilization [hpf]). During the blastula period, cell 
division becomes less coordinated with waves of division moving across the cell mass forming a 
domed mass on top of the yolk (Kimmel et al., 1995). Midway through the blastula period, two 
distinct and important developmental events occur: the formation of the yolk syncytial layer 
(YSL) and the mid-blastula transition (MBT) (Kane and Kimmel, 1993; Carvalho and 
Heisenberg, 2010). The YSL is thought to be unique to teleosts and is a layer formed from the 
marginal cells of the blastula, those cells still connected from early cleavage events, which 
degrade and release their cytoplasm into the yolk (Kimmel and Law, 1985b; Chen and Kimelman, 
2000). These cells continue nuclear division and remain positioned just under the developing 
blastula and appear to act as an organizing center for mesoderm and endoderm differentiation as 
well as later events in embryogenesis (Carvalho and Heisenberg, 2010). The MBT marks the 
onset of de novo transcription in the embryo and the degradation of most of the maternally 
deposited mRNA (Kane and Kimmel, 1993; Pelegri, 2003; Giraldez et al., 2006). The MBT is 
characterized by a lengthening of the cell cycle and a slowing of division rate, and seems to be 
triggered by a threshold ratio between the amount of nuclear and cytoplasmic material (Kane and 
Kimmel, 1993). In addition, the MBT is an early cell-fate differentiation point (Kimmel et al., 
1990). As these processes occur, the cells, now termed the blastoderm, continue to divide and 
amass atop the yolk, until they begin to spread thinly across the surface of the yolk hemisphere 
late in the blastula period (Ho, 1992). This process is termed epiboly; Figure 3 shows the 
difference between embryos before (A) and during (B) epiboly, the movement of the blastoderm 
cells down towards the vegetal pole can be seen (arrows indicate boundary). Epiboly is classified 
by the percent of yolk covered by the spreading blastula cells, and marks the transition from 
blastula to gastrula period at approximately 5 hpf (Kimmel et al., 1995). At 50% epiboly, 
gastrulation begins and cells at the edges of the spreading blastoderm begin the process of 
involution, in which they fold inward and form a second layer underneath the spreading cells (Ho, 
1992). As involution occurs, the blastoderm also continues to spread across the surface of the 
yolk towards the vegetal pole, eventually achieving near complete coverage of the yolk at the end 
of epiboly (Kimmel et al., 1995). Gastrulation events coincide with cell fate determination and 
studies have established fate maps of the embryo at 50% epiboly (Kimmel et al., 1990; Ho, 1992). 
Gastrulation also marks the primary period of dorsoventral patterning, beginning with the creation 
of the thickened shield region that will act as an organizing centre and becomes the dorsal region 
of the developing embryo (Ho, 1992; Schier, 2001; Montero, 2005). A number of well-
characterized developmental morphogens are involved in dorsoventral patterning, including 
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members of the fibroblast growth factor family (Furthauer, 2004), the hedgehog family (Johnson 
et al., 1994; Ekker et al., 1995), nodal-related genes (Rebagliati et al., 1998) and the bone 
morphogenetic proteins (BMPs; Hammerschmidt and Mullins, 2002). As involution continues 
and after the movements of epiboly are complete, the embryo thickens to form a ring-like region 
surrounding the yolk (see Figure 3C) that will soon become recognizable as the developing 
animal with a classical vertebrate body plan (Kimmel et al., 1995). Gastrulation ends at 
approximately 10 hpf with the embryo displaying a distinct axis and recognizable body shape, 
including a thickened head region at the shield and a smaller thickening at the tail (Ho, 1992; 
Kimmel et al., 1995). 
 After gastrulation, the next major stage of zebrafish development is the segmentation 
period. During this period the somitogenesis occurs and the tail becomes recognizable as the 
embryo develops and uncurls from around the yolk (Figure 3D; Schroter et al., 2008). Somites 
develop in bilateral pairs on either side of the developing notochord, which is the vertebral region 
progenitor tissue and also produces signals that will induce neural tissue formation (Glickman et 
al., 2003). Somite pairs form every 30 minutes until 30 pairs are complete after ~24 hpf (Stickney 
et al., 2000). Somites differentiate into the skeleton and skeletal muscle, as well as cartilage and 
epithelial tissue and develop a classical chevron shape as myosin chains form and elongate 
(Kimmel and Warga, 1987; Kimmel et al., 1995; Stickney et al., 2000; Patterson et al., 2010). 
Organogenesis also begins during the segmentation period, with the specification and 
organization of multiple organ primordia, including the kidneys, eyes, and brain (Kimmel et al., 
1995; Mueller and Wullimann, 2003). The neural plate thickens in response to signals from the 
developing notochord and eventually forms the neural tube, the source of the central nervous 
system tissue (Glickman et al., 2003; Mueller and Wullimann, 2003; Maier et al., 2011). As the 
segmentation period ends at approximately 24 hpf, the embryo begins random movements in the 
tail region as the developing muscle fibres contract and expand (Stickney et al., 2000).  
 The pharyngula period follows segmentation and many of the processes that began before 
24 hpf continue as the embryo enters the second day of development. The neural tube hollows 
and enlarges in the dorsal region to become the brain, forming five distinct lobe regions that will 
become the telencephalon, the diencephalon, the midbrain, the cerebellum, and the epiphysis 
(Kimmel and Law, 1985a; Mueller and Wullimann, 2003; 2005). Organogenesis also continues as 
the lateral line forms (Kimmel et al., 1995; Wada et al., 2010), the heart chambers enlarge and the 
preliminary cardiac tube loops (Chen and Fishman, 1996; Glickman and Yelon, 2002; Brand, 
2003), and the gastrointestinal tract differentiates and extends along with associated organs such 
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as the liver and pancreas (Field et al., 2003; Wallace et al., 2005). Most importantly, the embryo 
develops towards hatching with increased muscle contraction rate and strength, and the 
development of the hatching gland (Kimmel et al., 1995). The pharyngula period ends at 
approximately 48 hpf, which marks the beginning of the hatching period and the transition to 
larval stages as the animal begins to move, grow, and approaches feeding stages (Kimmel et al., 
1995; Lawrence, 2007). 
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Table 3 – Reviews regarding the use of the zebrafish model in developmental study 
Major Topic Reference 
Angiogenesis (Childs et al., 2002) 
Aquaculture (Aleström et al., 2006) 
Behaviour (Gerlai, 2003) 
Biomedicine (Barut and Zon, 2000) 
Biomedicine (Zon and Peterson, 2005) 
Biomedicine (Endocrinology) (Löhr and Hammerschmidt, 2011) 
Biomedicine (Endocrinology) (Schoonheim et al., 2010) 
Biomedicine (Muscle) (Lin, 2012) 
Biomedicine (Skin) (Li et al., 2011) 
Cardiovascular (Chico et al., 2008) 
Cardiovascular (Stainier and Fishman, 1994) 
Circadian Rhythm (Vatine et al., 2011) 
Development (Driever et al., 1994) 
Development (Eisen, 1996) 
Development (Grunwald and Eisen, 2002) 
Endocrinology (Bourque and Houvras, 2011) 
Endocrinology (McGonnell and Fowkes, 2006) 
Endocrinology (Schaaf et al., 2009) 
Endocrinology (Steenbergen et al., 2011) 
Immune System (Traver et al., 2003) 
Myelopoiesis (Berman et al., 2005) 
Myogenesis (Chong et al., 2009) 
Neurogenesis (Abraham et al., 2009) 
Neuroscience (Friedrich et al., 2010) 
Physiology (Briggs, 2002) 
Toxicology (Ali et al., 2011) 
Toxicology (Lele and Krone, 1996) 
Toxicology (Segner, 2009) 
  
 


















Figure 3 – Representative images of key milestones in zebrafish development 
Certain major developmental stages in zebrafish embryogenesis are readily assessed by simple 
microscopy. In this figure, we show images of the pre-epiboly zebrafish embryo (A), the 50% 
epiboly (B; arrow indicates blastoderm border), the post-gastrulation embryo (C), and the 24 hpf 
embryo with fully developed somite pairs (D; arrow indicates developed somites). 
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1.5 Roles of bone morphogenetic proteins in development 
One of the major findings of this dissertation is that signaling by the bone morphogenetic proteins 
(BMPs) may be modulated by glucocorticoids. The BMPs are a family of conserved proteins that 
are active developmental morphogens in a variety of animals (Nikaido et al., 1997; Miyazono et 
al., 2005; Yanagita, 2005; Wagner et al., 2010). BMP ligands are members of the transforming 
growth factor-ß (TGFß) family of developmental signaling molecules (Miyazono et al., 2005). 
BMP ligands bind to integral membrane BMP receptors, which then cause the activation of 
members of the Smad family of signaling proteins that act as transcription factors to affect gene 
expression (Bubnoff and Cho, 2001; Miyazono et al., 2005; Wagner et al., 2010). BMP signaling 
regulation is complex, with specific Smad molecules producing either inhibitory or excitatory 
signals (Dick et al., 1999; Zhang et al., 2007) as well as numerous other antagonizing pathways 
and molecules that act to oppose BMP signaling (Miyazono et al., 2005; Yanagita, 2005; Walsh 
et al., 2010; Sylva et al., 2011). To date, 14 BMP ligands, 5 BMP receptors, and 10 Smad 
molecules have been identified in zebrafish (ZFIN Staff, 2006) and together they play roles in a 
diverse array of embryogenic events. In addition to early axial patterning (Kishimoto et al., 1997; 
Hammerschmidt and Mullins, 2002), BMP signaling is implicated in a variety of processes 
throughout development, including myogenesis (Patterson et al., 2010), angiogenesis (David et 
al., 2009), organogenesis (Shin et al., 2007; Chung et al., 2008; McCulley et al., 2008), and 
craniofacial development (Nie et al., 2006). 
1.6 Development of the zebrafish corticosteroid stress axis 
In this section we present an overview of the known molecular mechanisms regulating stress axis 
development in zebrafish. Specifically we will highlight the formation of the hypothalamus, 
pituitary, and interrenal tissue in zebrafish, noting the time at which precursors are determined, 
the morphogenic movements that occur, and major molecular signaling molecules that are 
involved (see Figure 4 for summary). Very little is known about cortisol regulation of key genes 
involved in the development of the HPI axis. This would be an area of intense interest given the 
findings that cortisol content can vary in teleost oocytes due to maternal stressor exposure 
(Stratholt et al., 1997; McCormick, 1998; Eriksen et al., 2007; Giesing et al., 2011). 
1.6.1 Structure and development of the hypothalamus 
The hypothalamus is a major regulating center for control of bodily functions, and activation of 
this region of the brain is the first step in the whole organism cortisol-mediated response to stress 
(Wendelaar Bonga, 1997; Charmandari et al., 2004b; de Kloet et al., 2005; Chrousos, 2006). It is 
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located at the posterior basal region of the forebrain, positioned between the thalamus and the 
pituitary (Mueller and Wullimann, 2003; 2005). There are two major cell groups in the zebrafish 
hypothalamus, dopaminergic neurons and OXT-like neurons, which are analogous to mammalian 
parvocellular and magnocellular neurons, respectively (Blechman et al., 2007). OXT-like 
neurons, named for the oxtl (oxytocin-like) transcripts that mark their specification, produce 
neurohormones, including oxytocin and vasopressin (Machluf et al., 2011). Dopaminergic 
neurons produce trophic hormones that act on the pituitary, including corticotropin-releasing 
hormone (CRH) and gonadotropin-releasing hormone (Machluf et al., 2011).  
 The regulation of hypothalamic development is unclear in teleosts, but the diencephalon 
develops from the anterior neuroectoderm, migrating from the neural plate inward during early 
somitogenesis stages (~12 hpf; (Russek-Blum et al., 2009)). Hypothalamic neurons develop later 
in development, with dopaminergic neurons specified during gastrulation and directly observed 
by 18 hpf, and OXT-like neurons detectable at 36 hpf (Russek-Blum et al., 2008; Machluf et al., 
2011). Some of the most well studied developmental signaling pathways have been implicated in 
hypothalamic neurogenesis. For instance, release of nodal, bmp7, and wnt from the prechordal 
plate induces the hypothalamus to develop (Dale et al., 1997; Mathieu et al., 2002; Machluf et al., 
2011), and lef1, a member of the Wnt pathway, restricts and determines dopaminergic neuron 
specification (Kapsimali, 2004; Lee et al., 2006). The forebrain marker fezf2, which is regulated 
by the Wnt pathway, is required for dopaminergic neuron development and regulates other 
neurogenic morphogens, including neurogenin 1 (ngn1), and the two zebrafish paralogs of 
orthopedia homolog (otp), a well-characterized mammalian hypothalamic developmental 
regulator (Wang and Lufkin, 2000; Del Giacco et al., 2006; Jeong et al., 2006; Del Giacco et al., 
2008). 
1.6.2 Structure and development of the pituitary 
The morphology of the pituitary is well known and has been characterized in zebrafish (Herzog 
et al., 2004b; Chapman et al., 2005). In general, the pituitary has two subregions, termed the 
neurohypophysis and the adenohypophysis. The neurohypophysis, also known as the posterior 
pituitary, is a neural component that contains projections of the dopaminergic cells that originate 
in the hypothalamus (Chapman et al., 2005). The adenohypophysis, or anterior pituitary, is an 
endocrine gland containing cells producing a variety of hormones, including thyroid stimulating 
hormone, follicular stimulating hormone, luteinizing hormone, and ACTH, that act on target 
tissues (Chrousos, 2000). Adenohypophyseal release of hormones occurs in response to 
hypothalamic stimulation via trophic hormones from OXT-like neurons. The pituitary is located 
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in a pocket of the skull, just below the hypothalamus (Chapman et al., 2005). There are some 
structural differences between the teleost and mammalian HP axis. In teleosts, the 
neurohypophysis is positioned dorsal to the adenohypophysis, instead of the posterior-anterior 
positioning seen in mammals (Mueller and Wullimann, 2005). Another major difference is that 
teleosts lack the hypothalamo-hypophyseal portal system that is found in higher vertebrates 
(Pogoda and Hammerschmidt, 2007). The portal system is a network of blood vessels that 
transport the trophic hormones released by the hypothalamus directly to the adenohypophysis, 
bypassing general circulation. Instead of this system, the teleost adenohypophysis is directly 
innervated by input from the hypothalamus, similar to the neurohypophysis (Pogoda and 
Hammerschmidt, 2007).  
 The development of the adenohypophysis has been extensively studied in zebrafish 
(Herzog et al., 2003; 2004b; Pogoda and Hammerschmidt, 2007). The first determination of 
adenohypophyseal cells begins at approximately 10 hpf in the anterior region of the pre-placodal 
ectoderm (Dutta et al., 2005). By 18-20 hpf, the first adenohypophysis-specific markers are 
expressed in the newly thickened placodal ectoderm; specifically lim3, a Lim-domain homeobox 
gene, and pit1, a Pou-domain homeobox gene (Glasgow et al., 1997; Nica et al., 2004). By 24 
hpf, the pituitary is structurally distinct from the brain and surrounding region (Chapman et al., 
2005; Pogoda and Hammerschmidt, 2007). Over the next few hours the cells migrate internally as 
a solid mass of cells towards the final position below the hypothalamus (Chapman et al., 2005; 
Pogoda and Hammerschmidt, 2007; 2009). This is different from the mammalian and avian 
model, in which the cells form a hollow outpocket (Rathke’s pouch) that eventually fuses to form 
the solid pituitary (Sheng, 1997). Within the developing zebrafish pituitary, the corticotrope cells 
differentiate early in the lateral regions, and begin to express the ACTH precursor 
proopiomelanocortin (POMC) as early as 18-20 hpf, with strong expression observable by 24-26 
hpf (Herzog et al., 2003; Liu et al., 2003a). Specific genes have been identified as necessary for 
pituitary formation; a key factor being pitx3 (Dutta et al., 2005). There are numerous pitx genes 
found in mice, with overlapping functions, but only pitx3 is expressed in zebrafish, and it appears 
to assume all the developmental functions necessary for pituitary formation (Dutta et al., 2005). 
Signaling from the hedgehog system is also required for adenohypophysis specification, with 
requirements for both sonic hedgehog (shh) and tiggy winkle hedgehog (twhh) (Herzog et al., 
2003; Sbrogna et al., 2003). Other genes necessary for pituitary cell survival are fibroblast growth 
factor 3 (fgf3), which seems to prevent regional apoptosis (Herzog et al., 2004a), ascl1a, which is 
necessary for all adenohypophyseal hormone production (Pogoda et al., 2006), and eya1, which 
signals with shh to induce corticotrope cell specification (Nica et al., 2006). 
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1.6.3 Structure and development of the interrenal tissue 
Another major difference between mammalian and teleost stress axis organs is that piscine 
models lack a distinct adrenal gland. Instead, steroidogenic and chromaffin cells are dispersed in 
the interrenal tissue, located in the head kidney region in the dorsal region of the body cavity, 
posterior to the post-cardinal vein (Wendelaar Bonga, 1997). Interrenal development begins at 22 
hpf, as cells are specified within the pronephric primordia, which are two regions on either side of 
the developing neural crest (Hsu et al., 2003). From 24-36 hpf, the presumptive interrenal cells 
migrate to the midline and merge together (Hsu et al., 2003). At 28 hpf, steroidogenesis 
commences, marked by increased expression of key steroidogenic marker genes, including 
cytochrome P450 side chain cleavage enzyme (p450scc), steroidogenic acute regulatory protein 
(star), and 3-beta-hydroxysteroid dehydrogenase (3ß-HSD) in discrete regions of the migrating 
cells (Liu, 2007; To et al., 2007; Alsop and Vijayan, 2008; 2009). Chromaffin cells develop 
relatively late in the process, and are not detectable until 48 hpf, and by 72 hpf they have 
interspersed with the steroidogenic cells and interrenal development is complete (Liu, 2007; To et 
al., 2007). As with the pituitary, there are similarities in the genetic contributors to interrenal 
development in mammals and teleosts. In mammals, the primary driver of adrenal development is 
the sf1 gene, a Ftz-F1 gene identified as an orphaned nuclear receptor (Chai and Chan, 2000; 
Savage et al., 2003; Ishimoto and Jaffe, 2011). In zebrafish, two orthologs have been identified, 
ff1b and ff1d (Chai and Chan, 2000). ff1b is the earliest visible marker of interrenal cells, and its 
knockdown results in a complete lack of interrenal tissue formation (Chai et al., 2003). While ff1b 
is required for specific interrenal development, other signaling molecules are required both prior 
to and after the initial specification. For example, the formation of the pronephric primordia 
requires wt1, and without it no further development of pronephros or the interrenals occurs (Hsu 
et al., 2003). Later on, dax1 and prox1 are required for the development of steroidogenic cells 
(Liu et al., 2003b; Zhao et al., 2006). The mechanisms that regulate these genes, and whether any 
hormonal input is involved, remain unclear and require further examination.  
 














Figure 4 – Summary of zebrafish hypothalamus-pituitary-interrenal development. 
The hypothalamus (HT), pituitary (adenohypophysis [AH], and neurohypophysis [NH]), and 
interrenal (IR) develop simultaneously during development, and in advance of the activation of 
the coordinated response to stress. HT develops from 12-36 hpf, and corticotropin-releasing 
factor (CRF) transcripts are maternally deposited in the oocyte. AH formation occurs from 10-26 
hpf, with corticotropes distinguishable in the lateral AH regions at 24-26 hpf. IR tissue develops 
initially from 22-36 hpf, with steroidogenic ontogeny occurring at 28 hpf. Chromaffin cells 
develop late, differentiating at 48 hpf and interspersing with the established steroidogenic cells by 
72 hpf. The earliest coordinated response to a perceived stressor leading to the release of cortisol 
occurs at around 72 hpf in zebrafish. 
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1.7 Ontogeny of stress response in zebrafish 
Although the signaling and steroidogenic components of the zebrafish HPI axis are present 
around the time of hatching (see Figure 4 for summary), the earliest induction of a stress response 
occurs at 72 hpf (Alderman and Bernier, 2009; Alsop and Vijayan, 2009). This delay in the ability 
to perceive a stressor and evoke a cortisol surge, despite the presence of the molecular signaling 
components of the HPI axis, is common in teleost species, having been observed in rainbow trout 
(Onchorynchus mykiss; (Barry et al., 1995)), yellow perch (Perca flavscens; (Jentoft et al., 
2002)), tilapia (Oreochromis mossambicus; (Pepels and Balm, 2004)), common carp (Cyprinus 
carpio; (Stouthart et al., 1998)) and chinook salmon (Oncorhynchus tshawytscha; (Feist and 
Schreck, 2001)). All of these fish display a classical response to stress some time after hatching. 
There is a similar stress hyporesponsive period in both mice and rats, which are unable to respond 
to a stressor for an extended period after birth (Levine, 2001; Schmidt et al., 2003). It is unclear 
whether this delay in stressor responsiveness is functionally relevant. However, it can be 
hypothesized that if glucocorticoids are developmental regulators, the delay in HPI/HPA 
activation may be protective, as stress-activated cortisol or corticosterone surges may disrupt 
glucocorticoid-sensitive developmental pathways. Interestingly, the general pattern and timing of 
stress axis organogenesis and activation is relatively well conserved, when controlled for 
gestational time, in vertebrates (see Table 4). This pattern, along with the similarity in stress axis 
activation and the molecular markers involved in HPA axis organogenesis, indicates that the 
ontogeny of the stress response and the developmental role of corticosteroid identified in 
zebrafish may be conserved in higher vertebrates. 
 Cortisol and GR are maternally deposited into the zebrafish oocyte and decrease in 
concentration during pre-hatch embryogenesis, then begin to rise after hatching  (Alsop and 
Vijayan, 2008; Alderman and Bernier, 2009; Alsop and Vijayan, 2009; Pikulkaew et al., 
2009).This variation in cortisol concentration prior to hatching is conserved in teleosts (de Jesus 
et al., 1991; Hwang and Wu, 1993; Barry et al., 1995; Sampath-Kumar et al., 1995; Stouthart et 
al., 1998; Nechaev et al., 2006). Interestingly CRF is also present in the oocyte, along with its 
receptors and binding proteins, although whether this deposition is functionally relevant remains 
unknown (Alderman and Bernier, 2009). Although the ACTH precursor POMC is not expressed 
until approximately 18-24 hpf (Liu et al., 2003a), a potential role for the CRF system in the early 
development of a functional corticotropic system remains to be examined, as well as whether 
CRF has other independent developmental roles. Steroidogenic enzymes are not measurable until 
after 28 hpf, indicating that early glucocorticoid effects are only due to maternally deposited 
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cortisol, not zygotically synthesized steroids (Liu et al., 2003a; To et al., 2007; Alsop and 
Vijayan, 2008; 2009). 
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Table 4 – The time of first onset of stress axis signal synthesis and stress responsiveness in 
various model animals in relation to total gestation/hatching time (shown as percentage).  
 Gestation time (%)  




ACTH  GC  
  
Stress  References 
Danio rerio  
(~ 48 h) 
0-13 50 75-100 150 (Liu, 2007; Alsop and 
Vijayan, 2008; 
Alderman and Bernier, 
2009; Alsop and 
Vijayan, 2009) 
Gallus gallu 
 (22 days) 
63 45 45 113 (Jenkins and Porter, 
2004; Saito et al., 2005) 
Musculus musculus 
 (20 days) 
65 93 75 160 (Keegan et al., 1994; 
Sheng, 1997; Heikkila et 
al., 2002; Schmidt et al., 
2003) 
Rattus norvegicus  
(21 days) 
80 76 86 166 (Chatelain et al., 1979; 
Baram and Lerner, 1991; 
Mitani et al., 1999; 
Levine, 2001)  
CRF: corticotropin-releasing factor; CRH: corticotropin-releasing hormone; ACTH: 
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1.8 Developmental role for glucocorticoid signaling 
The presence of HPI signaling molecules and receptors in zebrafish oocytes, and their persistence 
throughout embryogenesis, indicates that they may be developmentally active. In this section we 
will detail established roles for glucocorticoid in organogenesis based on mammalian studies, as 
well as indications from other egg-laying species and what little is known in zebrafish. The 
conservation of the stress axis signaling between teleosts and mammals and the presence of a 
similar GR gene expression and splicing profile to humans suggests that evidence from zebrafish 
study may be applicable to human health and disease. 
1.8.1 Developmental roles of glucocorticoids in mammals 
In mammals, numerous known developmental effects of glucocorticoids center on organogenesis. 
Glucocorticoid signaling has been implicated in the maturation and functional activation of 
multiple organ structures, including the heart, lungs, gut, pancreas, and kidneys, with research 
conducted in a variety of animals (Rall et al., 1977; Majumdar and Nielsen, 1985; Liggins, 1994; 
Pierce et al., 1995; Langdown et al., 2003; Gesina et al., 2004; Lumbers et al., 2005). Synthetic 
glucocorticoids are often given to prematurely-born infants to help speed organ development 
(Chrousos and Gold, 1992; Rehan, 1996). In various mammals, glucocorticoids have been shown 
to increase respiratory surfactant production and accelerate overall lung development (Ballard and 
Ballard, 1974; Mescher et al., 1975; Pierce et al., 1995; Bolt et al., 2001). In mice, knockout of 
the GR gene fatally impairs lung development, causing complete prenatal mortality (Cole et al., 
2001). There have been a number of other identified roles for corticosteroids in developmental 
organogenesis in varied mammalian models. Glucocorticoids have been found to accelerate renal 
tissue development (Celsi et al., 1993; Wang et al., 1994; Djouadi et al., 1996), modulate 
pancreatic development (Rall et al., 1977; Sangild et al., 1994; Gesina et al., 2004), regulate cell 
communication in the small intestine (Schaeffer et al., 2000), and to increase osteoblast activity 
(Shalhoub et al., 1992; Boden et al., 1996). Glucocorticoids also have detrimental effects on the 
brain, delaying development of neurons and glial cells, slowing myelination, and impairing 
vascularization (Huang et al., 1999; 2001). However, little is known about the mechanism of 
action of corticosteroid in these processes. Organogenesis is a complex process, and the 
transcription factors and/or morphogens that respond to glucocorticoid treatment in the 
maturation or activation of these developmental processes are still unclear. Attempts to determine 
the mechanistic action of GR-mediated cortisol signaling in mammalian embryos has been 
difficult due to lack of understanding behind the specific molecular signaling pathways of 
organogenesis as well as the difficulty in studying changes in utero.  
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 Glucocorticoid programming is a known consequence of elevated pre-natal 
glucocorticoids in mammals, referring to effects that last into adulthood, and has been identified 
as the cause of various human disease states (Seckl, 2001; Matthews, 2002; Seckl and Meaney, 
2004). For instance, pre-natal elevation of glucocorticoid levels affects the cardiovascular system, 
resulting in chronic hypertension and cardiovascular risk, modulating cardiac genes such as 
PPARγ and calreticulin (Seckl, 2001; Langdown et al., 2003). Elevated glucocorticoids during 
development also result in lasting disruption of brain function, via altered hippocampal neuronal 
content and reduced corticosteroid receptor expression (Welberg and Seckl, 2001; Welberg et al., 
2001). Other major programming effects involve the priming of the stress response (Matthews, 
2002), and disruption of glucose metabolism, the effects of which persist for multiple generations 
in treated rats (Drake et al., 2005). As with the direct effects of prenatal glucocorticoids on 
embryogenesis, the opacity of mammalian fetal development models obscures the mechanisms at 
work to create these lasting effects. 
1.8.2 Developmental role of glucocorticoids in non-mammalian models 
In teleost species, maternal stress and/or increased steroid deposition in the oocyte is associated 
with a reduction in larval performance and survival (McCormick, 1998; Mccormick, 1999; Li et 
al., 2010; Sloman, 2010; Åberg Andersson et al., 2011). The deposition of cortisol, GR, and 
possibly CRF and its receptors, could be a mechanism for transmitting this message from stressed 
mothers to progeny. This kind of maternal-embryonic communication is a common concept in 
avian models, where steroid deposition into egg affects priming of the stress response, decreasing 
the sensitivity of the HPA axis (Hayward and Wingfield, 2004), and in reptiles, where it can 
affect growth and philopatry (Shine and Downes, 1999; De Fraipont et al., 2000). In zebrafish, 
exposure of embryos to exogenous glucocorticoids has revealed novel glucocorticoid-responsive 
genes that have known developmental roles. Glucocorticoids modulate specific members of the 
matrix metalloproteinase (MMPs) family that act in degradation of the extracellular matrix, such 
as mmp2, mmp9, and mmp13, the latter of which is required for somitogenesis and craniofacial 
development (Hillegass et al., 2007; 2008). Matrix metalloproteinases are involved in a variety of 
cell remodeling actions that occur in development (Zhang et al., 2003; Yoong et al., 2007; 
Rozario and DeSimone, 2009), and GR-mediated alteration of their expression could cause 
widespread disruption of embryogenesis and birth defects. In combination, these actions of 
glucocorticoids in development provide interesting avenues for further exploration. However, 
comparatively little is known regarding glucocorticoid effects on development of birds and lower 
vertebrates, especially teleosts, when compared to mammals. 
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1.9 Major techniques utilized in zebrafish developmental studies 
This section will summarize two prominent techniques that are used in studies of zebrafish 
embryogenesis but may not be particularly common to many researchers: the use of morpholino 
oligonucleotides for the blocking of protein translation; and the use of microinjection for the 
delivery of morpholino oligonucleotides and other molecules into the developing zebrafish 
embryo. Other common techniques in this thesis that are better established, such as quantitative 
polymerase chain reaction (qPCR) and in situ hybridization (ISH) for transcript analysis or 
western blotting and immunohistochemistry for protein expression quantification, are described in 
the methods of each individual chapter, but an exploration of the theory behind them was deemed 
redundant due to their familiarity to most developmental, physiological, and molecular biology 
researchers. 
1.9.1 Morpholino oligonucleotides 
Morpholino oligonucleotides (MOs) are short sequences of modified nucleic acid that are 
commercially available from GeneTools, LLC in California. MOs are modified by the 
replacement of the deoxyribose or ribose sugars normally found in DNA or RNA with a nuclease 
resistant morpholine ring (see Figure 5 for structure; (Summerton and Weller, 1997)). MOs are 
designed against regions that will disrupt either transcription or translation and render cell unable 
to express the target protein for periods of time (Summerton and Weller, 1997). In this thesis 
(Chapters 2 and 4), an MO was targeted against the start site of translation from the zebrafish gr 
mRNA product. The binding of the MO at this region prevents ribosomal assembly and 
establishes what is termed a “knockdown” of GR protein (Nasevicius and Ekker, 2000). Another 
option is to block an intron/exon boundary to disrupt the splicing of the mRNA after transcription 
and prevent a functional protein from being produced (Summerton and Weller, 1997). This is a 
useful technique if one does not have a functional antibody for the protein of interest, as PCR 
amplification of the disrupted transcript can describe the efficacy of the MO (Eisen and Smith, 
2008). Controls for MO studies can be specific or non-specific. Specific MO controls are usually 
in the form of a mispair (MP) MO, in which 5 random basepairs are changed (out of the 20-25 bp 
MO sequence), which is enough to affect the binding of the MO to the target sequence 
(Summerton and Weller, 1997; Eisen and Smith, 2008). Non-specific controls either use a 
standard oligo for a given species, meant to control for any effects of the morpholine ring; or by 
the use of a p53 coinjected-MO to suppress p53 activity, as MOs are known to cause non-specific 
effects via p53 mediated mechanism (Heasman, 2002; Eisen and Smith, 2008). In the studies 
presented in subsequent chapter, the primary control used is a 5 bp mispair oligonucleotide 
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specifically designed to control for effects of the MO designed against the start site of GR 
translation, although we also use a p53 MO co-injection in chapter 2 as a further control for non-
specific effects. 
1.9.2 Microinjection into single-cell zebrafish embryos 
The optically clear nature of zebrafish embryos makes them ideal for developmental study, and 
the previously mentioned delay in first cleavage (~40 minutes), meroblastic cleavage pattern, and 
cytoplasmic streaming (Kimmel et al., 1995) mean that injection into the yolk of zebrafish 
embryos is an excellent and minimally traumatic way to alter the content of the fertilized zygote 
and the initial daughter cells. No puncturing of cells is required, and contents are rapidly taken up 
into the first daughter cells and then subsequently divided during cleavage and blastula stages 
(Kimmel and Law, 1985a; Nasevicius and Ekker, 2000). It should be noted that the length of time 
of clearance of molecules in the developing embryo is highly variable, with some MO sequences 
remaining effective up to 48-72 hpf (Nascevicius and Ekker, 2000), but dynamics in the embryo 
must be characterized, preferably by quantification of target molecules. 
  
 












Figure 5 – Structures of DNA and morpholino oligonucleotides 
This schematic shows the difference in chemical structure between a DNA nucleotide and 
morpholino nucleotide. Morpholinos have the deoxyribose sugar replaced with a morpholine ring 
to confer resistance from nuclease degradation. The phosphodiester bond in DNA is therefore 
replaced with a phosphorodiamidate linkage. 
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1.10 Objectives 
Generally, this chapter has attempted to highlight the relative lack of knowledge about the role of 
glucocorticoids in early vertebrate development relative to the well known, conserved, and 
characterized pathways of morphogenesis. The major objectives of this thesis stem from the 
primary hypothesis that the presence of cortisol and GR in the oocyte is functionally relevant, and 
that glucocorticoid signaling is important in zebrafish embryogenesis. This chapter also 
highlighted the utility of zebrafish as an excellent model for testing the above hypothesis.  
The specific objectives of this thesis are as follows:  
1) Characterize the broad actions of GR on early zebrafish development. 
This objective is addressed throughout the dissertation, but is the primary finding of 
Chapter 2, examined by the use of morpholino oligonucleotides to inhibit GR signaling. 
2) Identify novel developmental pathways and genes that are GR-modulated.  
This objective is studied throughout this thesis, with findings in Chapters 2, 3, and 4. 
Major pathways are identified in Chapter 4 by high-density microarray analysis of 
changes in global gene expression in response to morpholino knockdown of GR. 
3) Determine the effect of abnormal maternal cortisol deposition on early zebrafish 
development. 
This objective is examined in Chapter 3, by use of exogenous cortisol administration that 
mimics elevated maternal deposition. 
4) Determine the role of maternal cortisol on zebrafish stress axis development and 
functioning. 
This objective is examined in Chapter 5, by use of exogenous cortisol administration to 
mimic elevated maternal deposition and a cortisol-specific antibody that sequesters the 
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Chapter 2 
Glucocorticoid receptor signaling is essential for mesoderm 
























Note: this chapter is reproduced with permission from {Nesan, D., Kamkar, M., Burrows, J., 
Scott, I.C., Marsden M., and Vijayan, M.M. 2012. Glucocorticoid receptor signaling is essential 
for mesoderm formation and muscle development in zebrafish. Endocrinology. 153(3), 1288-
300.} © {2012} The Endocrine Society.  
Specific coauthor contributions:  
J Burrows and Dr. IC Scott contributed in situ hybridization data and images to Figures 1 and 2 
Dr. M Kamkar designed the GR-GFP construct and contributed to GR rescue mRNA construct 
creation 
Some imaging for Figures 1 and 2 was carried out in Dr. M Marsden’s lab. 
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2.1 Overview 
Glucocorticoid receptor (GR) signaling is thought to play a key role in embryogenesis, but its 
specific developmental effects remain unclear. In zebrafish (Danio rerio), de novo cortisol 
synthesis takes place only after hatching, indicating that pre-hatch cortisol signaling events are of 
maternal origin. Using early zebrafish developmental stages, we tested the hypothesis that GR 
signaling is critical for embryo growth and hatching. In zebrafish, maternal GR mRNA is 
degraded quickly, followed by zygotic synthesis of the receptor. GR protein is widely expressed 
throughout early development and we were able to knock down this protein using morpholino 
oligonucleotides. This led to a >70% reduction in mRNA abundance of mmp13, a glucocorticoid-
responsive gene, supporting suppressed GR signaling. The GR morphants displayed delayed 
somitogenesis, defects in somite and tail morphogenesis, reduced embryo size, and rarely 
survived after hatch. This correlated with altered expression of myogenic markers, including 
myogenin, myostatin, and specific myosin heavy chain and troponin genes. A key finding was a 
70-90% reduction in the mRNA abundance of bone morphogenetic proteins (BMPs), including 
bmp2a, bmp2b, and bmp4 in GR morphants. Bioinformatics analysis confirmed multiple putative 
glucocorticoid response elements upstream of these BMP genes. GR morphants displayed 
reduced expression of BMP modulated genes, including eve1 and pax3. Zebrafish GR mRNA 
injection rescued the GR morphant phenotype and reversed the disrupted expression of BMPs and 
myogenic genes. Our results for the first time indicate that GR signaling is essential for zebrafish 
muscle development, and we hypothesize a role for BMP morphogens in this process. 
2.2 Introduction 
Glucocorticoid signaling in adults has been extensively studied, and the functioning of the 
hypothalamic-pituitary-adrenal axis is essential for stress adaptation (Sapolsky et al., 2000). 
However, comparatively little is known about the developmental roles of glucocorticoid hormone 
and its signaling molecule, the glucocorticoid receptor (GR), a cytosolic ligand-bound 
transcription factor. Cortisol signaling is essential for late-term organ development (Liggins, 
1994), and GR knockout mice did not survive after birth due to impaired lung development (Cole 
et al., 2001). Also, exposure of the developing fetus to elevated glucocorticoid levels leads to 
lowered fetal birth weight and disrupted glucocorticoid responsiveness later in life (Ward, 2004). 
While these studies clearly implicate a critical role for corticosteroid signaling in fetal 
development, the role of glucocorticoid receptor activation on developmental programming 
events are far from clear.  
 
  37 
Zebrafish (Danio rerio) is an excellent model to identify the early developmental effects 
associated with GR signaling. This is because de novo synthesis of cortisol, the primary GR 
ligand, happens only after hatch in this species, leading to maternal cortisol as the sole contributor 
for early developmental programming (Alsop and Vijayan, 2008). This was further reinforced by 
the gradual decrease in maternal cortisol and GR transcripts prior to hatching in zebrafish (Alsop 
and Vijayan, 2008).  Also, unlike other teleosts that have multiple copies of GR, zebrafish only 
has a single GR gene in the genome (Alsop and Vijayan, 2008; Schaaf et al., 2008), making the 
species amenable for genetic manipulations. Additionally, a GRß splice variant, similar to 
humans, was recently discovered in zebrafish, leading to the proposal that this species is an 
excellent model for biomedical research, especially pertaining to developmental abnormalities 
associated with glucocorticoid excess or resistance to this hormone action (Schaaf et al., 2008; 
Schoonheim et al., 2010). Also, a recent study demonstrated that knocking down maternal GR 
leads to developmental defects in mesoderm formation in zebrafish (Pikulkaew et al., 2011).  
Zebrafish embryogenesis has been extensively characterized and several transcription 
factors, including MyoD (Ochi and Westerfield, 2007; Chong et al., 2009), and insulin-like 
growth factors (IGFs) (Duan et al., 2010) have been associated with early muscle development. 
Also the temporal expression of morphogens, including the bone morphogenetic proteins (BMPs) 
and their signaling is essential for mesoderm differentiation and dorsoventral patterning in the 
developing zebrafish embryo (Nikaido et al., 1997; Pyati et al., 2005). BMP signaling is highly 
conserved and upregulates the Smad family of proteins (Bubnoff and Cho, 2001; Miyazono et al., 
2005) and specific BMPs, including bmp2a, bmp2b, and bmp4 also affect myogenesis, 
angiogenesis, and organogenesis during zebrafish development (Stickney et al., 2000; Brand, 
2003; Chung et al., 2008; Patterson et al., 2010). Consequently, transient expression of BMPs are 
essential for mesoderm differentiation, dorsoventral patterning, and embryo survival (Stickney et 
al., 2000; Pyati et al., 2005; Patterson et al., 2010). Several endogenous regulators of BMPs have 
been identified, including their receptor antagonists that play key roles in affecting embryogenesis 
(Bubnoff and Cho, 2001; Little and Mullins, 2006).  
Here we tested the hypothesis that glucocorticoid receptor signaling is essential for fetal 
programming of mesoderm formation and muscle development in zebrafish. This was tested by 
assessing the phenotypic traits in response to reduced GR signaling, by knocking down this 
receptor protein expression and investigating changes in developmental and myogenic gene 
expression prior to hatching in zebrafish. Given the established role of BMPs in mesoderm 
formation and differentiation (Patterson et al., 2010), we also examined the expression of bmp2a, 
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bmp2b, and bmp4, and markers of their downstream signaling events to ascertain if these 
morphogens are regulated by GR signaling in zebrafish. Our results underscore a critical role for 
GR signaling in the fetal programming of mesoderm formation and myogenesis in zebrafish. Our 
results lead us to propose that BMPs may be involved in the developmental changes associated 
with GR knockdown in zebrafish.  
2.3 Materials & Methods 
2.3.1 Zebrafish care 
Adult zebrafish were maintained in 10L tanks at 28.5oC in a recirculating system (Aquatic 
Habitats) with a 14h light: 10h dark photoperiod and were fed 2-3 times daily with dry pellets 
(Zeigler). Egg traps were placed just before the start of the dark period and embryos were 
collected within 30 min of light and reared in embryo medium (Westerfield, 2007) with added 
methylene blue (3 ppm) in 10 cm petri dishes at 28.5oC with medium replaced at 12 and 36 hours 
post-fertilization (hpf). The zebrafish protocol was approved by the animal care committee at the 
University of Waterloo, and is in accordance with the Canadian Council for Animal Care 
guidelines.  
2.3.2 Embryo GR expression 
Wild-type zebrafish embryos were collected to determine GR gene and protein expression by 
whole-mount in-situ hybridization (ISH) and immunohistochemistry (IHC), respectively. 
Embryos were fixed in 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS) 
overnight at 4oC, dehydrated in 100% methanol (MeOH), and frozen at -20oC. Prior to analysis, 
embryos were thawed and rehydrated with a series of 5 min washes: 75% MeOH/25% PBS, 50% 
MeOH/50% PBS, 25% MeOH/75% PBS, and 100% PBS. ISH was performed according to 
standard protocols (Thisse and Thisse, 2008). Riboprobes were created with the DIG RNA 
labeling kit (Roche) as follows:  
GRLEFT 5’-GGAAGAACTGCCCTGCCTGTCG-3’  
GRRIGHT 5’ CACCCACCAAGTCGTGCATGG-3’  
The embryos were bright-field imaged using a Leica MZ16 microscope with a Leica DFC 
320 camera. ISH was used to identify GR mRNA abundance in wild-type embryos at the 
following time-points: 16-cell, 4, 6, 8, 10, 12, 24, and 48 hpf. Sense strand hybridizations at each 
time-point ensured probe specificity.  
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 The primary antibody used for both IHC and later western blotting was a custom-made 
affinity-purified polyclonal rabbit antibody generated against a peptide fragment 
(KIKDNGDLILSSPKC) of zebrafish GR protein (Genscript Corp.). The specificity of the 
antibody was confirmed by western blotting of serially diluted zebrafish and rainbow trout 
tissues. 
For whole mount IHC, rehydrated embryos were rinsed for 15 min (repeated 3x) in PBS 
with 1% Triton-X100 (PBST), then rinsed in blocking solution of PBST with 10% fetal bovine 
serum for 1 h (3x).  Primary antibody (polyclonal rabbit anti-zebrafish GR, 1:500 dilution) 
incubation was for16 h at 4oC. Embryos were then rinsed in blocking solution for 1 h  (3x). 
Secondary antibody incubation (Alexa-fluor 594 coupled goat anti-rabbit, Invitrogen; 1:2000 
dilution) was for 3 h in the dark. Embryos were rinsed for 15 min (3x) with blocking solution and 
15 min (3x) in PBST in the dark. All rinses and incubations were carried out with gentle rocking. 
Images were taken with a Zeiss Lumar V.12 stereomicroscope. IHC was used to identify 
distribution of GR protein in wild-type zebrafish embryos at 24, 36 and 48 hpf. 
2.3.3 GR promoter activation 
To confirm the temporal and regional onset of de novo GR mRNA synthesis, a GR promoter-GFP 
reporter construct was created. A ~3.5 kb segment upstream of the zebrafish GR start codon was 
identified as the putative promoter region and coupled to the enhanced green fluorescent protein 
(EGFP) coding sequence. The primers used to amplify the putative promoter region are shown in 
Table 1 (see GR Promoter), while the sequence and annotations of the amplified region are 
provided in the Appendix A. PCR was carried out with DNA extracted from adult zebrafish tail 
and each 25 µL reaction mixture contained 2.5 µL 5x Reaction Buffer, 0.5 µL of 10mM dNTPs, 
1.5 µL of 25mM MgCl2, 0.13 µL Taq Polymerase (all from MBI Fermentas), 17.87 µL of RNase 
free water (Qiagen), 1.25 µL of 10 µM primer pair, and 1.25 µL of DNA template. The PCR 
conditions were as follows: 2 min at 95oC; 35 cycles of 30s at 94oC, 4 min at 58oC, and 5 min at 
72oC; and a final 10 min at 72oC. The resulting PCR product was run on an agarose gel and 
purified with the Qiaquick Gel Extraction kit (Qiagen). The PCR product was ligated into pCRII-
Topo vector with the Topo-TA cloning kit (Invitrogen). Both the GR (in pCRII-Topo) and a 
pEGFP-1 vector (Clonetech) were digested with XhoI and BamHI restriction enzymes, then 
ligated overnight at 16oC using ligase enzyme (MBI Fermentas). The construct was sequenced 
(York University DNA Sequencing Facility) to ensure that the correct cassette was inserted. The 
construct was microinjected into the cell of 1-cell embryos using a nitrogen-powered 
microinjector (Narishige). The injection concentration was 100 µg/µL in sterile water, and 
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approximately 500 pL was injected into the cell. Control embryos were injected with a promoter-
less pEGFP-1 vector. The embryos were imaged at 12, 15, and 18 hpf with an AZ100 
microscope, Intensilight fluorescent module and DS-Ri1 camera (all from Nikon). 
2.3.4 GR knockdown 
Morpholino oligonucleotides (MO; Gene-Tools) were targeted to the start site of translation for 
the zebrafish GR gene, while a 5 bp mispair (MP) served as the control. The sequences of the MO 
and MP are:  
MO – 5’-CTCCAGTCCTCCTTGATCCATTTTG-3’;  
MP – 5’TGcTATgTTTAcTCTCgATACgTG-3’,  
small letters indicate mismatched basepairs.  
The MO was fluorescein-tagged to track dispersion in the embryo. The oligonucleotides 
were dissolved in sterile water to 1.0 mM with added phenol red. Titration studies (0.1, 0.25, 0.5 
and 1.0 M) were carried out to establish the MO concentration that did not result in early embryo 
mortality.  The MO and MP were injected into the yolk of 1-2 cell embryos and the concentration 
used in this study (0.5 M; 4.4 ng/nL) allowed the embryos to survive beyond 12 hpf. As a further 
control, a p53 morpholino was co-injected with the GR morpholino. The resulting double 
morphants displayed the same characteristics as those injected with the GR-MO alone, indicating 
that the observed GR knockdown effects were specifically caused by reduced GR protein 
translation, independent of any non-specific MO effects due to the loss of p53. The effectiveness 
of GR knockdown was established by whole-mount ISH, IHC, western blotting, and quantitative 
real-time PCR (qPCR). 
2.3.5 Western blotting 
Pools of 24 hpf MP and MO embryos were dissected to isolate the tails to prevent yolk protein 
contamination and sonicated for 10s on ice with a Model 60 Sonic Dismembrator (Fisher 
Scientific). Sample protein concentration was determined by the bicinchoninic acid method with 
bovine serum albumin (Sigma) standards. The resulting homogenate was diluted with Laemmli’s 
buffer and 30 µg of protein was loaded onto an 8% SDS-PAGE gel and electrophoresed and 
immunodetected exactly as described before (Boone and Vijayan, 2002). The proteins were 
transferred onto a nitrocellulose membrane and were probed with the rabbit anti-zebrafish GR 
primary antibody (1:750 dilution) and goat anti-rabbit HRP-conjugated secondary antibody 
(1:3000 dilution, Bio-Rad) for 1 h each at room temperature with gentle rocking.  Protein bands 
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were detected with ECL Plus western blotting detection reagent (GE Healthcare) and the intensity 
of the bands scanned with the Typhoon Variable Mode Imager (GE Healthcare) and quantified 
using AlphaEase software (Alpha Innotech). 
2.3.6 Gene expression 
RNA extraction was carried out on pools of embryos with the RNeasy Mini Kit (Qiagen) with 
DNase treatment (Qiagen) to remove genomic DNA contamination. RNA quantification was 
performed with a Nanodrop spectrophotometer at 260 nm (Thermo Scientific) and 1 µg of total 
RNA was reverse transcribed with the First Strand cDNA Synthesis Kit (MBI Fermentas) using 
M-MuLV reverse transcriptase to produce a 20 µL mixture according to the manufacturer’s 
protocol.  
RT-PCR was performed on 24 and 36 hpf MP and MO embryos to assess the transcript 
expression of the following genes: igf1, igf2, bmp2a, bmp2b, and bmp4, with β-actin as a control 
for equal loading. 1.25 µL of the cDNA mixture was used for RT-PCR analysis. The PCR 
conditions were: 94oC for 3 min, 40 cycles of 30s at 94oC, 30s at Tm (Table 1), and 30s at 72 oC; 
followed by 10 min at 72 oC. PCR mixtures were run on agarose gels with added SYBR Safe gel 
stain (Invitrogen) and imaged with an AlphaImager (Alpha Innotech).  
Primers used for real-time quantitative PCR (qPCR) analysis are listed in Table 1, in 
bold. The 25 µL qPCR mixture contained: 0.75 µL of template, 12.5 µL iQ SYBR green 
supermix (Bio-Rad), 0.75 µL of 10 µM primers, 11µL RNase free water (Qiagen). The sample 
mixtures were run in triplicate on an iCycler iQ thermocycler (Bio-Rad) using the following 
conditions: 94oC for 2 min, 40 cycles of 30s at 95oC, and 30s at Tm (see Table 1, bold), followed 
by 10 min at 72oC. To assess the effectiveness of the GR knockdown, the mRNA abundance of 
GR and matrix metalloproteinase-13 (mmp13), a known GR-responsive gene (Hillegass et al., 
2007), was quantified from pools of 24 hpf MP and MO embryos. Standard curves were created 
for GR and mmp13 by insertion of the amplicon into a PGEM-Teasy vector (Promega) using 
established protocols (Aluru et al., 2010). qPCR was also used to measure observed changes in 
the mRNA abundance of BMP genes (bmp2a, bmp2b, bmp4) and markers of BMP signaling 
(eve1, pax3, pax7). To determine changes in expression related to altered mesodermal formation, 
we quantified the mRNA abundance of the following myogenic markers: myod, myogenin 
(myog), myostatin (mstnb), slow muscle myosin heavy chain 1 (smyhc1), fast muscle specific 
myosin heavy chain (myhz2), slow muscle troponin C (stnnc), and fast muscle troponin I (tnni2a). 
qPCR primers for all myogenic marker genes other than myod were previously characterized 
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(Palstra et al., 2010).  The mRNA abundance of these genes was quantified from pools of 24 and 
36 hpf MP and MO embryos using the delta-delta Ct method of quantification (Livak and 
Schmittgen, 2001) using β-actin as the housekeeping gene (values were similar across samples). 
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2.3.7 Embryo survival and morphology 
Embryos were counted, imaged and sampled at 12, 24, 36 and 48 hpf and dead or unfertilized 
embryos were removed. Bright-field embryo images were captured and processed after 
dechorionation with a Nikon AZ-100 microscope and DS-Ri1 camera. By annotation with NIS-
elements software (Nikon), the number of formed somites was counted at 12 and 15 hpf, and the 
embryo length (as measured around the dorsal edge from head to tail) and the head-trunk angle 
(as measured between the eye-ear axis and the notochord) were measured at 24 hpf. 
2.3.8 Zebrafish GR mRNA synthesis and rescue 
To synthesize the GR coding sequence mRNA, a ~2.2 kb region was amplified using the 
following primers:  
F 5’-ATG GAT CAA GGA GGA CTG GA-3’   
R 5’- TCA TTT CTG GTG AAA GAG CAG C-3’ 
PCR and cloning of the amplicon was performed as noted above for the GR-GFP 
construct. The resulting vector was transformed into competent DH5α E. coli cells by heat shock 
(15s, 42oC), which were grown on lysogeny broth (LB) media plates with 10 mM ampicillin for 
14h at 37oC. Transformed colonies were grown in LB media for 14h at 37oC. Plasmids were 
eluted in sterile water with the GenElute Plasmid Miniprep Kit (Sigma), following manufacturer 
protocols. Plasmids were quantified on a Nanodrop spectrophotometer (Thermo Scientific). To 
ensure proper insertion, the plasmid was sequenced (York University DNA Sequencing Facility). 
Before in vitro transcription, the plasmid was linearized with EcoRV restriction enzyme (1 hour, 
37 oC). The mMessage mMachine T7 kit (Ambion) was used to create capped mRNA according 
to the manufacturer’s protocol and diluted to 1 µg/µL in sterile water.  
 GR mRNA was diluted to 50 pg/nL and 200 pg/nL for initial titration and assessment of 
rescue. As 200 pg/nL was found to rescue a higher percentage of embryos, with no adverse 
effects on embryos when injected alone, this concentration was used for further rescue injections. 
One-cell embryos were injected with 1 nL of GR MO, GR MP, GR mRNA alone, or GR mRNA 
and MO co-injections. Embryos were grown as noted previously, and survival, somite 
development, and growth were measured exactly as before. Gene expression of rescue embryos 
was analyzed at 36 hpf by qPCR exactly as described for MO knockdown embryos, quantifying 
the mRNA abundance of bmp2a, bmp2b, bmp4, myog, and smyhc1.  
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The following abbreviations are used in the text: MP - embryos injected with mispair 
only; MO - GR morphants, only injected with morpholino; RNA - embryos injected with GR 
mRNA only; and MO+RNA - the morpholino and mRNA coinjection rescue embryos. MP and 
MO groups presented as part of the GR mRNA rescue data are independent from those presented 
as part of the examination of GR receptor knockdown effects, as they represent separate injection 
trials. 
2.3.9 Promoter analysis 
A bioinformatics approach was used to analyze the regions upstream of the transcriptional start 
sites of myod, igf1, igf2, bmp2a, bmp2b, and bmp4. For each gene, a 7.5 kb regions was identified 
using NCBI’s Entrez Gene and Sequence Viewer (myod: NC_007136.5; igf1: NC_007115.5; igf2: 
NC_007118.5; bmp2a: NW_003040445.1; bmp2b: NW_001878149.2; bmp4: NW_001877808.2). 
These sequences were analyzed using the Matinspector software suite (Genomatix), and the 
Transcription Element Search System (TESS) to identify putative glucocorticoid response 
elements (GREs). Only regions that were identified by both software packages were accepted as 
likely sites. 
2.3.10 Statistical analysis 
All data are presented as mean ± standard error of the mean (SEM). Data comparison for two 
samples (MO and MP) utilized Student’s t-test, while multiple treatments were compared using 
either one-way analysis of variance (ANOVA) or two-way ANOVA (Sigmastat, Systat Software). 
A probability value of p<0.05 was considered significant. 
2.4 Results 
2.4.1 Temporal GR expression in zebrafish embryos 
GR mRNA was observed in embryos at the 16-cell stage (Fig. 1A I) and at 4 hpf (Fig 1A II), but 
at 6 and 8 hpf, no GR mRNA were detectable in the developing embryo (Figs. 1A III and IV). GR 
mRNA transcripts were detected again at 10 hpf in the anterior end (Fig. 1A V), and were widely 
expressed by 12 hpf (Fig. 1A VI). GR mRNA was seen throughout the developing embryo with 
strong detection in the somites at 24 hpf (Fig 1A VII). By 48 hpf, the GR mRNA expression is 
reduced in the tail and is predominantly localized in the developing head and trunk (Fig 1A VIII, 
see arrow). Sense strand hybridizations at 24 and 48 hpf (Figs. 1A IX and X) confirm the 
specificity of the GR riboprobes. Similar to GR transcripts, GR protein expression was also 
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widely expressed throughout the embryo at 24 and 36 hpf (Fig. 1B I and II), but reduced at 48 hpf 
and was detectable only in discrete regions in the head, trunk, and tail (Fig. 1B, III, see arrows). 
We used a GR-GFP reporter construct (see Appendix A for sequence and diagrams, Fig. 
A1) to confirm the zygotic expression of GR. Using this construct the earliest de novo GR 
promoter activation was observed at 15 hpf in the ventral midtrunk region. By 18 hpf, GFP was 
also visible at somite boundaries. Negative control embryos showed no GFP fluorescence. 
Representative images are included in supplemental data (See Appendix A, Fig. A2). 
  
 


















Figure 1 – Glucocorticoid receptor (GR) gene and protein expression in wild-type embryos.  
GR mRNA and protein exhibit dynamic spatial expression during early embryogenesis. (A) 
Spatial GR mRNA abundance in wild-type (WT) embryos at 16-cell (I), 4 hpf (II), 6 hpf (III), 8 
hpf (IV), 10 hpf (V), 12 hpf (VI), 24 hpf (VII), and 48 hpf (VIII) stages (n=10-15 embryos at each 
stage). Sense strand hybridizations at 24 hpf (IX) and 48 hpf (X) display probe specificity. (B) 
Spatial GR protein expression in WT embryos (n=10-12 embryos) at 24 hpf (I), 36 hpf (II), and 
48 hpf (III). Fluorescent images (left) show GR protein distribution detected by specific antibody 
(polyclonal rabbit anti-zebrafish GR) binding, bright-field images (middle) display whole embryo 
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2.4.2 GR knockdown 
The post-injection dispersion of morpholinos (MO) was observed by microscopic observation of 
fluorescein tagged-GR MO embryos. Fluorescein was ubiquitously spread throughout the cells 
from the two-cell stage, and continued to be observable until 40 hpf (data not shown). The 
knockdown of GR protein was confirmed by whole-mount immunohistochemistry (IHC; Fig. 2A) 
and western blotting (Fig. 2B). There was a >50% reduction in GR protein content in the MO 
embryo at 24 hpf by western blotting (Fig. 2B) and this was also confirmed by a decrease in GR 
protein expression observed by IHC at 24 and 36 hpf (Figs. 2A I and II). Essentially no GR 
protein expression was seen in the tail after morpholino injection (Fig. 2A, see dashed inset). GR 
mRNA abundance was not affected by MO injection as seen by in situ hybridization (ISH; Fig. 
2C) and qPCR (Fig. 2D). MMP-13 expression was suppressed by >70% in the MO embryos 















Figure 2 – Glucocorticoid receptor protein knockdown by morpholino injection.  
Injection of morpholino oligonucleotides (MO) causes a significant decrease in GR protein 
expression in developing embryos, but does not affect GR mRNA content. 
(A) Whole-mount immunohistochemistry shows widespread loss of GR protein in morpholino-
injected (MO, right) embryos compared to mispair-injected embryos (MP, left) at both 24 hpf (I) 
and 36 hpf (II). Reduced GR protein expression in the developing somites at 24 hpf is shown in 
the expanded dashed inset. (B) A representative western image of GR protein expression in the 
tail of MP and MO embryo is shown and the band intensity (% MP) is displayed as a histogram 
(n=4 pools of 30 embryo tails). (C) GR mRNA expression was unchanged in 24 hpf wild-type 
(WT, left) and MO embryos (right) (n=10 embryos each). (D) GR mRNA abundance (n=5 pools 
of 16 embryos) of 24 hpf MO and MP embryos expressed as percentage of MP. (E) Matrix 
metalloproteinase-13 (MMP-13; a known GR-responsive gene) mRNA abundance in 24 hpf 
embryos expressed as percentage of MP (n=4 pools of 16 embryos). All values shown are mean ± 
standard error of mean (SEM); * significantly different (Student’s t-test, p<0.05). 
  
 




































  54 
2.4.3 GR signaling is important for embryo growth and survival 
There was embryo mortality associated with microinjection compared to uninjected wild-type 
(WT) embryos (Fig. 3A, 3B). However, there were no differences in embryo survival or 
morphology between the WT and mispair (MP) embryos at any time point (Figs. 3A and 3B). 
Hence, all data comparisons included only MP control and MO embryos. There was no 
significant difference in embryo survival between the MO and MP group at 12 hpf (Fig. 3A I).  
GR knockdown reduced embryo survival compared to the MP control by ~30% at 24 hpf (Fig. 3A 
II) and by >90% at 48 hpf (Fig. 3A III). Growth and early developmental rate was also affected 
by GR knockdown. A significant decrease in embryo length (Fig. 4C) and head-trunk angle (Fig. 
4D) was seen in the MO compared to MP embryos. There was a significant decrease in the rate of 
somite formation in the MO embryos at 12 and 15 hpf compared to the MP group (Figs. 3C I and 
3D I). In addition to slower rates of somite formation, morphant embryos often exhibited more 
prominent tail formation defects (Fig. 4A and 4B). At 24 hpf (Fig. 4A), GR knockdown embryos 
often exhibited kinked tails compared to the normal smooth and straight extension displayed by 
MP embryos. At 36 hpf (Fig. 4B), in addition to tail malformations (see arrows), MO embryos 
were seen to exhibit misshapen and unusually sized somites (see dashed inset). Low-
magnification images of embryos are included to show the common nature of these defects in 
only the GR morphants (Fig. 4B). 
 The injection of 200 pg of GR mRNA along with the MO was able to rescue most of the 
morphant phenotypes. There was no significant difference in survival between the controls and 
rescued embryos at either 24 or 48 hpf (Fig. 3B II and III). The rate of somite formation was also 
rescued by mRNA injection. At both 12 and 15 hpf (Fig. 3C II and 3D II), the number of somites 
was significantly higher in the rescue embryos relative to the MO embryos. Later in development, 
the rescue embryos displayed far fewer morphological defects (Fig. 4A and 4B). The rescued 
embryos were similar to MP embryos with fewer tail disruptions, including kinked tails and 
somite patterning and shape at 24 and 36 hpf (Fig. 4A and 4B). The relative rarity of defects in all 
groups other than the GR knockdown embryos can be seen from the low magnification images of 
multiple embryos (Fig. 4A, II, see arrows). The coinjection of GR mRNA also rescued the 
significant reduction in embryo length (Fig. 4C) and head-trunk angle (Fig. 4D) that was evident 
in the 24 hpf MO embryos. 
  
 









Figure 3 – Effect of glucocorticoid receptor knockdown on embryo survival and 
development. 
GR morphants display increased mortality and slowed somitogenesis, but these effects are 
reversed with GR mRNA rescue. (A) Embryo survival at 12 hpf, (I), 24 hpf (II), and 48 hpf (III), 
comparing mispair-injected (MP, n=9 pools of 86-351 embryos) and morpholino-injected 
embryos (MO, n=14 pools of 84-218 embryos). Data is presented as percentage of wild-type 
(WT) survival (n=19 pools of 33-356 embryos). (B) Embryo survival was similarly measured 
after mRNA rescue, comparing MP (n=6 pools of 56-113 embryos), MO (n=8 pools of 42-136 
embryos), RNA-injected (RNA, n=6 pools of 89-149 embryos), and RNA and MO co-injected 
embryos (RNA+MO, n=10 pools of 56-149 embryos). Data is presented as a percentage of WT 
survival (n=5 pools of 33-224 embryos). (C) Number of formed somites in 12 hpf MP and MO 
embryos (I, n=11-15 embryos) and 12 hpf MO, MP, RNA, and RNA+MO embryos (II, n=8-22 
embryos). (D) Number of formed somites in 15 hpf MP and MO embryos (I, n=11-15 embryos) 
and 15 hpf MO, MP, RNA, and RNA+MO embryos (II, n=8-22 embryos). Representative images 
are shown (arrows indicate region of formed somites). Values shown are mean ± SEM; * 
significantly different (Student’s t-test, p<0.05); bars with different letters are statistically 
different (ANOVA, p<0.05). 
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Figure 4 – Effects of glucocorticoid receptor knockdown on morphogenesis. 
GR morphants display disrupted tail structures and reduced growth; these characteristics are 
corrected by GR mRNA coinjection. 
Representative images of tail morphological abnormalities in 24 hpf (A) and 36 hpf (B) 
morpholino-injected embryos (MO) compared to mispair-injected embryos (MP), mRNA-injected 
embryos (RNA), and mRNA and MO co-injected embryos (RNA+MO); arrows indicate 
malformed tails.  Malformed somites are shown in the magnified dashed inset (B, center). Low-
magnification images (B, bottom half) are shown to indicate the common nature of defects in the 
GR morphants. (C) Length of 24 hpf MP and MO embryos, as measured along the outer edge of 
the embryo (representative image, white line; n=6-12 embryos). (D) Head-trunk angle of 24 hpf 
MO, MP, RNA, and RNA+MO, embryos, as measured between the eye-ear axis and the 
notochord (representative image, white line; n=6-12 embryos). Values shown are mean ± SEM; 
bars with different letters are statistically different (ANOVA, p<0.05). 
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2.4.4 GR signaling is essential for mesoderm patterning 
Due to defects in the mesodermally-derived tissues, we examined the expression of a suite of 
genes that are well established mesoderm and growth markers. RT-PCR showed no discernible 
differences in igf1 or igf2 mRNA abundances in the MO group compared to MP control groups at 
either 24 or 36 hpf (Fig. 5A). However, bmp2a, bmp2b, and bmp4 expression was strongly 
reduced in the MO at both 24 and 36 hpf (Fig. 5A), and this was further confirmed using qPCR. 
bmp2a (Fig. 5B I), bmp2b (Fig. 5B II), and bmp4 (Fig. 5B III) mRNA abundances were all 
significantly reduced by ~70-90% in GR morphants compared to the MP control at both 24 hpf 
and 36 hpf. A time-dependent change in gene expression between 24 and 36 hpf was seen only 
for bmp2b, but not for bmp2a and bmp4 (Figs. 5B I-III). For bmp2b, mRNA abundance of MP, 
but not MO embryos were significantly reduced at 36 hpf compared to 24 hpf (Fig. 5B II). In 
addition, we show that the expression of eve1 is downregulated in GR morphants at both 24 and 
36 hpf (Fig. 6A). 
To determine if reduced GR signaling is involved in the disrupted mesoderm phenotype, 
we examined key marker genes involved in myogenesis in the morphant embryos at 24 and 36 
hpf. pax3 mRNA abundance (Fig. 6B) was reduced by 90% in GR morphants at 24 hpf only, with 
no significant change observed at 36 hpf. pax7 mRNA abundance was unchanged in GR 
morphants (Fig. 6C).  Myod mRNA abundance was unchanged at both 24 and 36 hpf (Fig. 7A). 
However, the mRNA abundance of myogenin (myog; Fig. 7B) and myostatin (mstnb; Fig. 7C) 
were both significantly different in GR morphants at 36 hpf. Myogenin expression was increased 
by a factor of 2, while myostatin was decreased by a factor of 3. Expression of slow muscle 
myosin heavy chain 1 (smyhc1; Fig. 8A) was increased by ~60% at 24 hpf and by ~30% at 36 hpf 
in GR morphants, but there was no change in mRNA abundance of fast muscle myosin (myhz2; 
Fig. 8B) at either time points. Also, both slow muscle troponin C (stnnc; Fig. 8C) and fast muscle 
troponin I 2a (tnni2a; Fig. 8D) were significantly increased by ~150% at 24 hpf, but remained 
unchanged in GR morphants at 36 hpf.  
GR mRNA rescue completely abrogated the suppression of BMP gene expressions (Fig. 
5C) and two selected myogenic genes (Fig. 9) seen in the MO group. For all three BMP genes, 
the rescued embryos had significantly higher mRNA abundance relative to MO embryos, and 
were not statistically different from the MP (exception was bmp2a) or mRNA control groups (5C 
I-III). The rescued embryos also showed significantly lower mRNA abundance of myog (Fig. 9A) 
and smyhc1 (Fig. 9B) compared to MO embryos, but were not statistically different from the MP 
or mRNA control groups. In addition, bioinformatics analysis of the region upstream of bmp2a, 
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bmp2b and bmp4 coding sequences indicate that there are multiple putative GREs within a 7.5 kb 
region upstream of each gene (Fig. 5D I-III). Bioinformatics analysis also indicated two putative 
GRE sites upstream of each of igf1, igf2, and myod (base pair regions are shown in Appendix A, 













Figure 5 – Effects of glucocorticoid receptor knockdown on expression of developmental 
genes.  
GR knockdown reduced expression of BMPs but not other developmental genes. BMP expression 
in the morphants is rescued by GR mRNA injection. (A) RT-PCR images of igf1, igf2, β-actin, 
bmp2a, bmp2b, and bmp4 mRNA expression in 24 and 36 hpf mispair (MP) and morpholino 
(MO) injected embryos (n=4 pools of 25 embryos). (B) mRNA abundance of bmp2a (I), bmp2b 
(II), and bmp4 (III) measured by qPCR in 24 hpf and 36 hpf MP and MO embryos (GR gene 
knockdown; n=4 pools of 25 embryos) or (C) MP, MO, RNA injected (RNA), and RNA and MO 
co-injected (RNA+MO) embryos (GR mRNA rescue; n=4 pools of 25 embryos). Values shown 
are mean ± SEM; bars with different letters are statistically different (ANOVA, p<0.05). (D) 
Schematics of putative glucocorticoid response elements (GREs; number starting base pair) 
upstream of BMP2A (I), BMP2B (II) and BMP4 (III). 
 








































































































































































































































































































































































































































Figure 6 – Effects of glucocorticoid receptor knockdown on expression of BMP signaling 
markers 
GR morphants exhibited reduced expression of specific BMP responsive genes, indicating a 
functional reduction of BMP signaling. mRNA abundance of eve1 (A), pax3 (B), and pax7 (C) in 
24 hpf and 36 hpf mispair (MP) and morpholino (MO) embryos as quantified by qPCR. Values 
shown are mean ± SEM; bars with different letters are statistically different (n=4 pools of 25 
embryos, ANOVA, p<0.05). 
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Figure 7 – Effects of glucocorticoid receptor knockdown on expression of myogenic 
transcription factors 
GR receptor protein knockdown resulted in altered expression of key transcription factors 
involved in myogenesis at 36 hpf. mRNA abundance of myod (A), myogenin (myog; B), and 
myostatin (mstnb; C) in 24 hpf and 36 hpf mispair (MP) and morpholino (MO) embryos as 
measured by qPCR. Values shown are mean ± SEM; bars with different letters are statistically 
different (n=4 pools of 25 embryos, ANOVA, p<0.05). 
  
 






























Figure 8 – Effects of glucocorticoid receptor knockdown on mRNA abundance of muscle 
specific proteins 
GR morphants exhibited increased mRNA abundance of several muscle-specific proteins. mRNA 
abundance of slow muscle myosin heavy chain 1 (smyhc1; A), fast muscle myosin heavy chain 
(myhz2; B), slow muscle troponin C (stnnc; C), and fast muscle troponin I 2a (tnni2a; D) in 24 
hpf and 36 hpf mispair (MP) and morpholino (MO) embryos as measured by qPCR. Values 
shown are mean ± SEM; bars with different letters are statistically different (n=4 pools of 25 
embryos, ANOVA, p<0.05). 
  
 


























Figure 9 – GR receptor knockdown and mRNA rescue of disrupted expression of myogenic 
genes. 
Injection of GR mRNA restores the mRNA abundance of key myogenic genes. mRNA 
abundance of myogenin (myog; A) and slow muscle myosin heavy chain (smyhc1; B) in mispair 
(MP), morpholino (MO), RNA-injected (RNA), and RNA and MO co-injected (RNA+MO) 36 
hpf embryos. Values shown are mean ± SEM; bars with different letters are statistically different 
(n=4 pools of 25 embryos, ANOVA, p<0.05). 
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2.5 Discussion 
A novel finding from this study is that GR signaling is playing a key role in mesoderm formation 
and muscle development in zebrafish. We showed recently that GR gene expression decreases 
during early embryogenesis in zebrafish (Alsop and Vijayan, 2008; 2009) leading to the proposal 
that this receptor signaling may be playing a key role in early development. Our results from this 
study clearly reveal a ubiquitous distribution of maternally derived GR mRNA during the early 
cleavage stages and is in agreement with a recent study in zebrafish (Pikulkaew et al., 2011). 
Following the degradation of maternally deposited transcripts, zygotic expression of GR was seen 
throughout the embryo and GR promoter activation was specifically observed at the somite 
boundaries, suggesting a role for GR signaling in somite formation. This is further supported by 
the strong GR gene and protein expression in the somites and developing mesoderm suggesting a 
morphogenic role for this receptor activation during early development. As cortisol is the primary 
ligand for GR activation in fish, and this steroid biosynthesis commences only after hatch (Alsop 
and Vijayan, 2008), we hypothesize that maternal cortisol orchestrates proper mesodermal 
development and myogenesis in zebrafish.    
A role for GR in the developmental regulation of myogenesis was reinforced by our GR 
knockdown studies that displayed disruptions in somitogenesis and tail deformations. The 
suppression of GR signaling in the morphant zebrafish was confirmed by the reduced protein 
expression of this steroid receptor as well as downregulation of mmp13, a well established GR-
responsive target gene (Hillegass et al., 2007). Our finding is in agreement with a recent study 
that also showed GR morphants exhibiting abnormal muscle phenotypes in zebrafish (Pikulkaew 
et al., 2011), suggesting a key role for GR in mesoderm development. The transiently higher 
expression of GR protein in the tail muscle prior to hatch suggests a key role for GR signaling in 
early muscle development in zebrafish. Indeed, the 12-36 hpf window prior to hatching, where 
GR transcripts and protein accumulate throughout the tail, is a critical period in muscle 
development with muscle cell pioneers being determined from 12 to 24 hpf, and further 
specification and specialization occurring after 24 hpf (Stickney et al., 2000; Ochi and 
Westerfield, 2007).  
Further support for GR signaling as a key player in the developmental regulation of 
myogenesis is supported by the changes seen in the expression of important myogenic regulatory 
factors and muscle-specific genes in GR morphants (Xu et al., 2000; Du et al., 2003; Ochi and 
Westerfield, 2007). The temporal expression pattern of genes, including myogenin, myostatin, 
slow myosin heavy chain, fast muscle myosin and slow and fast muscle troponins, suggest time-
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specific modulation of molecular events involved in myotomal development by GR signaling. We 
observed that GR mRNA rescue reversed the changes in expression of myogenin and slow 
muscle myosin, indicating that these effects are GR-specific, while the mechanisms and 
downstream regulatory pathways involved remains to be elucidated. Several transcription factors 
and signaling molecules have been implicated in the developmental regulation of myogenesis 
(Ochi and Westerfield, 2007), and our results for the first time implicate GR in this process. To 
this end, IGFs and MyoD are developmentally regulated in zebrafish embryos and critical for cell 
cycle control and embryo growth (Ochi and Westerfield, 2007; Duan et al., 2010). The absence of 
any changes in myod, igf1, and igf2 expression in GR morphants, despite the presence of two 
putative GREs upstream of their promoter regions, points to additional control factors involved in 
the regulation of embryo growth in response to GR signaling.  
A key family of morphogens implicated in a variety of developmental processes, 
including dorsoventral patterning, somitogenesis, mesodermal differentiation, and myogenesis are 
the BMPs (Reshef et al., 1998; Bubnoff and Cho, 2001; Miyazono et al., 2005; Pyati et al., 2005; 
Patterson et al., 2010). The suppression of bmp2a, bmp2b, and bmp4 prior to hatching in the GR 
morphant in the present study for the first time underscores a role for GR signaling in the 
developmental regulation of morphogens in zebrafish. The rescue of morphant phenotype, 
including the restoration of BMP mRNA abundance, by GR mRNA provides further confirmation 
that GR signaling modulates developmental expression of BMPs in zebrafish. Furthermore, 
bioinformatics analysis suggests the presence of putative GRE sites upstream of the BMP genes 
pointing to a possible direct transcriptional regulation of these morphogens by ligand-activated 
GR. To our knowledge this is the first study to establish a link between GR signaling and 
developmental regulation of BMPs in vertebrates, while the mechanism involved remains to be 
established.  
 A direct functional role for BMPs in the observed tail deformation and myogenesis in 
response to GR knockdown was not ascertained in the present study. However, GR morphant 
phenotype showed morphogenic defects similar to those seen in studies that modulated BMP 
signaling, including altered somitogenesis (Patterson et al., 2010) and disrupted tail formation 
(Kishimoto et al., 1997; Pyati et al., 2005; Stickney et al., 2007; Tucker et al., 2008). The 
mechanisms involved in the developmental regulation of myogenesis by BMPs are not very clear.  
For instance, overexpression of BMP increased expression of muscle precursor markers, 
including pax3 and pax7, and led to a temporal delay in muscle differentiation in zebrafish 
(Patterson et al., 2010).  However, inhibition of BMP signaling did not seem to reverse the effects 
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seen with overexpression suggesting complex interaction with other myogenic factors in 
regulating myogenesis (Patterson et al., 2010). The suppression of eve1, a BMP-responsive gene 
involved in mesoderm formation in zebrafish (Seebald and Szeto, 2011), in the GR morphants 
argues for a role for BMP signaling in orchestrating the mesoderm differentiation associated with 
GR activation. This was also supported by the reduced expression of pax3, but not pax7, observed 
in 24 hpf GR morphants. While the functional significance of these observed gene expressions 
patterns are not known, we hypothesize that BMPs may be a factor involved in GR-mediated 
effects on early muscle development and growth. This is increasingly likely given the role played 
by these morphogens in mesoderm differentiation, including angiogenesis (Tucker et al., 2008; 
David et al., 2009), myogenesis (Patterson et al., 2010), and organogenesis (Chin et al., 1997; 
Brand, 2003; Shin et al., 2007; Chung et al., 2008). Consequently, the downregulation of BMPs 
in the GR morphants may be a key factor leading to embryo mortality seen in GR morphants by 
48 hpf.  This may include severe disruption of heart function, especially because BMPs have been 
identified as factors in cardiac cell specification and heart looping (Brand, 2003). This would also 
account for the increased mortality seen at hatch because prior to that simple diffusion will meet 
the oxygen demand of the embryos, whereas a functioning heart is critical at hatch (Pelster and 
Burggren, 1996). We hypothesize that GR is an important developmental regulator, acting 
upstream of other key developmental factors, including BMPs in zebrafish.  
Overall, we have identified GR signaling as a key modulator of mesoderm differentiation 
and muscle development in zebrafish. The suppression of BMPs and downstream targets involved 
in myogenesis in the GR morphants leads us to hypothesize that this morphogen is a key player in 
orchestrating the GR-mediated developmental effects in zebrafish. However, the GR effect on 
myogenesis may not be limited to just BMP signaling, as several molecular mechanisms are 
involved in mesoderm formation and muscle development (Ochi and Westerfield, 2007; Chong et 
al., 2009; Patterson et al., 2010). As cortisol is the primary ligand for GR activation in teleosts 
(Mommsen et al., 1999), and de novo synthesis of this steroid commences only after hatch (Alsop 
and Vijayan, 2008), we hypothesize that maternal cortisol via GR signaling orchestrates the 
developmental programming of mesoderm differentiation and muscle development. We posit that 
GR is a key transcription factor acting upstream of multiple important pathways essential for 
embryogenesis, including BMPs and muscle regulatory transcription factors and muscle-specific 
proteins. Consequently, any abnormalities in GR signaling, including abnormal cortisol 
deposition or exposure during this critical developmental window prior to de novo cortisol 
biosynthesis may lead to long-term growth defects, including reduced survival.  
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Chapter 3 
Embryo exposure to elevated cortisol level leads to cardiac 
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3.1 Overview 
In zebrafish (Danio rerio), de novo cortisol synthesis commences only after hatching, providing 
an interesting model to study the effects of maternal stress and abnormal cortisol deposition on 
embryo development and performance. We hypothesized that elevated cortisol levels during pre-
hatch embryogenesis compromise cardiac performance in developing zebrafish. Cortisol was 
microinjected into one-cell embryos to elevate basal cortisol levels during embryogenesis. 
Elevated embryo cortisol content increased heart deformities, including pericardial edema and 
malformed chambers, and lowered resting heartbeat post-hatch. This phenotype coincided with 
suppression of key cardiac genes, including nkx2.5, cardiac myosin light chain 1, cardiac troponin 
type T2A, and calcium transporting ATPase, underpinning a mechanistic link to heart 
malformation. The attenuation of the heartbeat response to a secondary stressor post-hatch also 
confirms a functional reduction in cardiac performance.  Altogether, high cortisol content during 
embryogenesis, mimicking increased deposition due to maternal stress, decreases cardiac 
performance and may reduce zebrafish offspring survival.  
3.2 Introduction 
Cortisol is the primary circulating corticosteroid in teleosts and it is produced by the 
steroidogenic cells distributed predominantly around the post-cardinal veins (interrenal tissue) in 
the head kidney region (Wendelaar Bonga, 1997). A key stimulus for this steroid release is the 
activation of the hypothalamus-pituitary axis, culminating in the release of adrenocorticotrophic 
hormone (ACTH) from the pituitary. ACTH binding to its target receptor, the melanocortin 2 
receptor (MC2R), activates corticosteroid biosynthesis, leading to elevated circulating levels of 
this steroid in response to stress (Aluru and Vijayan, 2008; Hontela and Vijayan, 2009). Cortisol 
has wide-ranging effects on animal physiology and a major role that is evolutionarily conserved is 
the metabolic adjustments to restore homeostasis in the face of stressor insult (Wendelaar Bonga, 
1997; Mommsen et al., 1999). Glucocorticoid effects are mediated via glucocorticoid receptor 
(GR) and/or mineralocorticoid receptor (MR) activation (Sapolsky et al., 2000), and teleosts 
express multiple paralogs of these receptors (Bury et al., 2003; Prunet et al., 2006). While the role 
of MR in cortisol signaling is not very clear in fish, GR signaling is involved in all aspects of 
animal physiology, including ion regulation, metabolism, immune function and reproduction 
(Mommsen et al., 1999; Aluru and Vijayan, 2009). The majority of these studies have been 
carried out in juvenile fish and cell system models, resulting in a paucity of information on the 
developmental regulation of cortisol in fish. Recent studies using GR gene knockdown with 
morpholino oligonucleotides points to a key role for signaling by this receptor in zebrafish (Danio 
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rerio) early developmental events, including mesoderm formation (Pikulkaew et al., 2011; Nesan 
et al., 2012 [Chapter 2]). 
In zebrafish, cortisol content during early embryogenesis is of maternal origin as de novo 
synthesis of this steroid commences only after hatch (Alsop and Vijayan, 2008). Also, the ability 
to increase cortisol levels in response to stress is not active until 3-4 days post fertilization (dpf), 
as the embryo approaches first feeding (Alsop and Vijayan, 2008; Alderman and Bernier, 2009). 
Consequently, there is a temporal decrease in maternally deposited cortisol content in the 
embryos up until hatch in zebrafish (Alsop and Vijayan, 2008). This is also true for other fish 
species studied, including rainbow trout (Oncorhynchus mykiss; [Barry et al., 1995; Auperin and 
Geslin, 2008]) and common carp (Cyprinus carpio; [Stouthart et al., 1998]), leading to the 
hypothesis that a corticosteroid hyporesponsive period is essential for early development in fish. 
Indeed, studies have shown that elevated prenatal glucocorticoid exposure disrupts growth and 
development in animal models (Breuner et al., 2008; Seckl and Meaney, 2004; Kapoor, 2006),  
including fish (Eriksen et al., 2006), but a clear mechanistic link is missing.  
During zebrafish development, the 24 to 48 hours post fertilization (hpf) window is a key 
period for organogenesis, including heart formation and angiogenesis (Thisse and Zon, 2002; 
Kimmel et al., 1995). It is also during this time that embryo cortisol content is at its lowest (Alsop 
& Vijayan, 2008). During this period of cardiac myogenesis there is a marked regulation of 
structural and functional cardiac muscle proteins, including myosin chains, troponins, and ion 
transporters (Yelon, 2001; Chen et al., 2008; Hsiao et al., 2003; Ebert et al., 2005). Also, the key 
cardiac transcription factor, nkx2.5, is expressed during this period and it is essential for heart 
development (Chen and Fishman, 1996) and cardiovascular performance at hatch (Yelon, 2001). 
Our recent investigation on the role of GR signaling in early embryogenesis indicated a link 
between GR activation and modulation of bone morphogenetic proteins  (BMPs) expression in 
zebrafish (Nesan et al., 2012 [Chapter 2]). BMPs are key morphogens regulating the expression 
of genes involved in organogenesis, including heart development (Chin et al., 1997; Chen et al., 
1997), providing a potential link between GR-mediated cortisol signaling and cardiac 
morphogenesis. There have been studies linking cortisol to abnormal heart development and 
cardiac gene expression in fetal sheep (Lumbers et al., 2005; Reini et al., 2008) and to cardiac 
hypertrophy in adult salmon (Johansen et al., 2011). However, few studies have examined the 
role of cortisol in the developmental regulation of cardiac function in fish.  
Against this background, we tested the hypothesis that elevated cortisol levels in the 
embryos, mimicking increased transfer of this steroid from mothers in stressed environments, 
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may disrupt cardiac development and performance after hatching in zebrafish. The optically 
transparent zebrafish embryo provides the opportunity to observe cardiac development directly, 
and zebrafish express only a single GR gene with two splice variants, an unusual characteristic 
for teleosts, but interestingly similar to humans (Alsop and Vijayan, 2008; Schaaf et al., 2008). 
Additionally, zebrafish embryos can survive without a functional heart until 4-5 dpf (Pelster and 
Burggren, 1996), allowing for investigation on heart development and malformations without 
compromising embryo viability. Taken together, zebrafish is a well-established model for 
developmental, endocrine, and cardiac research  (Chico et al., 2008; Lohr and Hammerschmidt, 
2011), providing a uniquely suited test organism for biomedical research on maternal stress 
effects on development.  
We microinjected cortisol into one-cell zebrafish embryos resulting in elevated levels of 
this steroid compared to the wild-type embryo during pre-hatch embryogenesis. We monitored 
embryo cortisol content, glucocorticoid receptor gene and protein expressions, and confirmed 
enhanced GR signaling from cortisol treatment by measuring transcript abundance of a known 
glucocorticoid-responsive gene (matrix metalloproteinase-13 [mmp13]; Hillegass et al., 2007). 
Cardiac morphogenesis was examined by microscopic observation, as well as by analyzing the 
transcript abundance of genes encoding key proteins in cardiac development, including nkx2.5, 
cardiac myosin light chain 1 (cmlc1), cardiac troponin type T2A (tnnt2a), and calcium 
transporting ATPase (atp2a2a). Cardiac performance was assessed by measuring heartbeat at rest 
and after an acute stressor challenge at 72 hpf.   
3.3 Materials and Methods 
3.3.1 Zebrafish care 
Care and breeding of adult zebrafish and rearing of embryos were performed exactly as described 
previously (Nesan et al., 2012 [Chapter 2]). Wild-type adult zebrafish were purchased from a 
commercial source (Big Al’s Aquarium Services, Kitchener, ON). The zebrafish care protocol 
was approved by the animal care committee at the University of Waterloo, and is in accordance 
with the Canadian Council for Animal Care guidelines. 
3.3.2 Cortisol injection 
Cortisol (Hydrocortisone; Sigma, St. Louis, MO) stocks were prepared by first diluting in ethanol, 
then evaporating off the ethanol and reconstituting in sterile water. The final concentrations of the 
steroid used for embryo injection were 0, 8, 16, and 32 pg/nL. The vehicle for control injections 
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was prepared exactly the same but without cortisol. Initial trials were performed with each 
concentration and pools of 25 embryos were frozen at 12, 24, 36, and 48 hpf for measurement of 
cortisol content. Our preliminary experiment showed that only 32 pg/nL concentration cortisol 
was able to consistently maintain elevated cortisol content above basal levels compared to control 
embryos during the early developmental period prior to hatch. Consequently, all experiments 
were carried out only with this concentration of cortisol. Briefly, one-cell stage embryos were 
microinjected with 1 nL (~0.5% of total embryo volume) of either vehicle (sterile water) or 
vehicle containing cortisol (32 pg/nL) using a nitrogen-powered microinjector (Narishige, East 
Meadow, NY). Embryos were observed at 24, 36, and 48 hpf using an AZ100 microscope and 
images captured with a DS-Ri1 camera (Nikon, Melville, NY). Embryos (20-25 per sample with a 
sample size of 3-6 per treatment) were frozen at various time-points for measuring cortisol 
content and also for molecular and protein analyses. 
3.3.3 Embryo morphology 
After cortisol injection, embryos were reared until 48 hpf, at which point they were examined and 
classified into one of four groupings according to the severity of their morphological 
deformations: “unaffected” - indistinguishable from wild-type; “mild” – visible pericardial edema 
only; “moderate” - embryos displayed more prominent pericardial edema and visibly malformed 
heart structures (such as distension or ballooning of the heart chambers); “severe” - embryos 
showed a ruptured pericardia with no visible/functioning heart structures and mildly deformed 
curvature. Cortisol-injected embryos did not show a significant increase in mortality during 
embryogenesis. 
3.3.4 Cardiac performance 
Control and cortisol-injected larvae were subjected to a standardized physical stressor at 72 hpf, 
which is the earliest point at which an activated stress response has been shown in zebrafish 
(Alsop and Vijayan, 2008; Alderman and Bernier, 2009). Only embryos exhibiting the “mild” or 
“unaffected” cardiac phenotypes were selected for the performance test as the extreme 
phenotypes displayed irregular heartbeats that were difficult to visualize and quantify. Also, we 
were interested in assessing whether cortisol effects were evident even in embryos with no visible 
malformation of cardiac phenotypes. The stressor exposure consisted of placing 100 larvae in a 
beaker with 80 mL of embryo medium (Westerfield, 2003) and swirling them with a pipette once 
every second for 60 s. The embryos were maintained at 28.5ºC in an incubator (Fisher Scientific, 
Ottawa, ON) over the course of the stressor exposure and post-stressor recovery period. After 
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swirling, individual embryos were transferred to 35mm petri dishes (Fisher Scientific, Ottawa, 
ON) in embryo medium for heartbeat assessment and maintained in the incubator for the post-
stressor period. The heart rates (beats per minute; bpm) of the embryos were counted by viewing 
under the Nikon AZ100 microscope prior to stressor exposure and at 5, 30, and 60 min post-
stressor. The petri dish with a single embryo was removed from the incubator only for the 
duration of the heartbeat assessment (60s). 
3.3.5 Cortisol ELISA 
Embryo cortisol concentrations were measured with a commercially available ELISA (Neogen 
Corp., Lexington, KY) according to the manufacturer’s protocol exactly as described previously 
(Gonçalves et al., 2012). 
3.3.6 Gene expression 
RNA was extracted and quantified from pools of 48 hpf control and cortisol-injected embryos as 
described previously (Nesan et al., 2012 [Chapter 2]). 1 µg of RNA was reverse-transcribed with 
the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA) to 
produce a 20 µL mixture according to the manufacturer’s protocols. 
Real-time quantitative PCR (qPCR) was used to assess gene expression in 36 and 48 hpf 
control and cortisol-injected embryos. The following genes were measured: gr, mmp13, nkx2.5, 
cmlc1, tnnt2a, and atp2a2a, and β-actin. Primer pair sequences, melting temperatures, and 
amplicon sizes are included in Table 1. Primer pairs for gr, mmp13, andβ-actin have been 
described and characterized previously (Nesan et al., 2012 [Chapter 2]). Primer pairs for the 
remaining genes were designed from GenBank sequences: CU019640 (nkx2.5); AL845516 
(cmlc1); AL662880 (tnnt2a); CR407563 (atp2a2a). qPCR analysis was run in triplicate on an 
iCycler iQ thermocycler  using iQ SYBR Green supermix (BioRad, Hercules, CA) and gene 
expression was calculated exactly as described previously (Nesan et al., 2012 [Chapter 2]), using 
β-actin as the housekeeping gene (levels of this transcript were consistent across samples).  
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3.3.7 Protein expression 
Pools of 36 and 48 hpf control and cortisol-injected embryos were processed for measurement of 
protein expression by immunoblotting. Total protein concentration was determined by the 
bicinchoninic acid method with bovine serum albumin (Sigma, St. Louis, MO) as the standard 
and 25 µg was loaded onto 8% SDS-PAGE gels for electrophoresis as described previously 
(Nesan et al., 2012). The GR protein was immunodetected with a polyclonal rabbit anti-zebrafish 
GR antibody exactly as previously described (Nesan et al., 2012 [Chapter 2]). 
3.3.8 Statistical analysis 
All data are presented as mean ± standard error of the mean (SEM). Data comparisons for 
multiple time-points and treatments utilized two-way analysis of variance (ANOVA), while 
Student’s t-test was used for two sample comparisons. Significant interactions with two-way 
ANOVA were further analyzed using one-way ANOVA for temporal differences (within 
treatment groups) and Student’s t-test for treatment differences at each time point. A Bonferroni 
post-hoc test was used to determine significance for multiple comparisons. All data were 
normally distributed without need for transformation. All statistical analyses were carried out 
with the Sigmastat software package (Systat Software, Chicago, IL). A probability value of 
p<0.05 was considered significant. 
3.4 Results 
3.4.1 Cortisol levels 
Cortisol content in newly fertilized embryos was approximately 3.6 pg and this level was 
significantly reduced at 12 (2.7 pg), 24 (2.0 pg) and 36 hpf (2.2 pg) (Fig. 1). After hatch, embryo 
cortisol content increased at 48 hpf (3.8 pg) to levels similar to that seen in the newly fertilized 
embryo but was significantly higher at 72 hpf (Fig. 1). Embryos injected with 32 pg cortisol per 
embryo displayed elevated steroid content above control embryos at all time points, and did not 
display the temporal decrease at 12 (3.5 pg), 24 (3.7 pg) and 36 hpf (3.8 pg) that was observed in 
the control group. The post-hatch cortisol content in the cortisol-injected embryo was 
significantly higher at 48 and 72 hpf (6.3 pg) compared to the pre-hatch values as well as with the 
control group (Fig. 1). 
  
 












Figure 1 – Whole body cortisol content. 
One-cell stage embryos were microinjected with either water (control) or cortisol (32 pg/embryo) 
and sampled at 12, 24, 36, 48 and 72 hpf. 0 hpf measurement was prior to microinjection. All 
values shown are mean ± standard error of mean [SEM; n=4 pools of 25 embryos]; different 
letters indicate significant time effects within each treatment group, while the lower and 
uppercase denotes significant treatment effects (two-way ANOVA, p<0.05).  
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3.4.2 GR expression and signaling 
There was no significant change in GR mRNA abundance (Fig. 2A) or protein expression (Fig. 
2B) at 36 or 48 hpf in the cortisol-injected group compared to the control group (Fig. 2A). There 
was a temporal reduction in GR protein expression (~70%) in both groups at 48 hpf relative to 36 
hpf (Fig. 2B). To assess GR signaling we quantified mmp13, and the mRNA abundance of this 
gene was significantly higher in cortisol-injected embryos at both 36 hpf (26 fold increase) and 48 
hpf (21 fold increase) compared to controls (Fig. 2C).  
  
 













Figure 2 – Glucocorticoid receptor (GR) and glucocorticoid responsive gene expressions 
One-cell stage embryos were microinjected with either water (control) or cortisol (32 pg/embryo) 
and sampled at 36 and 48 hpf to measure GR mRNA abundance (A), GR protein expression (B) 
and mmp13, a glucocorticoid responsive gene, mRNA abundance (C). Data is expressed as 
percentage 36 hpf control. All values shown are mean ± standard error of mean [SEM; n=4-6 
pools of 20 embryos for transcripts (A and B) and n=4 pools of 25 embryos for protein (C)]; 
different letters indicate significant difference (two-way ANOVA, p<0.05). 
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3.4.3 Cardiac morphogenesis 
97% of control embryos were indistinguishable from wild-type embryos throughout development. 
Injection of 32 pg cortisol/embryo resulted in a range of cardiac phenotypes (Fig. 3). Nearly 51% 
of embryos treated with cortisol were similar to the control phenotype and were classified as 
“unaffected” (Fig. 3, first row), while 31% showed a “mild” phenotype (Fig. 3, second row) 
characterized by pericardial edema, 14% showed a “moderate” phenotype (Fig. 3, third row) 
consisting of pericardial edema and visibly deformed heart structure (distended or ballooned heart 
chambers) and 5% were “severe” phenotype (Fig. 3, fourth row) categorized by ruptured 
pericardia and no visible heartbeat. 
  
 











Figure 3 – Heart deformity phenotypes 
One-cell stage embryos were microinjected with either water (control) or cortisol (32 pg/embryo) 
and imaged at 48 hpf for morphological deformities. Unaffected embryos (first row) were 
indistinguishable from wild-type embryos. Mild embryos (second row) displayed pericardial 
edema only (see arrow); moderate embryos (third row) displayed pericardial edema and 
malformed heart structures (see arrows); severe embryos (fourth row) exhibited a ruptured 
pericardium (see arrows) and no heartbeat was ever visible. Percent phenotype from multiple 
trials are shown as mean ± standard error of mean (SEM) (control: n=16 trials of 37-120 
embryos; cortisol: n=14 trials of 53-184 embryos); N.D. - not detectable; * indicates significant 
difference (Student’s t-test, p<0.05). 
  
 



























% of control 
embryos 
% of cortisol 
embryos 
97 ± 0.4 50 ± 1.2  
3 ± 0.3 31 ± 0.8 
N.D. 14 ± 0.6 
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3.4.4 Marker genes for cardiac development 
The observed cardiac deformations were also reflected in disrupted expression of key cardiac 
genes (Fig. 4). The mRNA abundance of the cardiac transcription factor nkx2.5 was significantly 
lower in the cortisol group at 36 hpf (61%) and 48 hpf (72%) compared to the control group (Fig. 
4A).  Transcription of specific cardiac muscle genes was also suppressed in cortisol-injected 
embryos relative to control embryos. The mRNA abundances of cardiac myosin light chain 1 
(cmlc1; Fig. 4B) and cardiac troponin type T2a (tnnt2a; Fig. 4C) was significantly reduced at 48 
hpf (73% and 66%, respectively), but not at 36 hpf compared to the control group. Also, the 
mRNA abundance of a cardiac muscle calcium transporter ATPase (atp2a2a; Fig. 4D) was 
significantly lower in the cortisol-injected embryos at both 36 (61%) and 48 hpf (49%) compared 
to the control embryos. 
  
 











Figure 4 – mRNA abundance of cardiac genes 
One-cell stage embryos were microinjected with either water (control) or cortisol (32 pg/embryo) 
and sampled at 36 and 48 hpf to quantify the mRNA abundance of nkx2.5 (A), cmlc1 (B), tnnt2a 
(C), and atp2a2a (D) by qPCR. Data is expressed as percentage 36 hpf control. All values shown 
are mean ± standard error of mean [SEM; n=4-6 pools of 25 embryos]; different letters indicate 
significant difference (two-way ANOVA, p<0.05). 
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3.4.5 Cardiac performance 
At 72 hpf, control embryos had a heart rate of 160 beats per minute (bpm) (Fig. 5), while embryos 
injected with 32 pg of cortisol displayed a significantly reduced resting heart rate (149 bpm) (Fig. 
5). Subjecting these embryos to an acute physical stressor significantly elevated the control 
embryo heart rate to 197 bpm by 5 min, after which the rate dropped to 173 bpm at 30 min and 
was back to the resting levels at 60 min post-stressor exposure (Fig. 5). The cortisol-injected 
embryos also displayed a transient increase in heart rate in response to stressor exposure, but the 
magnitude of response was significantly lower than the control group at 5 min (171 bpm), 30 min 
(157 bpm), and 60 min (151 bpm) post-stressor exposure (Fig. 5). 
  
 











Figure 5 – Cardiac performance 
One-cell stage embryos were microinjected with either water (control) or cortisol (32 pg/embryo) 
and the heartbeat rate of the larva was measured at 72 hpf either at rest (0 time) or 5, 30, and 60 
minutes after an acute stressor exposure.  Embryos injected with 32 pg of cortisol at fertilization 
displayed a disrupted heart rate response to a stressor at 72 hpf. All values shown are mean ± 
standard error of mean [SEM; n=13-17 embryos, post-stress heart rates were repeated measures]; 
different letters indicate significant time effects within each treatment group, while the lower and 
uppercase denotes significant treatment effects (two-way ANOVA, p<0.05).  
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3.5 Discussion 
The novel finding from this study is that high glucocorticoid exposure during early 
embryogenesis reduces cardiac performance in zebrafish. Studies have shown that maternal stress 
and the associated excess prenatal corticosteroid exposure leads to developmental abnormalities 
in the progeny of vertebrates (Seckl and Meaney, 2004; Eriksen et al., 2006; Kapoor, 2006; 
Breuner et al., 2008), but there is no clear understanding of the specific pathways that are 
impacted. Here we demonstrate for the first time that embryonic exposure to elevated cortisol 
levels involves suppression of genes critical for cardiac morphogenesis in zebrafish, establishing 
a mechanistic link between maternal stress and compromised fish performance.  
 Maternal transfer of cortisol to oocytes is well established in the piscine model and recent 
studies highlight a key role for this steroid deposition in the maternal programming of zebrafish 
development (Pikulkaew et al., 2011; Nesan et al., 2012 [Chapter 2]). This is because knocking 
down of glucocorticoid receptor, a key molecule activating cortisol signaling, led to 
developmental abnormalities and mortality in zebrafish embryos (Pikulkaew et al., 2011; Nesan 
et al., 2012 [Chapter 2]). However, little is known about post-hatch performance phenotype of 
embryos exposed to high levels of cortisol during the critical developmental window prior to 
hatching. Recent studies suggest that maternal stress affects egg characteristics and larval 
development (McCormick and Nechaev, 2002; Eriksen et al., 2006; Giesing et al., 2011), but this 
is not consistent among all species (Stratholt et al., 1997) and a clear understanding of how 
elevated cortisol levels bring about these developmental abnormalities is lacking. In zebrafish and 
other teleosts, the deposited maternal cortisol levels decrease over time up until hatching after 
which the de novo synthesis of the steroid commences (Alsop and Vijayan, 2008, 2009). This was 
also confirmed in the present study as cortisol exposure levels dropped during embryogenesis 
prior to hatching and increased strongly afterwards. Maintaining low cortisol levels during this 
critical early developmental window is thought to be essential for proper maternal programming 
of developmental events (Barry et al., 1995; Stouthart et al., 1998; Alsop and Vijayan, 2008; 
Auperin and Geslin, 2008; Alderman and Bernier, 2009). 
We tested this by elevating embryo cortisol levels above basal levels throughout 
embryogenesis by microinjection of 32 pg of cortisol into the zygote. The temporal changes seen 
in GR expression during development support our earlier study (Nesan et al., 2012 [Chapter 2]) 
while prehatch embryo exposure to elevated cortisol levels did not modulate GR expression. 
However, the upregulation of mmp13 in the cortisol group confirms enhanced GR activation, as 
this transcript is glucocorticoid responsive in zebrafish embryos (Hillegass et al., 2007). The 
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increased early embryonic cortisol stimulation led to clear cardiac phenotypes, including higher 
incidences of edema, malformed heart chambers, and pericardial rupture. To our knowledge, this 
is the first study to demonstrate cardiovascular defects in response to embryo exposure to 
elevated corticosteroid in any animal model. Mammalian studies have suggested cardiovascular 
dysfunction, including chronic hypertension, due to elevated prenatal glucocorticoids (Seckl and 
Meaney, 2004). In zebrafish, maternal stressors have been linked with reduced oocyte formation 
and larval viability (Orn et al., 1998; Carfagnini et al., 2009), but this was not linked to any 
changes in embryo cortisol content. Our results suggest that increased cortisol deposition and the 
associated impact on cardiac morphogenesis may be playing a role in this reduced larval viability. 
During cardiac development in zebrafish, cardiomyocyte progenitors arise from the 
lateral plate mesoderm, migrate towards the midline and fuse to form the heart tube, which 
becomes subdivided into the atrium and the ventricle (Glickman and Yelon, 2002). This process 
begins post-epiboly and is complete within 24 hpf, as the heart begins to beat sporadically. 
Involved in this differentiation and fusion process are a number of cardiac transcription factors 
whose effects are complex and interrelated, including nkx2.5, bmp2b, and other co-factors (Yelon, 
2001). As cardiac tissue develops, cardiac structural genes are upregulated, including myosin 
chains, troponins, and ion transporters. By 36 hpf, the heart tube begins to bend, positioning the 
atrium adjacent to the ventricle, and further development of the heart tissue (thickening of the 
walls, valve development) occurs over the next 12-36 hpf (Glickman and Yelon, 2002). Oxygen 
delivery via the circulatory system is not critical for embryo survival until 4-5 dpf, as tissue 
diffusion is sufficient until then (Pelster and Burggren, 1996), but it has been hypothesized that a 
functional heartbeat and pulsatile blood flow may aid in cardiac tissue maturation and/or 
angiogenesis (Burggren, 2004). Our results underscore a role for elevated cortisol levels during 
early embryogenesis in disrupting this developmental regulation of cardiac morphogenesis in 
zebrafish. The mechanism behind these observed deformations requires further study; however, 
we have identified some key genes involved in cardiovascular development that are 
downregulated in cortisol-injected embryos. The cardiac transcription factor nkx2.5, which is 
involved in heart field definition and myofibril development (Chen and Fishman, 1996; Sultana et 
al., 2008), is suppressed at both 36 and 48 hpf. Knockdown of nkx2.5 has been shown to cause a 
variety of cardiac defects in heart chamber formation as well as pericardial edema (Targoff et al., 
2008), similar to the phenotype observed in our cortisol-injected embryos. Also, downregulation 
of cmlc1 and tnnt2a expressions were reported in mutants that display reduced cardiomyocyte 
differentiation and reduction in nkx2.5 expression (Reiter et al., 1999; Yelon, 2001), suggesting a 
role for these transcripts in the disrupted cardiac morphogenesis in response to elevated 
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embryonic cortisol exposure. The calcium transporter atp2a2a, also known as SERCA2, is a key 
cardiac gene that is essential for contraction (Ebert et al., 2005). Transcript abundance of atp2a2a 
was suppressed in cortisol-injected embryos, and its depletion reduces the heart rate in zebrafish 
embryos by slowing the restoration of calcium ions in the sarcoplasmic reticulum between 
contractions (Ebert et al., 2005).  
The reduced transcript abundances of these critical genes provide a potential mechanism 
for the heart defects and the reduced heartbeat observed in larvae exposed to higher cortisol 
during prehatch embryogenesis. Post-hatch cortisol-injected embryos also exhibited a clear 
performance dysfunction, displaying an impaired ability to increase heart rate in response to an 
acute stressor relative to control embryos. Increased heart rate is a well-characterized response to 
an acute stressor and an essential part of the fight-or-flight response that is mediated by 
catecholamine signaling (Chrousos and Gold, 1992; Wendelaar Bonga, 1997). A reduction or loss 
of this ability will compromise the cardiovascular and metabolic adjustments to cope with stress, 
limiting post-hatch larval viability as a functional heart beat becomes critical for survival (Pelster 
& Burggren, 1996). Importantly, the performance dysfunction was seen in cortisol-treated 
embryos without an obvious heart defect phenotype, indicating a functional role for the observed 
reduction in transcript abundance of key genes involved in cardiac development.  
We hypothesize that elevated embryonic cortisol exposure prior to hatch disrupts the 
developmental programming of cardiac morphogenesis by directly acting on nkx2.5. The resulting 
decrease in cardiomyogenesis, as evidenced by reduced expression of cardiomyocyte markers, 
may compromise the contractile properties of the heart, with a key factor being decreased 
expression of atp2a2a that disrupts calcium signaling in the heart rhythm. This is supported by 
the lower basal heart rate at rest, as well as lower heart rate during stressor exposure and recovery 
in post-hatch embryos that were exposed to higher cortisol levels. Indeed, zebrafish mutants 
displaying abnormal cardiac phenotypes also exhibit reduced heart rate (Baker et al., 1997; 
Garrity et al., 2002), associating the slowed heartbeat to heart malformations in the present study. 
The lowered basal and stress-induced heart rate in our cortisol-injected embryos may be simply 
due to limited contractile ability as a result of cardiac malformations. However, we cannot rule 
out the possibility that elevated embryonic cortisol exposure may also affect the heart response to 
catecholamine stimulation by modulating of β-adrenergic receptors. For instance, knockdown of 
the β1-adrenergic receptor in zebrafish results in embryos with lowered resting heart rates and a 
reduced response to stressor stimulation (Steele et al., 2011). The observation that exogenous 
cortisol treatment of embryos via water exposure led to a higher heart beat in the tropical 
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damselfish (Pomacentrus amboinensis) (McCormick and Nechaev, 2002) suggest that the 
developmental regulation by this steroid may be species-specific and/or dependent on the timing 
of exposure. The treatment method in our study, microinjection of cortisol at one-cell stage, 
mimicked a maternal deposition scenario and underscores a key role for this steroid in 
programming cardiac development.  
In conclusion, maternal stress and the associated elevated cortisol deposition will have a 
marked effect on embryo heart morphogenesis and performance. Specifically, pre-hatch embryo 
exposure to elevated glucocorticoid exposure led to defective cardiac phenotype, and reduced 
cardiac performance in response to an acute stressor. This is the first study to link embryonic 
exposure to elevated cortisol levels to disruption of genes critical for cardiac development leading 
to performance defects in any animal model. Taken together, we propose that elevated early 
embryo cortisol content during the critical window prior to hatch affects developmental 
programming leading to longer term cardiac dysfunction in zebrafish. This is a novel finding, 
providing a potential link between maternal stress, and the associated elevated cortisol deposition 
in eggs, on reduced larval viability in fish. The ecological significance of this finding is the 
potential for a reduction in fitness and viability of progeny from chronically stressed mothers, 
leading to population decline in stressful environments. 
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Chapter 4  
Knockdown of glucocorticoid receptor protein expression 
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4.1 Overview 
Cortisol is the primary circulating glucocorticoid in teleosts and this steroid’s action occurs via 
activation of the glucocorticoid receptor (GR). In response to stressor exposure, cortisol is 
released through the coordinated action of the hypothalamic-pituitary-interrenal axis and a major 
role is in the mobilization of energy stores to reestablish homeostasis. GR transcripts and cortisol 
are deposited by maternal transfer into the oocyte prior to fertilization. In this study, we utilized 
the Agilent zebrafish microarray platform to investigate changes in global gene expression in 
response to morpholino oligonucleotide knockdown of GR at 24 and 36 hours post fertilization 
(hpf). A total of 1594 and 1002 significantly changed genes were observed at 24 and 36 hpf, 
respectively. Ingenuity Pathway Analysis software allowed for the functional organization of 
these genes into important processes and networks. Differences in select gene mRNA abundances 
observed with microarray were also confirmed by quantitative real-time PCR. Functional analysis 
of genes that either displayed high-fold changes or were significantly different from mispair 
controls at both timepoints revealed numerous developmental processes under GR regulation, 
including neurogenesis, eye development, skeletal and cardiac muscle formation. Together, this 
study underscores a critical role for glucocorticoid signaling in programming molecular events 
essential for zebrafish development.  
4.2 Introduction 
The glucocorticoid receptor (GR) is a key mediator of the vertebrate stress response (Wendelaar 
Bonga, 1997; Charmandari et al., 2004). It is a cytosolic receptor that, after activation by binding 
of its primary ligand, cortisol, acts as a transcription factor to modulate gene expression, leading 
to energy store mobilization to cope with stress (Mommsen et al., 1999; Chrousos, 2006). In 
teleosts, these actions are coordinated by the initial stressor recognition in the hypothalamus, 
followed by the release of corticotropin-releasing factor (CRF) that acts on the adenohypophysis, 
leading to release of adrenocorticotrophic hormone (ACTH) that triggers cortisol release from the 
interrenal tissue (Wendelaar Bonga, 1997). The effects of GR activation on other systems, 
including the immune and reproductive systems have been well characterized in a number of 
different model animals (Nesan and Vijayan, 2012c [Chapter 1]). In teleosts, stressor recognition 
and a subsequent cortisol response are only present in post-hatch larvae (Nesan and Vijayan, 
2012c [Chapter 1]). This inhibition of the stress response during embryogenesis, as assessed by 
the presence of a stressor-induced increase in circulating cortisol, occurs despite the completed 
functional development of the stress axis organs, the hypothalamus, the pituitary, and the 
interrenal tissue (Nesan and Vijayan, 2012c [Chapter 1]).  
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Recently, studies have revealed novel roles for glucocorticoid signaling in early zebrafish 
development. GR has been linked with a variety of key developmental factors, including matrix 
metalloproteinases (MMPs) (Hillegass et al., 2007; 2008; Nesan et al., 2012 [Chapter 2]), bone 
morphogenetic proteins (BMPs) (Nesan et al., 2012 [Chapter 2]), and myogenic and cardiogenic 
transcription factors (Nesan et al., 2012 [Chapter 2]; Nesan and Vijayan, 2012a [Chapter 3]). 
These specific molecular linkages occur alongside significant morphological deformations that 
result from knockdown of glucocorticoid receptor protein translation (Pikulkaew et al., 2011; 
Nesan et al., 2012 [Chapter 2]). Perhaps most interestingly, knockdown of maternal GR alters the 
degradation of maternal mRNA and results in an abnormal transcriptome available for translation 
after the mid-blastula transition (Pikulkaew et al., 2011). Together, these findings point to a major 
role for GR in development as a coordinator of a number of important embryogenic pathways. 
 The linkage of GR signaling to BMP expression indicates a key mechanism by which 
zygotic corticosteroids may influence embryogenesis. BMPs are a family of developmental 
morphogens that signal by binding to a number of BMP receptors, causing the activation of the 
SMAD family of intracellular transcription factors that then translocate into the nucleus to 
modulate target gene expression (Kondo, 2007; Xiao et al., 2007). BMP signaling has been linked 
to numerous major developmental events, including dorsoventral patterning, mesodermal 
patterning, somitogenesis, myogenesis, organogenesis, and craniofacial development (Myers et 
al., 2002; Willot et al., 2002; Nie et al., 2006; Kondo, 2007; Shin et al., 2007; Xiao et al., 2007; 
Chung et al., 2008; McCulley et al., 2008; Weber et al., 2008; Patterson et al., 2010; Maurya et 
al., 2011; Nesan et al., 2012 [Chapter 2]). Three specific BMP genes, bmp2a, bmp2b, and bmp4, 
are modulated by GR in zebrafish (Nesan et al., 2012 [Chapter 2]).  
 The period of zebrafish development from 24 to 48 hpf is extremely important for early 
morphogenesis. This window of time immediately follows the final stages of somitogenesis 
(Kimmel et al., 1995) and includes the upregulation of muscle progenitors as myogenic 
differentiation increases significantly (Xu et al., 2000). This is also a critical period of 
organogenesis, with the brain, pituitary, heart and vasculature, liver, gills, and interrenal tissue 
undergoing significant development (Kimmel et al., 1995; Brand, 2003; Liu, 2007; Pogoda and 
Hammerschmidt, 2009). By the end of this 24 h window, the embryo has a functional heartbeat 
and circulatory system and is ready to hatch (Kimmel et al., 1995), underlining the major 
developmental events that occur during this time. Previously, we have shown that without GR 
protein, zebrafish embryos cannot survive beyond the 48 hpf timepoint, indicating that this 
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receptor signaling may play a role in orchestrating these key developmental events (Nesan et al., 
2012 [Chapter 2]).  
 Given the recent findings that position GR as a key mediator of developmental 
organization (Nesan and Vijayan, 2012 [Chapter 1]), we tested the hypothesis that key molecular 
events involved in developmental programming are regulated by GR activation in zebrafish. We 
specifically sought to identify novel genes and pathways regulated by GR signaling during 
zebrafish development. To this end we knocked down GR protein translation using morpholino 
oligonucleotides exactly as described previously (Nesan et al., 2012 [Chapter 2]). A high-density 
zebrafish microarray was utilized to assess the role of GR signaling on global gene expression 
pattern within a critical window during early development. 
 
4.3 Materials and Methods 
4.3.1 Zebrafish care and breeding 
Care and breeding of adult zebrafish was carried out exactly as described previously (Nesan et al., 
2012 [Chapter 2]). Adult zebrafish were purchased from a commercial wholesaler (DAP 
International, Mississauga, ON) and maintained on a 14:10 light dark cycle in an AHAB 
recirculating system (Aquatic Habitats, Apopka, FL). Zebrafish care protocols were approved by 
the University of Waterloo Animal Care Committee in accordance with the Canadian Council for 
Animal Care guidelines. 
4.3.2 Morpholino microinjection 
A morpholino oligonucleotide (MO) was designed against the start site of translation for the 
zebrafish glucocorticoid receptor gene, and a 5 base pair mispair oligonucleotide (MP) was 
designed as a control; both oligonucleotides (Gene Tools, Philomath, OR) have been described 
and characterized previously (Nesan et al., 2012 [Chapter 2]). Oligonucleotide sequences are as 
follows (small letters indicate altered bases in mispair control): MO: 5’-
CTCCAGTCCTCCTTGATCCATTTTG-3’; MP: 5’-TGcTATgTTTAcTCTCgATACgTG-3’. 
Morpholino microinjection was performed exactly as described previously (Nesan et al., 2012 
[Chapter 2]). Briefly, 1 nL of MO or MP was injected into the yolk of one-cell zebrafish embryos, 
which were reared in embryo medium (Westerfield, 2007). Each independent sample consisted of 
a pool of 25 embryos that were flash-frozen at either 24 or 36 hpf. Three replicate pools of each 
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treatment per timepoint were frozen for microarray analysis, and 5-7 pools of each treatment per 
timepoint were frozen for qPCR confirmation. 
4.3.3 RNA extraction 
RNA was extracted from pools of embryos with the RNeasy Mini Kit (Qiagen, Mississauga, ON) 
with DNAse (Qiagen) treatment to remove genomic DNA contamination. Preliminary RNA 
quantification was performed via a Nanodrop spectrophotometer (260 nm; Thermo Scientific, 
Waltham, MA). 
4.3.4 Microarray scanning and analysis of resulting data 
Microarray analysis was carried out at the Laboratory for Advanced Gene Analysis at the 
Vancouver Prostate Centre (Vancouver, BC). Quantification and quality analysis of RNA was 
confirmed by use of the Agilent 2100 Bioanalyzer (Agilent, Santa Clara, CA). Microarray 
analysis was done on pooled samples from 24 and 36 hpf embryos injected with MP or MO (n=3 
pools per timepoint). 200 µg of RNA per sample was used for microarray analysis. Global gene 
expression in MP and MO samples was analyzed by hybridization to the Zebrafish V2 Gene 
Expression Microarray (Product ID 019161; Agilent, Santa Clara, CA), after one-colour labeling 
with the Low Input Quick Amp Labeling Kit (Agilent). Microarrays were scanned with the 
Agilent DNA Microarray Scanner and quantified with Agilent Feature Extraction 10.5.1.1. Data 
was normalized using the Agilent GeneSpring 7.3.1 software package by flooring values below 
0.05 to 0.05 and normalizing data per chip to a set of positive control genes with raw data above 
50 for all samples. The data will be uploaded to the Gene Expression Omnibus (GEO) database 
run by the National Center for Biotechnology Information (NCBI) for further possible analysis by 
interested parties. The dataset was restricted to only identified/annotated genes, omitting 
unidentified or hypothetical gene loci, thereby reducing the number of measured genes per 
sample to 12261. For genes with multiple oligo spots on the array, fold-changes were calculated 
and then averaged to yield a single fold-change value for each gene.. The resulting dataset was 
then subjected to statistical and pathway analyses. 
Statistical assessments were carried out using the R Statistical Computing environment (R 
Foundation, Vienna, Austria). For microarray results, the mean normalized expression was 
calculated for each gene at each treatment (MP or MO) and timepoint (24 or 36 hpf). These 
means were then compared within a timepoint using a student’s t-test, followed by false-
discovery rate (FDR) correction using the Benjamini-Hochberg method (Benjamini and 
Hochberg, 1995). All p-values listed for microarray analysis are FDR-corrected. Data was not 
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compared between timepoints. The complete lists of statistically significant genes at each 
timepoint are displayed in the supplemental information, along with each calculated fold-change 
and p-value (Appendix C, Tables C1, C2). Where required, data from qPCR analysis was log-
transformed to ensure normality prior to evaluation via student’s t-test, no false-discovery rate 
correction was used for qPCR data. For all comparisons, a value of p≤0.05 was considered 
significant. Functional analysis was performed with the Ingenuity Pathway Analysis software 
package (Ingenuity Systems, Redwood, CA) as well as use of Gene Ontology functional 
annotations. 
 
4.3.5 Quantitative PCR 
Quantitative PCR (qPCR) was used to confirm and explore microarray fold change 
measurements. Embryos were injected with MO and MP as outlined above, frozen at 36 hpf, and 
RNA was extracted by use of the Ribozol-chloroform extraction method (Amresco, Solon, OH), 
following the manufacturer’s protocol. After quantification of RNA via Nanodrop 
spectrophotometer, 1 µg of RNA was reverse transcribed with the High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems, Carlsbad, CA), with the Multiscribe recombinant 
Moloney murine leukemia virus reverse transcriptase, producing a 20 µL mixture according to the 
manufacturer’s protocols. qPCR was performed exactly as described previously (Nesan et al., 
2012 [Chapter 2]), using 2.5 µL of cDNA in a 25 µL reaction mixture with iQ SYBR green 
supermix (Bio-Rad, Hercules, CA) using an iCycler iQ thermocycler (Bio-Rad). The selected 
genes were generally unrelated, although some are part of related pathways or functions. The 
selected genes were as follows: the BMP ligand bmp7a, the clotting factor f5, the orphaned Ftz-
F1 receptor homolog ff1d, the structural muscle protein myom1a, the hormone receptor mc1r, and 
two genes involved with the stress axis and classical glucocorticoid signaling, the ACTH 
precursor proopiomelanocortin a (pomca) and the transport protein responsible for the rate-
limiting step in steroidogenesis, the steroidogenic acute regulatory protein (star). These genes 
were selected because their fold-changes were statistically significant and relatively high, as well 
as being of interest in our exploration of the GR knockdown phenotype. Only one gene was not 
statistically significant at 36 hpf, bmp7a, but it was chosen as it had the largest fold-change of any 
of the BMP ligands or receptors, and the BMP signaling pathway was considered a key target for 
qPCR confirmation. Primer sequences, Tm values, and amplicon sizes are provided in Table 1. 
Transcript abundance was normalized to β-actin as a housekeeping gene as its values did not 
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change across samples. Normalization was performed using the ΔCT method (Livak and 
Schmittgen, 2001) as performed previously (Nesan et al., 2012 [Chapter 2]). 
  
 































































































































































































































































































































































4.4.1 Major trends and characteristics of microarray results 
Statistical analysis revealed that 1594 genes were significantly changed between mispair and 
morpholino-injected embryos at 24 hpf, and 1002 genes were significantly changed at 36 hpf. At 24 
hpf, 715 of these genes were downregulated, and 877 were upregulated, while at 36 hpf, 273 genes 
were downregulated and 729 were upregulated (See Figure 1 and Appendix C, Tables C1, C2). The 
distribution of genes per range of fold-change at 24 hpf is displayed in Figure 2A. For 36 hpf, the 
distribution of genes per range of fold-change is displayed in Figure 2B. The 15 genes with the 
highest and lowest fold-changes for each timepoint are displayed in Tables 2 and 3 along with their p-
values, indicating the genes that were most affected by GR knockdown. Among the significantly 
changed genes at each timepoint, 343 were significantly changed at both 24 hpf and 36 hpf, indicating 
that these specific GR-modulated genes may be of particular importance in zebrafish development. Of 
these 343 genes, 275 were upregulated at both time points, 48 were downregulated at both timepoints, 
and 20 showed opposing changes between the timepoints. These genes are specifically highlighted in 
Appendix C (Tables C1, C2; green: both upregulated; red: both downregulated: blue: differential). 
Table 4 lists some genes that were deemed particularly interesting based on pathway analysis and 
gene ontology characterization of their functional grouping. These genes are organized by their 
general function, and listed with their fold-changes at each timepoint.  
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Table 2: Select genes (top ranked based on fold-change) that were significantly upregulated in 
response to GR knockdown at 24 and 36 hpf, with their respective fold-change values and p-values 





24 hpf 36 hpf 
Gene Fold 
Change 
P-value Gene Fold 
Change 
P-value 
esrrd 49.33 0.037 crygm2b 45.89 0.049 
chad 20.35 0.016 mip2 29.42 0.044 
mip1 19.25 0.033 crygm2a 29.38  0.035  
cryba2a 14.72 0.013 atp2a1l 25.43  0.045 
lim2.4 13.74 0.041 crygm3 19.99 0.05 
cx44.1 9.96 0.015 sparcl 15.23 0.047 
xirp2l 8.03 0.038 grifin 13.89  0.032  
cryba4 7.07 0.05 crybb1 13.09  0.045 
msn 7.04 0.016 slc25a4 13.08  0.041  
pvalb5 6.74 0.038 cryba4 11.94  0.049  
calca 6.71  0.040  xirp2l 11.93  0.031 
tnnt3b 6.42  0.039 cryba2a 11.49  0.034  
pvalb4 6.35  0.011  fabp11b 10.87 0.05 
cpt1b 6.29 0.009 pfkma 10.84 0.042 
tyrp1b 6.18 0.018 crygmx 10.21 0.02 
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Table 3: Select genes (top ranked based on fold-change) that were significantly downregulated in 
response to GR knockdown at 24 and 36 hpf, with their respective fold-change values and p-values 























24 hpf 36 hpf 
Gene Fold 
Change 
P-value Gene Fold 
Change 
P-value 
cha 0.047 0.026  lect2l 0.22 0.046 
lect2l 0.057 0.044  ptgds 0.24  0.022 
tbx16 0.066 0.024  trac 0.25 0.006 
gfi1.1 0.067 0.029 gadd45bl 0.26 0.020 
egln3 0.081 0.018 gnrh2 0.30 0.041 
psme1 0.084 0.040  oc90 0.30 0.049 
tbx24 0.096 0.027  flncb 0.34 0.049 
pim1 0.097 0.025  gpx4a 0.34 0.045 
tbx6 0.098  0.037 plekhf1 0.35 0.047 
pcdh8 0.104 0.045 cryaba 0.35  0.038 
ptgs2b 0.104 0.015 ddb2 0.36  0.042 
cyp24a1l 0.114  0.045  hdr 0.36  0.046 
ctsc 0.116 0.009 rspo1 0.37 0.044 
ripply2 0.121 0.042 optc 0.37 0.024 
cyp11a1 0.125 0.048 fech 0.39 0.040 
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Table 4: Functional grouping (based on Ingenuity Pathway Analysis and Gene Ontology databases) 
of select genes that were significantly affected by GR knockdown at both 24 and 36 hpf, with their 
fold-change values at each timepoint. 
Functional 
Grouping 




Cardiac ATPases: atp2a1 (1.76, 2.59), atp2a2a (0.21, 0.69)  
Muscle metabolism: ckmb (3.03. 2.92), pfkma (5.91, 10.91)  
Structural proteins: mylk3 (2.7, 3.35), mylz2 (3.93, 2.19), mylz3 (3.78, 4.37) 
myom1a (3.2, 2.9), tmod4 (2.46, 2.10), tnnc (2.12, 1.92), tnnt1 (1.84, 0.41), 




Cadherins: cadm2a (2.69, 2.73), cadm4 (1.46, 1.68) 
Claudins: cldne (0.54, 0.50), cldnf (0.69, 1.61) 
Collagens: col1a1 (2.2, 2.68), col1a2 (1.96, 2.12), col1a3 (3.19, 3.05), col6a1 
(2.14, 3.05), col6a2 (2.72, 2.99) 
Connexins: cx23 (4.15, 4.41), cx44.1 (9.96, 2.79) 
Protocadherins: pcdh17 (2.18, 1.97), pcdh1a4 (2.4, 1.37), pcdh1g18 (2.1, 1.69), 
pcdh1gb2 (2.03, 1.84), pcdh2ac (1.93, 2.35) 
Others: chad (20.3, 9.65), itgb1b.2 (3.15, 3.0) 
Developmental 
morphogens 
BMP signaling: smad3b (2.6, 2.96), smad7 (0.54, 1.71) 
Hairy-related proteins: her3 (0.56, 0.69), her5 (0.34. 2.77) 
Others: agr2 (2.51, 2.13), gdf11 (1.34, 2.58),  
Endocrine 
systems 
Hormones: avpl (1.85, 2.75), calca (6.71, 2.49), pyya (6.15, 9.89) 
Others: igfbp3 (1.63, 1.86), npy1r (2.54, 2.91), nr5a1b (3.18, 3.61) 
Neurogenesis Atonal homologs: atoh2a (2.71, 3.74), atoh2b (4.94, 3.00) 
LIM-domain proteins: ldb3a (2.2, 3.22), ldb3b (2.86, 3.18), lhx1b (1.61, 2.64), 
lhx6 (3.30, 6.82) 
Others: neurod4 (2.28, 3.27), sox4a (1.67, 2.732.), sox9b (0.39, 1.95) 
Organogenesis mmp23a (2.42. 2.57), pdlim7 (2.69, 2.70), otpb (2.73, 2.65) 
Vasculature Clotting factors: f5 (3.55, 2.72), f7i (2.46, 2.17) 















Figure 1 – Numbers of statistically significant genes upregulated and downregulated at 24 and 
36 hpf in response to GR knockdown 
Of 12261 potential unique genes, the mRNA expression of 1594 were found to be statistically 
significantly changed at 24 hpf, with 715 downregulated (grey) and 877 upregulated (black). 1002 
genes were changed with statistical significance at 36 hpf, of which 273 were downregulated and 729 
were upregulated. (n=3 pools of 25 embryos used for microarray analysis, P≤0.05, students t-test with 
Benjamini-Hochberg false-discovery rate correction). 
  
 




























Figure 2 – Distribution of fold-change for statistically significant genes at 24 and 36 hpf in 
response to GR knockdown 
This figure presents the frequency of genes that were up- or down-regulated at specific fold-change 
ranges at 24 hpf (A) or 36 hpf (B). In general, there was a relatively normal distribution at 24 hpf, 
with relatively few genes showing extreme fold changes and a balance between up and 
downregulation. At 36 hpf, a far greater percentage of genes were upregulated than downregulated, 
and  none showed reduction as severe as at 24 hpf. 
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4.4.2 Results of pathway analysis 
Functional analysis using Ingenuity Pathway Analysis revealed networks of genes with known major 
developmental effects that were affected by GR knockdown. We have selected the top 8 networks, 
based on the “high score” output obtained with the IPA program reflecting a large number of affected 
genes in a network, and they were categorized as developmentally relevant (Figure 3). The genes and 
the relative numbers that were upregulated or downregulated in each network at 24 hpf (Figure 3A) 
and 36 hpf (Figure 3B) are provided. The genes that are grouped into these networks, their 
corresponding fold changes, and their IPA scores are listed in Tables 5 (24 hpf) and 6 (36 hpf).  
The IPA software also generated pathway networks that show interaction among significantly 
different genes and are classified according to their function. These networks were used, along with 
information about the cellular location and the fold change of the genes, to create interactome 
networks that describe cellular and whole-animal processes that appear to be strongly GR-responsive 
(Figure 4). At both the 24 and 36 hpf timepoints, the development of the nervous system was 
identified as the process most strongly disrupted by GR knockdown (Figures 4A and 4B). In addition, 
we identified other functionally relevant processes that were identified as GR-responsive by the IPA 
software and that are indicative of the previously characterized GR knockdown phenotype (Nesan et 
al., 2012 [Chapter 2]). These include transcripts involved in DNA replication and metabolic 
regulation at 24 hpf (Figure 4C), and cardiovascular development (Figure 4D) and developmental 
disorders (Figure 4E) at 36 hpf. 
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Table 5: Gene-regulatory networks that are GR responsive as identified by Ingenuity Pathway 








ascl1, calhm2, cbp(family), cdc40, cs, etv4, fev, gad1, hdac, hes6, 
hes7, hes1, hlx, jag2, klf2, krt8, mapk3, mfng, mpzl2, mpzl3, mtf2, 
ndrg4, notch2, notch, rab38, smad2, smpx, spry2, tbr1, tbx3, 
tph2,ubtf, unc5b, zeb1 
45 
Cell death adh5, aig1, aox1, aplp1, btbd2, dhrs3, DNA-directed DNA 
polymerase, idh2, igsf21, mthfsd, nae1, piwil1, plk2, pola1, pold2, 
ppa1, prim1, rab5, ras homolog, rchy1, rho gdi, rprm, sat1, sec61a1, 





adcyap1, adora2a, arid3b, camkv, creb, dcaf13, gmps, grhl1, hnf1a, 
hnf4a, ins, insulin, isoc2, ldl, me3, mecr, mrps18c, nr4a2, opa3, penk 
pex12, plekha8, proinsulin, ptpn4, rab3d, rb1, rbks, rsk, runx1, shox, 





acat1, arnt2, atpase, bves, calb2, celf2, clstn1, cltc, ctss, entpd2, irx2, 
irx4, ldl-cholesterol, metap2, mmp, mogat2, myh6, myh7, napg, nsf, 
plp1, pp1 protein complex group, rab24, s100a4, snap25, snare, snx5, 




14-3-3, afmid, arl4a, arntl2, arrb1, box, cbp/p300, cryba2, cryba4, 
cyp11a1, epas1, gar1, growth hormone, gstt1, hcg, histone h3, histone 
h4, hmga2, hoxa10, igfbp2, igbp3, importin alpha, kpna2, lef1, maf, 




akap12, asf1a, bcam, c-src, dusp5, egln3, eif3e, figf, gata1, gata4, 
gata6, gata, gem, hbe1, hedgehog, heyl hmbs, hoxb7, htatip2, jmjd6, 
klf13, lama6, lamb2, lmo1, lmo2, mucin, os9, parp, pim2, ptpru, 





acot7, actn3, alpha actinin, alpha catenin, aph1a, aqp11, arrdc2, c8g, 
cadherin, cdd2ap, cdh2, cdh4, cdhe/cdhn, chmp4a, col6a1, col6a2, 
dmrt2, dynamin, egfr, endophilin, fah, g-actin, invs, lim2, matn2, 




alas2, apoa1, ck1, cpn1, creatine kinase, cry2, elastase, fbln1, fgb, 
fgf13, fgg, fibrin, fibrinogen, gpIIb-IIIa, integrin alpha V beta, mapk, 
myf5, myf6, myog, nr6a1, pde5a, per1, rgs20, scn4a, setd3, sgcd, sgce, 
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Table 6: Gene-regulatory networks that are GR responsive, identified by Ingenuity Pathway Analysis 








ap-3, bcl11a, calb2, cirh1a, crabp1, etv1, exoc6, fgf13, foxf1, 
gfap, ina, irx1, irx2, irx4, isl1, kcnd3, kcnip3, mab21l1, mlph, 
msi2, mtdh, myo5a, nefl, neurod4, nfkβ (complex), nop14, olig2, 
pdcd11, pdlim7, pou4f1, prph, rab3c, st9sia2, trim3 
55 
Cellular movement bmpr2, cofilin, dck, ddx56, dhx16, dhx37, DNA-directed RNA 
polymerase, eaf1, ebna1bp2, fbl, gtf2f1, hnrnpm, holo RNA 
polymerase II, med19, mybbp1a, nat10, ncl, nop56, npm1, oc90, 
p70 56k, pdcd4, pes1, polr1a, polr2b, polr2e, ras, rnr, rrp12, 




adrb, barx1, bmp, crmp, dpysl2, dpysl4, dpysl5, fbp2, gck, glud1, 
gng3, gng12, gpc3, hedgehog, ihh, insm1, jnk, l1cam, meis2, nbl1, 
neurod1, nkx2-2, pax6, pfkb2, plp1, ppp2c, proinsulin, ptprn2, 




ache, achr, akt, ampa receptor, cacn, cacna1s cacna2d1, cacng2, 
caveolin, chrna4, cnih2, gnb5, gria2, K channel, l-type calcium 
channel, magi1, musk, n—type calcium channel, napg, neurod2, 
nptn, nrxn1, nrxn2, nrxn3, nsf, nxph1, rgs7bp, snap25, snare, 




20s proteasome, 26s proteasome, abcc9, amt, arl15, c1qtnf4, 
cdh10, chemokine, clstn1, dcp1a, dennd4a, dnase1l3, estrogen 
receptor, gapdh, growth hormone, hsp70, hsp90, kal1, mdm2, 
mmp24, mmp, nfkbia, nos, nr3c1, onecut1, pax3, pgam1, ret, 




acsl4, avp, cdc2, cdkn18, creb, crhbp, cry2, csdc2, cyclin a, cyclin 
d, cyclin 3, ddx55, e2f, eif6, evx1, exosc8, fancd2, fancl, fdps, gcg, 
got, hexokinase, map2k1/2, mkrn1, mthfd1, pomc, ppargc1b, rb, 




14-3-3, acta1, actn3, aldh3b1, alpha actinin, alpha catenin, 
calmodulin, camk2a, camk2d, col1a1, col6a1, col6a2, collagen 
type I, ctnna2,edf1m elavl4, f actin, grin1, hsp27, itpr, kif23, ktn1, 
lrrtm1, neurod6, pdgf (complex), pp2a, raf, rap1, rgn, smad7, 
smad, smad2/3-smad4, spectrin, syt9, tpm3 
25 
Organ morphology Adam17 agr, ampk, bhlhe41, crlf1, dll1, edn1, elmo1, endothelin 
receptor, gtf3a, hdl, mlc, mphosph10, mstn, myl4, mylpf, myosin, 
nadph oxidase, notch, pk, plc beta, pp1 protein complex group, 
pro-inflammatory cytokine, ptf1a, rdx, rem1, rock, scn4a, 
secretase gamma, slc9a3r1, sp4, tsh, ttn, vam1, vegf 
22 
 













Figure 3 – Functional annotation (using Ingenuity Pathway Analysis software) of genes that 
were upregulated and downregulated by GR knockdown 
Ingenuity pathway analysis software identified prominent developmental pathways that were 
significantly affected by GR knockdown based on the significantly changed genes at 24 hpf (A) and 
36 hpf (B). Each pathway is named and the total number of genes as well as the number of 
upregulated and downregulated genes is listed (See Tables 5 and 6 for complete list of genes). 
  
 















Figure 4 – Interactome networks of select pathways identified as GR responsive by Ingenuity 
Pathway Analysis software  
The IPA software organized and classified genes to identify important networks that were modulated 
by GR knockdown. These interactome networks detail the regulatory connections between genes as 
detailed by the connective arrows. The most strongly affected process was nervous system 
development at both 24 hpf (A) and 36 hpf (B). Other interesting pathways are DNA replication and 
energy production at 24 hpf (C), cardiovascular development at 36 hpf (D) and developmental 
disorders at 36 hpf (E). These final 3 pathways each involve a gene that were quantified by qPCR 
(Figure 4): f5 (C, E), and pomca (D). Single-way arrows indicate one gene regulating another, two-
sided arrows indicate co-regulation, looped arrows indicate self-regulation. The shape of each 
member of the network indicates its cellular location (according to IPA software classifications): 
Extracellular (diamond); plasma membrane (hexagon); cytosol (square); nucleus (circle); unknown 
(triangle). The color of each member of the network indicates its mean fold change range: >2 (dark 
green); 1-2 (light green); unchanged (grey); 0.5-1 (light red), <0.5 (dark red). 
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4.4.3 Confirmation by quantitative PCR 
To confirm the reliability of the microarray results, abundance of selected transcripts were quantified 
using qPCR. Genes were selected that had relatively high fold-changes, which were also deemed of 
potential interest in understanding the developmental changes observed in GR morphants. These 
included selected genes from networks identified by IPA software as strongly affected (f5 - Figures 
4C, 4E; pomca - Figure 4D), as well genes identified as functionally important in development or 
which may be involved in the GR knockdown phenotype (bmp7a, ff1d, mc1r, myom1a, star). The 
qPCR analysis of gene expression was in agreement with the microarray findings, with all measured 
genes showing the same direction of change and similar magnitudes (Table 7, Figure 4) at 36 hpf. In 
addition, the fold-changes for all 7 genes were statistically significant with qPCR (Figure 4). This 
included bmp7a, which although having a strong reduction in fold-change (0.341), was not 
statistically significant in the microarray data. Table 7 shows the exact measured fold-changes and p-
values for each gene examined, and Figure 4 is a graphical representation of the normalized 
expression, in arbitrary units. 
  
 
















bmp7a 0.341 0.57 0.13 0.02 
f5 1.87 0.038 1.17 0.05 
ff1d 3.61 0.046 8.49 0.007 
mc1r 3.72 0.04 3.61 0.020 
myom1a 2.90 0.044 2.34 0.013 
pomca 3.64 0.042 5.99 0.022 
star 5.87 0.031 7.05 0.032 
 










Figure 5 – Confirmation of microarray findings by qPCR analysis  
qPCR analysis was performed on 7 genes to confirm the transcript abundance seen with the 
microarray analysis. The selected genes were bmp7a (A), f5 (B), ff1d (C), myom1a (D), pomca (E), 
star (F), mc1r (G). Data is presented as mean ± standard error of the mean (normalized to β-actin, 
SEM; n=5-7 pools of 25 embryos each); * denotes statistical significance (t-test, p<0.05). (See Table 
7 for fold-changes and p-values). 
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4.5 Discussion 
 Through the use of high-density microarray analysis, this study provides some very 
interesting connections between glucocorticoid receptor signaling and major developmental 
processes. The findings, further supported by confirmation of selected genes by qPCR, help to 
explain the developmentally disrupted GR-knockdown phenotype previously established in the 
literature (Pikulkaew et al., 2011; Nesan et al., 2012 [Chapter 2]). In addition, the sheer volume of 
changes found and the major developmental actions of the pathways and specific genes involved are a 
significant contribution to the recent supposition that GR may be a major developmental regulator 
(Nesan and Vijayan, 2012c [Chapter 1]). Together with a previous study that used a high-density 
microarray to examine GR-knockdown effects prior to MBT (Pikulkaew et al., 2011), it is becoming 
increasingly clear that GR actions during embryogenesis are complex but essential for development. 
 In presenting this data, we have attempted to characterize some large-picture changes that 
occur in response to GR knockdown at 24 and 36 hpf, and then to examine some specific genes and 
processes that we find intriguing and worthy of deeper study. It should be noted, as with most high-
throughput data studies, that we present only a subset of the findings. In this study, we found that 
there were far more significantly changed genes at 24 hpf than at 36 hpf, but that within these 
populations, there was a marked difference in the direction of change. At 24 hpf, the ratio of 
downregulated to upregulated genes was 45% to 55%, but at 36 hpf, there were far more upregulated 
genes (73%) than downregulated (27%). This was an unexpected result as it implies that GR could 
potentially be acting as a suppressor of numerous genes during development or suppressing the 
actions of some key developmental transcription factors that would otherwise be enhancing gene 
expression. Previous research has shown downregulation of key metabolic and/or stress-related genes 
in trout hepatocytes after GR activation (Aluru and Vijayan, 2007), but it is unknown as to whether 
this effect is conserved in teleosts in general or in the zebrafish specifically. The mechanism of GR-
mediated suppression of transcription has been studied in mammalian models and appears to act via 
monomeric interaction of the ligand-receptor complex with other transcription factors (Lu and 
Cidlowski, 2006; Bury and Sturm, 2007);  however, the extent to which this occurs in teleosts 
remains unclear.  
To attempt to verify the reliability of the fold-changes observed in the microarray analysis we 
selected 7 genes: bmp7a, f5, ff1d, mc1r, for qPCR confirmation (Figure 4). All 7 genes showed the 
same direction of fold-change and were often quite close in magnitude (Table 7), and all genes were 
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statistically significant, even in the one case where the microarray result was not (bmp7a, despite a 
large fold-change). This finding indicates that the microarray was an accurate measure of changes in 
global gene expression and our analysis is likely to be overly conservative in the number of genes we 
assess as we have mainly limited our observations and discussion to genes that were at or close to 
statistical significance. It should be noted that these transcripts results allowed us to identify candidate 
genes for hypothesis testing and for functional characterization using protein expression. Our results 
cannot confirm whether protein expression would follow the same trend as transcript abundance as 
we had no access to tools to measure expression of these proteins in zebrafish. Study of changes in 
protein content of the GR-responsive transcripts described here should be an area of immediate 
investigation. 
4.5.1 Confirmation that the BMP signaling pathway is GR responsive 
We have previously indicated that the BMP signaling pathway is suppressed in response to GR 
knockdown (Nesan et al., 2012 [Chapter 2]), and this may serve to explain some of these inhibitory 
effects of GR knockdown on global gene expression in zebrafish embryos. BMPs are important 
developmental morphogens that regulate developmental gene expression via the action of the smad 
family of intracellular transcription factors (Miyazono et al., 2005). In addition to the previously 
identified GR-responsive BMP ligands bmp2a, bmp2b, bmp4, in this study we find other members of 
the BMP signaling pathway that were significantly affected by GR knockdown. The microarray 
findings identified several novel BMP ligands and receptors that were affected by GR knockdown, 
including the ligands bmp3, bmp6, bmp7a, and the receptors bmpr1ab, and bmpr1b. All of these 
genes were significantly downregulated at 24 hpf (fold-changes and p-values listed in Appendix C), 
and we further confirmed these findings by quantifying bmp7a expression via qPCR (Figure 4A, 
Table 7). The expression of bmp7a showed a large fold-change reduction by microarray analysis, but 
was not statistically significant; however, qPCR both confirmed the large reduction and was 
statistically significant as well. It should be noted that in addition to the significantly downregulated 
genes listed above, all but one of the measured fold-changes for BMP ligands and receptors (17 total 
genes at two timepoints) showed downregulation, and several were near statistical significance 
(p≤0.1), such as bmp3, bmp7b, bmp8, and bmper. The combination of these measures and the finding 
that the bmp7a is significantly reduced when examined via qPCR implies that the reduction in BMP 
ligand and receptor expression may be more extensive than previously expected. The expression of 
the intracellular smad genes that transduce signals from BMP receptor binding (Miyazono et al., 
 
  138 
2005) also show a similar trend of suppression. Specific smad genes were significantly 
downregulated at 24 hpf, such as smad2 and smad7, as well as smad1, which was also significantly 
reduced at 36 hpf. It should be noted that some smad genes were increased by GR knockdown to 
varying degrees: smad 3a, smad3b, and smad7. However, these genes have been shown to be linked 
together to repress BMP signal transduction, as smad3 regulates smad7, which has an inhibitory 
effect on the binding of other smad proteins to DNA (Pogoda and Meyer, 2002; Zhang et al., 2007). 
Therefore, despite upregulation of some smad genes, our findings remain consistent with a cohesive 
suppression of the BMP signaling pathway in response to GR knockdown. Together, these results 
indicate a strong disruption of BMP-mediated functions and BMP-responsive genes. BMP signaling 
regulates a variety of important developmental processes, including dorsoventral patterning and initial 
mesodermal differentiation (Nikaido et al., 1997; Pyati et al., 2005), as well as later morphogenic 
developments such as angiogenesis, myogenesis, and organogenesis (Brand, 2003; Chung et al., 
2008; Patterson et al., 2010). These results are striking and intriguing, and the implications for GR 
control of the BMP pathway naturally lead to questions about the influence of maternally deposited 
cortisol and glucocorticoid receptor transcripts and proteins at initial fertilization, as BMP signaling is 
involved in early patterning and developmental cell fate determinations (Nikaido et al., 1997; Tiso et 
al., 2002). 
4.5.2 Novel pathways identified for the GR knockdown phenotype 
In addition to confirmation of the reduction in BMP signaling, other previously established aspects of 
the GR knockdown phenotype were supported by microarray analysis. At both 24 hpf and 36 hpf, the 
Ingenuity Pathway Analysis (IPA) software identified pathways leading to skeletal/muscular 
disorders as being severely affected by GR knockdown (Tables 5 and 6). This supports previously 
published characterizations that displayed disrupted mesoderm formation, somitogenesis, and tail 
extension in GR morphant embryos (Pikulkaew et al., 2011; Nesan et al., 2012 [Chapter 2]). There 
were several major muscle proteins among the genes that were significantly changed at both 
timepoints (Table 4), including myosins (mylz2, mylz3), troponins (tnnt1, tnnt3a, tnnt3b), titins (ttna, 
ttnb), and tropomodulin (tmod4). All of these genes were significantly upregulated at both timepoints, 
further supporting and reinforcing the role of GR as a regulator of myogenesis. Muscle metabolic 
genes were also affected, such as phosphofructokinase (pfkma) and creatine kinase (ckma), which 
were upregulated at both timepoints. Together these results indicate that both muscle differentiation 
and muscle activity are increased in response to GR knockdown, although the coordination of this 
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activity remains unclear. Previously we identified myostatin b (mstnb) as downregulated in response 
to GR knockdown (Nesan et al., 2012 [Chapter 2]), but in this study the microarray results for mstnb 
were not conclusive. There were six different oligos for mstnb, and while all showed downregulation 
at 24 hpf, none were statistically significant and only two showed p-values less than 0.1. At 36 hpf, 
two of the spots showed statistically significant increases (fold changes: 2.6 and 3.36) but the 
remaining 4 spots showed only small increases or decreases without any statistical significance, 
making it difficult to assess the reliability of the oligos that displayed increases. The mechanism of 
GR-mediated myogenesis remains a key area for further study as it is a novel finding only found to 
date in teleosts and may point to possible conserved mechanisms or areas of interest in the early 
development of higher vertebrates. Alongside the changes to skeletal muscle genes, we also saw 
consistent disrupted expression of cardiac muscle structural genes at both timepoints (Table 4), 
including structural fibre proteins (mylk3, tnnc), atpases (atp2a1, atp2a2a), and the cardiac 
transcription factor pdlim7 (Camarata et al., 2010). Previously, we have shown that exogenous 
cortisol administration disrupted zebrafish cardiac development, and identified some key genes that 
were downregulated in response to increased embryonic cortisol (Nesan and Vijayan, 2012b [Chapter 
3]). Our findings in this study point to a complex regulation of cardiac development by glucocorticoid 
signaling. Most of the genes listed above were upregulated, which is expected if cortisol signaling is 
an inhibitor of cardiac development as our previous study suggested (Nesan and Vijayan, 2012b 
[Chapter 3]). However, certain genes were downregulated here in response to GR knockdown, 
including atp2a2a, the calcium ATPase that was shown to also be suppressed by increased cortisol 
administration, as well as nkx2.5, the cardiac transcription factor also previously shown to be reduced 
in response to increased cortisol, which was also significantly reduced at 24 hpf (Appendix C Table 
C1, fold change 0.53). The observed changes in these genes were unexpected, and raise some 
questions as to the mechanisms of cortisol action on cardiogenesis. It is possible that activation of the 
mineralocorticoid receptor (MR) may be involved in the disrupted cardiogenic effects of increased 
embryonic cortisol. The function of the zebrafish MR is unknown, but cortisol will bind and activate 
the receptor in vitro, although the extent of in vivo action is unclear (Pippal et al., 2011). MR is 
known to be expressed in mammalian heart tissue and is involved in cardiac muscle hypertrophy 
(Okoshi et al., 2004), but whether it has any effects on cardiac muscle tissue in zebrafish or other 
teleosts remains unknown. It should be noted that the GR knockdown phenotype did not display 
cardiac edema, but there was no observable blood flow in the morphant embryos at any point in 
development (Nesan and Vijayan, unpublished). It is unclear whether this lack of blood flow was due 
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to disrupted cardiogenesis or abnormal vascularization, but the microarray results imply that disrupted 
angiogenesis may also occur in GR morphants. The vascular transcription factor vegfab was 
moderately upregulated at both 24 hpf and 36 hpf (Table 4). Knockdown of vegfab inhibits 
angiogenesis and hematopoiesis (Bahary et al., 2007); however, no studies have tested the effects of 
overexpression of vegfab on the developing zebrafish embryo. Our findings also show a sustained 
upregulation of two clotting factors, f5 and f7i, presenting a possible mechanism for the lack of blood 
flow in morphant embryos. If clotting factors are overexpressed, it may impede blood flow or prevent 
extension of developing vasculature. We further confirmed the upregulation of f5 by qPCR (Figure 
4B). A linkage between VEGF and clotting factors has been established in mammalian models (Nagy 
et al., 2007) and while VEGF is known to induce hematopoiesis in zebrafish (Liang et al., 2001; 
Bahary et al., 2007), it is unclear whether it regulates clotting factors for this action. Angiogenesis in 
the zebrafish embryo is a complex process and there exist numerous subpathways and genes of 
interest that GR may affect, but the sustained upregulation of vegfab implies that glucocorticoid 
signaling likely plays a role in modulating this critical developmental process, and possibly explains 
the lack of circulation in GR morphants. 
4.5.3 Neurogenesis and eye formation affected by GR knockdown 
An unanticipated pathway identified by IPA software was nervous system development, which was 
ranked as the most strongly affected by GR knockdown (Tables 5 and 6, Figures 5A and 5B). The 
IPA analysis also determined that the overall quantity of neurons would be increased at 36 hpf. This 
outcome is reflected in the consistent upregulation of key genes involved in neurogenesis at both 
observed timepoints (Table 4). These include zebrafish homologs of the classical proneural gene 
atonal from Drosophila (atoh2a, atoh2b). These two genes are also known as neurod6a and 
neurod6b, and a third neurogenic differentiation gene (neurod4) was also shown to be upregulated at 
both timepoints. These genes are expressed in the zebrafish olfactory bulb (Liao et al., 1999; Kuo et 
al., 2005), and play a role in vertebrate retinal patterning (Bassett and Wallace, 2012), indicating that 
glucocorticoid signaling may play a role in mediating the formation of sensory apparatus and 
receptors. Retinal malformation may also occur as a result of the disrupted expression of sox9b, 
which was one of the rare genes that displayed differential changes among the timepoints, as it was 
downregulated at 24 hpf (Table 4, fold change 0.39) and upregulated at 36 hpf (Table 4, fold change 
1.95). Numerous sox9 targets have been identified, including cartilage and the pectoral fin, but 
analysis of sox9 mutants showed a linkage to retinal neurogenesis in zebrafish (Yokoi et al., 2009). 
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The effects of GR knockdown on genes associated with retinal development is of particular interest as 
some of the most strongly upregulated genes at each timepoint were lens crystalline proteins (Tables 
5; cryba2a, cryba4, crygm2a, crygm2b). Initial characterizations of the GR morphants did not 
indicate any noticeable effects on eye formation (Pikulkaew et al., 2011; Nesan et al., 2012 [Chapter 
2]). However, as the morphant embryos were only studied until 48 hpf and were developing at a 
slower pace (Nesan et al., 2012 [Chapter 2], there may have been changes to lens or retinal formation 
that were not readily apparent. In zebrafish lens development, crystallins are the most abundant 
proteins, and are subdivided into three groupings, alpha-, beta-, and gamma-crystallins (Posner et al., 
2008). The beta-crystallins, such as cryba2a and cryba4, are expressed mainly during embryogenesis 
and gamma-crystallins, such as crygm2a and crygm2b, are expressed more prominently after 
embryogenesis in the lens of the juvenile zebrafish (Greiling et al., 2009). Alpha-crystallins tend to 
dominate in the mature and aging zebrafish lens (Greiling et al., 2009). The only alpha-crystallin to be 
significantly affected by GR knockdown, cryaba, was downregulated at 36 hpf (fold change 0.35). 
This result implies that lens formation and/or maturation may be a glucocorticoid sensitive process, as 
cortisol-GR signaling may control the switch from beta/gamma crystalline abundance in development 
to alpha-crystallin predominance during aging. The reduction of cryaba with GR knockdown 
indicates that it may be under direct glucocorticoid control in zebrafish, a linkage that has already 
been identified in mammalian cell culture models (Scheier et al., 1996). In mammals, the alpha-
crystallins are expressed in various extracellular regions where they act as small heat shock proteins 
(HSP) to protect cells from damage due to heat and metal stress. Alpha-crystallins do not seem to 
accumulate outside of the lens in zebrafish (Posner et al., 1999), and although some isoforms appear 
to be responsive to heat-shock, their localization remains unclear (Elicker and Hutson, 2007). The 
function of glucocorticoid influence on lens proteins requires further study, to our knowledge there 
have been no studies linking beta- or gamma-crystallins to the stress response, so GR influence on 
them may be only for the purposes of lens development. At this stage, the linkage of GR to alpha-
crystallins may be either part of the aging process for the lens or for an independent HSP-related 
action, and presents an intriguing area for future study.  
 Another key class of neurogenic genes that are affected by GR knockdown are the LIM-
domain proteins, three of which (ldb3a, ldb3b, lhx1b), were all significantly up-regulated at both 
observed timepoints (Table 4) and are all involved in brain development. The two LIM domain 
binding proteins (ldb3a and ldb3b), are anterior CNS markers during development (Toyama et al., 
1998) and lhx1b (also known as lim6) is a telencephalon marker (Toyama and Dawid, 1997). 
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Together, the overexpression of these genes is consistent with the predicted results of the IPA 
software of increased neuronal development. A second telencephalonic marker, lhx6, was also found 
to be significantly upregulated at 24 hpf (fold change 3.3; Appendix C Table C1), and was very close 
to a statistically significant increase at 36 hpf (fold change 6.8, p-value 0.053). The only other LIM-
domain related gene that was statistically significant at either timepoint, lhx8, showed only a modest 
decrease at 24 hpf (fold change 0.76; Appendix C Table C1). In addition to these telencephalon 
markers, the hypothalamic marker otpb was significantly upregulated at both timepoints. The 
hypothalamus develops from the diencephalon and otpb is necessary for the development of 
hypothalamic dopaminergic neurons (Blechman et al., 2007; Ryu et al., 2007). Also, otpb seems to be 
specific to only these cells as morpholino knockdown did not disrupt forebrain patterning (Eaton and 
Glasgow, 2006). The potential involvement of glucocorticoid signaling in patterning the zebrafish 
hypothalamus is a very interesting finding, as the hypothalamus is the initial organizer for the stress 
response in vertebrates, recognizing a stressor and beginning the hormone cascade that results in 
cortisol release from the teleost interrenal cells via the hypothalamic-pituitary-interrenal (HPI) axis 
(Wendelaar Bonga, 1997; Charmandari et al., 2004). The dopaminergic neurons that are regulated by 
otpb produce the trophic hormones such as corticotropin-releasing hormone (CRH; or corticotropin-
releasing factor, CRF, in fish) that will act on the anterior pituitary as part of the stress response and 
other coordinated endocrine actions (Nesan and Vijayan, 2012c [Chapter 1]). Developmental 
regulation of the hypothalamus has been previously demonstrated in the ovine model where 
exogenous developmental glucocorticoids disrupt the stress response in the mature animal by 
disrupting circulating levels of corticotrophin-releasing hormone (Welberg et al., 2001). The concept 
of glucocorticoid priming of the stress response is well-described in birds and reptiles, where 
maternal deposition into the egg is hypothesized as a stress signal that prepares the fetus for adverse 
conditions (De Fraipont et al., 2000; Hayward and Wingfield, 2004), but whether this occurs in 
teleosts remains unclear. We also observe the increased expression of other prominent genes 
associated with the stress response, such as the ACTH precursor pomca (Liu et al., 2003; Miller, 
2007), and star, the cholesterol transport protein involved in the first step of steroidogenesis (Miller, 
2007), both of which were also confirmed by qPCR (Figures 4E, 4F, Table 7). Expression of pomca 
was significantly increased at 36 hpf (Table 7) and was close to statistical significance at 24 hpf (fold-
change 4.37, p-value 0.068). The expression of star displays the same pattern in response to GR 
knockdown, with a significant increase at 36 hpf (Appendix C Table C2, fold-change 5.87), and a 
measured increase at 24 hpf that was not statistically significant (fold-change 2.14, p-value 0.117), 
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but this may be obscured by the conservative nature of microarray analysis. This linkage between 
embryonic GR,  hypothalamic development, and stress axis signaling provides a putative method by 
which maternal cortisol, which is the sole source of glucocorticoids in the pre-hatch teleost embryo 
(Alsop and Vijayan, 2008; Nesan and Vijayan, 2012b [Chapter 3]), may regulate HPI axis 
development and its activity in adult zebrafish. A final indicator that general neurogenesis outside of 
the brain is also increased by GR knockdown is that expression of sox4a, a known mediator of spinal 
neurogenesis (Gribble et al., 2009), was significantly upregulated at both 24 and 36 hpf. This lends 
further evidence to the posited action of GR signaling as acting in an inhibitory manner upstream of 
neurogenesis. It remains unclear as to whether GR action would be directly inhibiting neurogenesis, 
or whether it may work via intermediate action on other organizing factors. Despite the lack of clarity 
in the mechanism of action, it appears that key developmental regulators of the telencephalon, the 
hypothalamus, and possibly other CNS regions, are modulated by GR signaling. 
4.5.4 Effects of GR knockdown on endocrine signaling 
In addition to the possible disruption of hypothalamic trophic hormone production and homeostasis 
from increased proliferation to dopaminergic neurons, other hormones and receptors are increased in 
response to GR knockdown, including arginine vasopressin (avpl), which has both osmoregulatory 
(Nielsen et al., 1995) and complex social actions (Eaton et al., 2008) in mammals, but in fish appears 
to predominantly act to regulate social behavior in dominant/subordinate relationships (Larson et al., 
2006). Interestingly, the previously-mentioned dopaminergic neuron differentiator otpb, is also 
required for development of vasopressin-releasing cells (Eaton et al., 2008). This is an interesting 
linkage between GR knockdown and increased aggression via modified vasopressin expression in the 
brain. Numerous species of teleosts are known to adopt dominant/subordinate relationships within 
populations (Gilmour et al., 2005), and in trout this has been linked to differential activation in the 
stress response as measured by cortisol release (Pottinger and Carrick, 2001; Overli et al., 2004). Our 
findings in this study lead us to hypothesize that otpb, which is involved in development and 
differentiation of corticotropin-releasing factor producing dopaminergic neurons and vasopressin-
expressing cells (Eaton et al., 2008; Nesan et al., 2012 [Chapter 2]), may be active in the development 
of this social behavior and regulate the dominant or subordinate status of individual fish. As with 
previous pathways, with early embryonic GR activation only occurring via maternally deposited 
cortisol stores, this provides a potential role for the maternal stress state and subsequent possible 
alterations in cortisol deposition into the oocyte to determine the social status of offspring.  
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 Other hormones, receptors, and endocrine signaling components are also significantly 
upregulated after GR knockdown, but their effects in the developing embryo are more difficult to 
assess. Calcitonin (calca), the hormone produced by the ultimobranchial bodies associated with the 
zebrafish thyroid that regulates calcium homeostasis (Porazzi et al., 2009; Lafont et al., 2011), was 
found to be upregulated at both observed timepoints (Table 4). At this stage it is unclear whether the 
increased expression of calca implies a functionally increased level of calcium sequestration or an 
increase in the size or productive capacity of the ultimobranchial bodies, or both, but the apparent 
cross-regulation of other endocrine signaling axes via GR knockdown is a prominent area of future 
investigation. In addition, we also find genes that are classically involved in feeding and appetite to 
be upregulated at both timepoints, such as peptide YY (pyya), and the NPY receptor npy1r 
(Sundström et al., 2008; Matsuda et al., 2012), both of which were observed to increase at 24 and 36 
hpf. The impact of these genes in the pre-hatch, pre-feeding embryo is unclear, but if they are 
modulated by GR signaling, the post-hatch impact of the previously described GR priming effects on 
the HPI axis may control feeding patterns. The changes we observed in the hypothalamic 
dopaminergic neuron marker otpb, if it disrupts the stress response, could then affect appetite by 
changing circulating levels of peptide YY or the expression of the NPY receptor. Finally, we also 
observed a significant increase in an insulin-like growth factor binding protein (igfbp3), which may in 
part explain the reduction in growth observed in the GR morphants (Nesan et al., 2012 [Chapter 2]). 
Insulin-like growth factors (IGFs) are produced by the liver and mediate the actions of growth 
hormone as well as having roles in early developmental patterning of the zebrafish embryo as well as 
notochord formation (Duan et al., 2003; Eivers et al., 2004; Zou et al., 2009). IGF binding proteins 
(IGFBPs) chaperone IGFs and can increase their circulating halflife, but also have complex actions as 
to whether they increase or decrease signaling depending on the IGF member, the tissue type, and 
other factors (Duan and Xu, 2005). IGFBP3 is the most common binding protein and the majority of 
IGFs are complexed with at least one IGFBP3 peptide, indicating that an increase in igfbp3 
expression may have a reductive effect on free IGFs available to bind to receptors and act on tissues. 
This is a potential explanation for the reduced body size that occurred in embryos after GR 
knockdown (Nesan and Vijayan, 2012b [Chapter 3]), which was reversed by GR mRNA rescue 
indicating a GR specific effect in developing zebrafish. Additionally, it should be noted that IGFBP3 
has effects independent of IGF ligands, including some aspects of skeletal development (Li et al., 
2005). Part of IGFBP3 action also results from its antagonizing effects against the BMP signaling 
pathway (Zhong et al., 2011), and BMP1 inactivates IGFBP3 by proteolytic action (Kim et al., 2011). 
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While bmp1 expression was not significantly changed in our microarray analysis, it is of interest that 
upregulated igfbp3 will further suppress BMP signaling action by its inhibitory effects. Generally, 
between overexpression of the key hypothalamic marker otpb and these more disparate changes to 
various hormone and receptors, it appears that endocrine system disruption may be a prominent effect 
of GR knockdown. This supposition is also supported by the IPA software analysis, which lists 
disorders of the endocrine system as a major affected pathway based on the genes that were 
significantly altered at 24 hpf (Table 5). 
4.5.5 GR knockdown disrupts expression of cell-adhesion molecules 
The final major class of genes that were significantly affected by GR knockdown are those involved 
in cell-to-cell adhesion and the extracellular matrix. Cell-to-cell signaling, cellular assembly, and 
connective tissue development were among the major pathways identified as significantly affected by 
GR protein knockdown by IPA analysis (Tables 5 and 6). Multiple classes of cell adhesion genes 
showed sustained increases in expression at both timepoints, including cadherins, protocadherins, and 
numerous collagen fibres (Table 4). Cadherins have a variety of roles in development, mainly 
involving the movement of cells and tissue sheets during morphogenesis (Halbleib and Nelson, 
2006), and the specific cadherins upregulated at both timepoints (cadm2a and cadm4) are among 
those involved in nervous system development (Pietri et al., 2008; Hunter et al., 2011). 
Protocadherins are a major subclass of cadherins, and have a variety of effects in development, with 
recent research showing prominent protocadherin expression in the nervous system, specifically at 
synaptic boundaries (Suzuki, 2000; Frank and Kemler, 2002). Multiple variants of protocadherin-1 
(pcdh1a4, pcdh1g18, pcdh1gb2), a protocadherin-2 gene (pcdh2ac), and protocadherin-17 (pcdh17) 
were all significantly upregulated at both 24 and 36 hpf (Table 4). The roles of the protocadherin-1 
and -2 genes are generally unknown in zebrafish, although there is evidence linking protocadherins in 
general to zebrafish neurogenesis, as lack of alpha-protocadherins triggers neuronal death (Emond 
and Jontes, 2008). Studies in mice have implicated protocadherin-1 in multiple developmental 
processes, including many that overlap with established GR effects from previous studies or what we 
have inferred from the microarray findings. These pathways include neurogenesis, cardiovascular 
development, angiogenesis, and organogenesis (Redies et al., 2008), and protocadherin-2 also affects 
neurogenesis in human fetal models (Pinky, 2004). Protocadherin-17 is the best studied of the 
affected genes in zebrafish, and interestingly, it is expressed prominently in the eye, and its 
knockdown results in reduced cell proliferation in the retina (Biswas and Jontes, 2009; Chen et al., 
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2012). There is also further evidence for disrupted eye formation in GR morphant embryos, as the 
two connexin genes that are significantly upregulated at both timepoints, cx23 and cx44.1, are both 
expressed in the embryonic eye (Cason et al., 2001; Cheng et al., 2003; Iovine et al., 2008). Together, 
the specific cadherins, protocadherins, and connexins that are upregulated in response to GR 
knockdown only lend further supporting evidence to our posited role of glucocorticoid signaling in 
neurogenesis and eye formation. Another prominent group of proteins upregulated by GR knockdown 
are the extracellular matrix fibril collagens. Three type I collagens (col1a1, col1a2, col1a3) and two 
type VI collagens (col6a1, col6a2) displayed sustained significant upregulation in GR morphants at 
both observed timepoints. The type I collagens tend to be expressed in the developing somites, and 
then are expressed in high abundance in the dermis tissue (Li et al., 2011) (Thiesse and Thiesse, 
2004). It is unclear what the functional significance of the overexpression of these genes may be, but 
GR morphants did display slowed somitogenesis, and errors in ECM structure and density could 
contribute to this disruption, as type I collagens form the connective tissue that surrounds developing 
myotomal regions (Rescan et al., 2005). The upregulation of the type VI collagens appear to be more 
functionally relevant to the GR morphant phenotype. Knockdown of col6a1 in zebrafish embryos 
results in muscle disorders and motor abnormalities (Telfer et al., 2010). In GR morphants, we 
observed a marked reduction in movement as they approached the normal period of hatching 
compared to control embryos (Nesan & Vijayan, unpublished), and there is theoretical potential for 
this to be caused by col6a1 upregulation. However, this is only supposition at this point and requires 
further study. Additionally, studies in mice have found congenital heart defects resulting from 
overexpression of col6a2, although this requires the co-overexpression of other molecules (Grossman 
et al., 2011). No evidence for this kind of effect has been observed in zebrafish, so it remains unclear 
as to whether type VI collagen overexpression may contribute to the previously described cardiogenic 
disruptions in GR morphant embryos. 
4.5.6 Conclusions 
Clearly, from the breadth of this discussion, the microarray analysis of global gene expression in 
response to GR knockdown has provided a wealth of information and yielded numerous areas that 
require further investigation. In general, this study provides a number of novel genes, pathways, and 
processes involved in development that are affected by GR protein expression. We have found 
multiple major groupings of genes that support and help to explain the previously established GR 
knockdown phenotype and other effects of modulated GR signaling in the newly fertilized zebrafish 
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embryo, such as myogenic, cardiovascular, and angiogenic disruption as well as the widespread 
suppression of BMP signaling molecules and receptors. In addition, we have identified some 
unexpected developmental pathways that appear to be significantly affected by loss of GR signaling, 
such as neuronal differentiation, hypothalamic development, and eye formation. Altogether, this study 
provides strong evidence further supporting the growing consensus that developmental 
glucocorticoids are important developmental regulators, and that the glucocorticoid receptor is a 
critical morphogen that modulates a variety of important developmental processes. 
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Chapter 5 
Maternal cortisol is critical for stress axis development in zebrafish 
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5.1 Overview 
Cortisol is the primary circulating glucocorticoid in teleosts. It is released from the interrenal tissue 
and functions in post-hatch animal to respond to stressor exposure, including energy substrate 
mobilization. This steroid is secreted by the coordinated activation of the hypothalamic-pituitary-
interrenal (HPI) axis, involving the release of corticotropin-releasing-factor from the hypothalamus 
and adrenocorticotrophic hormone from the anterior pituitary. This stress response is generally highly 
conserved in vertebrates. There is a growing body of evidence that cortisol signaling, mediated by 
binding and activation of the glucocorticoid receptor (GR), is critical to the development of the pre-
hatch zebrafish embryo. Cortisol synthesis does not begin until hatching in zebrafish, so maternal 
deposition is the only source of the ligand for early GR activation. In this study, we modulated the 
amount of embryo cortisol available at fertilization. We increased embryonic cortisol content by 
injection of exogenous cortisol. Also, we reduced maternal cortisol content by use of a cortisol 
antibody to sequester the steroid in the yolk. Characterization of the phenotype revealed distinct 
treatment effects, including mild cardiac edema with cortisol excess and deformed mesoderm and tail 
structures with cortisol reduction. Also, compared to wild type embryos, excess cortisol led to longer 
embryos at both 48 and 72 hours post fertilization (hpf), while lower cortisol content resulted in 
shorter embryo at 48 hpf only. Cortisol antibody embryos also showed impaired straightening of the 
tail at 72 hpf, remaining curled around the yolk. There was a clear difference in the post-hatch cortisol 
stress response between the two treatments. Elevated embryo cortisol content completely abolished 
the stressor-mediated cortisol increase seen in the wildtype zebrafish. The sequestering of maternal 
cortisol had the opposite effect, displaying a heightened cortisol response to stress. These changes 
were correlated with altered expression of key HPI axis genes, including crh, 11β hydroxlase, pomca, 
star, which were all downregulated in embryos injected with exogenous cortisol, and upregulated in 
those that experienced reduced cortisol during embryogenesis. Altogether, maternal cortisol is 
essential for mesoderm formation and muscle development and dysregulation of embryo cortisol 
content will lead to abnormal stress axis functioning in zebrafish. 
5.2 Introduction 
The HPI axis is a coordinated set of organs that sense and respond to stressor insult in teleost fish 
(Wendelaar Bonga, 1997). The hypothalamus is the site of initial stressor recognition, resulting in the 
release of corticotrophin-releasing factor (CRF) from dopaminergic neurons (Mommsen et al., 1999; 
Machluf et al., 2011). CRF acts on the anterior pituitary gland by binding to receptors on cells that 
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release adrenocorticotrophic hormone (ACTH) into circulation. ACTH binds to the melanocortin 2 
receptor (MC2R) expressed on the steroidogenic cells of the interrenal tissue to induce the release of 
cortisol (Mommsen et al., 1999; Nesan and Vijayan, 2012b [Chapter 1]). The interrenal tissue is 
analogous to the adrenal gland in higher vertebrates (Liu, 2007) and cortisol is the primary circulating 
glucocorticoid in fish. Cortisol has a variety of effects in teleosts, but its most well-studied function is 
to enhance metabolism and mobilize energy stores needed to restore homeostasis (Mommsen et al., 
1999). 
Recently, studies have described a number of unexpected roles for glucocorticoid signaling in 
developing zebrafish embryos that are unrelated to the established functions of the HPI axis and the 
conserved vertebrate stress response (reviewed in Nesan and Vijayan, 2012b [Chapter 1]). 
Knockdown of GR protein translation in the newly-fertilized zebrafish embryo disrupted multiple 
developmental processes such as somitogenesis, myogenesis, and reduced overall growth and survival 
(Pikulkaew et al., 2011; Nesan et al., 2012 [Chapter 2]). Also, exogenous cortisol administration led 
to disrupted heart formation and the downregulation of key genes involved in cardiac development 
(Nesan and Vijayan, 2012a [Chapter 3]). Other studies have also linked larval craniofacial 
development and osmoregulation to glucocorticoid signaling in the zebrafish embryo (Hillegass et al., 
2008; Kumai et al., 2012). Altogether, these findings position GR as a major developmental 
morphogen and key mediator of embryogenesis.  
Glucocorticoid receptor transcripts are found in the newly-fertilized embryo, although there is a 
complete turnover of maternally deposited transcripts just after the mid-blastula transition, and newly 
produced GR mRNA and protein is widespread in the embryo by 12-24 hpf (Nesan et al., 2012 
[Chapter 2]). Cortisol is also maternally deposited into the zebrafish oocyte prior to spawning and 
fertilization, but it persists in diminishing quantities until de novo cortisol synthesis and accumulation 
begins at approximately 48 hpf and rises dramatically after hatching (Alsop and Vijayan, 2008; Nesan 
and Vijayan, 2012a [Chapter 3]). This lack of early cortisol synthesis indicates that the identified GR 
effects, to the extent that they are mediated by classical GR signaling after binding and activation by 
cortisol, are dependent entirely on the maternal deposition of cortisol prior to fertilization.  
The factor limiting cortisol synthesis in the developing zebrafish embryo is unclear. The coordinated 
response to stress is not inducible in zebrafish until 72 hpf, but the three organs of the HPI axis all 
begin to differentiate and organize relatively early in embryogenesis (Nesan and Vijayan, 2012b 
[Chapter 1]). The CRF-producing neurons are fully developed by 36 hpf, and CRF is detectable from 
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fertilization onwards (Alderman and Bernier, 2009; Machluf et al., 2011; Nesan and Vijayan, 2012b 
[Chapter 1]), as are the ACTH corticotropes of the anterior pituitary, which are differentiated by ~26 
hpf (Liu et al., 2003; Nesan and Vijayan, 2012b [Chapter 1]). While the interrenal tissue is not 
developmentally mature until post-hatching, it is the chromaffin cells and not the steroidogenic cells 
that are late to form and migrate to their final position (Nesan and Vijayan, 2012b). Key steroidogenic 
enzymes, including 11ß-hydroxylase and StAR, are expressed in the embryo by ~28 hpf (Alsop and 
Vijayan, 2008; Liu, 2007; Nesan and Vijayan, 2012b [Chapter 1]), indicating that the embryo has a 
functional steroid biosynthesis pathway prior to hatching. With the synthesis and signaling 
components of the stress axis functionally developed prior to the actual ontogeny of the stress 
response, there remains a question as to whether HPI axis development or its post-hatch function can 
be affected by embryonic signals.  
The concept of negative feedback in the regulation of stress axis function is well known in a variety 
of models, as circulating cortisol has been shown to regulate activity of the HPI axis organs in 
different models, including teleosts (Mommsen et al., 1999; Sathiyaa and Vijayan, 2003; Veillette et 
al., 2007) and mammals (Bradford et al., 1992; Dallman et al., 1992; Gómez et al., 1998). Numerous 
studies also link neonatal stress or diminished maternal care with long-term patterning of the stress 
response (Francis et al., 1996; Caldji et al., 2000; Fish et al., 2004). Additionally, there is established 
evidence from mammalian models that levels of circulating glucocorticoids during development can 
affect the functioning of the stress axis in the mature animal, including rats, guinea pigs, and sheep 
(Kapoor, 2006; Kapoor et al., 2008).  Finally, in the fields of bird and reptile physiology, there is 
research indicating that the deposition of glucocorticoids into the yolk of eggs by the mother may 
serve as a regulatory signal during development to prepare offspring for potentially stressful 
conditions (Hayward and Wingfield, 2004; Cadby et al., 2010).  
Against this background of extensive information about stress axis development and regulation from 
a variety of models and the growing body of knowledge regarding the role of glucocorticoid signaling 
in zebrafish development, we hypothesized that maternally deposited cortisol can regulate HPI axis 
development in zebrafish embryos. To test this, we used microinjection techniques to alter the levels 
of cortisol available to the developing zebrafish embryo after fertilization. We used a commercially 
available cortisol antibody to sequester cortisol in the yolk of embryos, thereby reducing maternal 
cortisol content for the developing embryos. Also, we microinjected cortisol (as we have done 
previously, Nesan and Vijayan, 2012a [Chapter 3]) into the yolk of embryos to artificially elevate 
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cortisol content in the developing embryos. By examining the expression of key genes involved in 
HPI axis organogenesis and function throughout development as well as assessing the larval stress 
response, this paper for the first time identifies linkages between maternally deposited cortisol and 
long-term stress axis programming in zebrafish. 
5.3 Materials and Methods 
5.3.1 Zebrafish care and breeding 
Care and breeding of adult zebrafish was carried out exactly as described previously (Nesan et al., 
2012 [Chapter 2]). Adult zebrafish were purchased from a commercial wholesaler (DAP 
International, Mississauga, ON) and maintained on a 14:10 light-dark cycle in an AHAB recirculating 
system (Aquatic Habitats, Apopka, FL). Zebrafish care protocols were approved by the University of 
Waterloo Animal Care Committee in accordance with the Canadian Council for Animal Care 
guidelines. 
5.3.2 Treatment injections 
Adult zebrafish were placed in breeding traps (Aquatic Habitats) within system tanks before the onset 
of the dark period. Single-cell zebrafish embryos were collected from breeding tanks within 30 
minutes of light exposure, and cleaned in system water prior to injection. All injections were 
performed exactly as described previously using a nitrogen-powered microinjector (Narishige, Japan) 
(Nesan et al., 2012 [Chapter 2]) . The injection treatments were as follows: undiluted cortisol 
antibody (MP Biomedicals, Solon, OH), previously characterized and used for radioimmunoassay 
studies (Ings et al., 2012); undiluted commercially available yeast-specific antibody (polyclonal rabbit 
anti-yeast GCN4, 200 µg/mL; Santa Cruz Biotechnology, Santa Cruz, CA); 32 pg cortisol per egg 
(prepared and injected exactly as characterized previously, Nesan and Vijayan, 2012a [Chapter 3]); 
sterile vehicle control (prepared and injected exactly as characterized previously, (Nesan and Vijayan, 
2012a [Chapter 3]). GCN4 is a yeast-specific transcriptional activator with no known homolog in 
zebrafish (Arndt and Fink, 1986). Prior to this study, the anti-GCN4 yeast antibody was titred and 
characterized to assess whether it affects zebrafish embryogenesis, and no changes in embryogenesis 
were observed at any point, all embryos at any injection concentration were indistinguishable from 
wild-type embryos. This antibody was therefore accepted as a useful control against non-specific 
antibody effects. The vehicle control was prepared exactly as the cortisol solution (dissolving in 
ethanol, then evaporation and reconstituting in sterile water). In our previous study, we classified a 
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series of increasingly severe phenotypes for zebrafish embryos injected with 32 pg of cortisol (Nesan 
and Vijayan, 2012a [Chapter 3]). In this study, only embryos displaying a phenotype without major 
deformations (“unaffected” or “mild” in the previous study) were used for all quantitative analyses in 
an attempt to conservatively assess changes arising from modulated cortisol instead of secondary 
effects of gross malformations in embryogenesis. The injection volume for all treatments was ~1 nL, 
injected directly into the yolk of the fertilized embryo. After injection, embryos were reared in 
embryo medium (Westerfield, 2007) and incubated at 28.5 C, with fresh medium at 12 and 36 hpf, 
exactly as described previously (Nesan et al., 2012 [Chapter 2]). After incubation, pools of embryos 
were collected at 4, 12, 24, 48, and 72 hpf, flash frozen on dry ice, and subsequently stored at -80C 
for later analysis of cortisol concentrations and expression of key genes involved in HPI axis 
function. 
5.3.3 Characterization of embryo phenotypes 
Embryos from each treatment group were observed throughout development for changes in 
morphology. Previously, we categorized and characterized a phenotype associated with the injection 
of exogenous cortisol in one-cell zebrafish embryos and displayed embryos with increasingly severe 
morphogenic deformations. At 48 hpf and 72 hpf, embryos were observed and bright-field imaged 
with an AZ-100 dissecting microscope and DS-R1 camera (Nikon, Melville, NY). These images were 
then used to measure morphometrics in the developing embryos by use of the NIS-Elements software 
package (Nikon).  Embryo growth and extension differences between treatment groups were assessed 
by two morphometrics: whole embryo length, and head-trunk angle, which were measured exactly as 
described previously (Nesan et al., 2012 [Chapter 2]). 
5.3.4 Stressor exposure 
At 72 hpf, larvae from each treatment group were exposed to a physical stressor to assess the 
functioning of the HPI axis in response to changes in cortisol concentrations in the early embryo. The 
stress protocol was performed exactly as described previously (Nesan and Vijayan, 2012a [Chapter 
3]). Briefly, 100 larvae were placed in an 100 mL beaker containing 80 mL of embryo medium, then 
swirled with a plastic pipette once per second for 60 s. Embryos were then allowed to recover over a 
60 minute period. Pools of 15 larvae were collected prior to stressor exposure, and at 5, 30, and 60 
minutes post-stressor. Larvae were then flash-frozen on dry ice and stored at -80C for analysis of 
cortisol content. 
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5.3.5 Cortisol extraction and quantification 
Cortisol was measured from treated embryos during embryogenesis (24, 48, 72 hpf), as well as from 
72 hpf treated embryos that were exposed to a physical stressor (pre-stressor and 5, 30, 60 minute 
post-stressor). Pools of 25 embryos (24 and 48 hpf) or 15 embryos (72 hpf) were homogenized briefly 
(15s) with a PowerGen 125 homogenizer (Fisher Scientific, Ottawa, Canada) in 200 uL of 50mM 
TRIS buffer with added protease inhibitor (Roche, Laval, Canada). Cortisol was then extracted from 
these embryos using separation with diethyl ether via a modification of the method described 
previously (Alsop and Vijayan, 2008). Briefly, 1 mL of ether was added to the homogenate, which 
was then frozen on dry ice to isolate the aqueous phase and allow for decanting. This process was 
repeated for a total of three extractions and the ether was evaporated off overnight at room 
temperature. Cortisol quantification was performed via a commercially available colormetric cortisol 
ELISA (Neogen Corp, Lexington, KY) which has been used and characterized previously (Gonçalves 
et al., 2012; Nesan and Vijayan, 2012a [Chapter 3]), according to the manufacturer’s protocols. 
Steroid samples were reconstituted in extraction buffer from the ELISA kit. 
5.3.6 Gene expression 
Expression of genes involved in HPI axis function was measured by real-time quantitative PCR 
(qPCR) in embryos from each treatment group at 48 hpf, in order to assess changes to the stress 
response capacity that resulted from modulated embryonic cortisol content. RNA was extracted via 
the Ribozol-chloroform extraction process (Amresco, Solon, OH) according to the manufacturer’s 
protocols. Extracted RNA was quantified with a Nanodrop Spectrophotometer (Thermo Scientific, 
Ottawa, Canada). First-strand synthesis of cDNA was carried out via the High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA) with 1 ug of total RNA per sample. 
qPCR analysis was performed exactly as described previously (Nesan et al., 2012 [Chapter 2]), with 
samples run in triplicate in an iCycler iQ thermocycler using iQ SYBR green supermix as a 
fluorophore (both from Biorad, Hercules, CA). The genes measured were: crh, gr, mc2r, mr, pomca, 
star, and 11β hydroxylase. Primer pairs, annealing temperatures, amplicon size, and references for 
previous characterizations of primers (if applicable) are presented in Table 1. Gene expression was 
quantified as described previously (Nesan et al., 2012 [Chapter 2]) using the ΔΔCt method (Livak and 
Schmittgen, 2001) with β-actin as a housekeeping gene (values were similar across all samples). 
  
 
  155 
Table 1 – Primer pair sequences, characteristics, and applicable references used for qPCR 
 










crh caccgccgtatgaatgtaga gaagtactcctcccccaagc 60 118 n/a 




tgtgctgaaggtgattctcg gctcatgcacattctgagga 60 115 (Alsop and 
Vijayan, 2008) 
mc2r ctccgttctcccttcatctg attgccggatcaataacagc 60 127 (Alsop and 
Vijayan, 2008) 
mr cccattgaggaccaaatcac agtagagcatttgggcgttg 60 106 (Alsop and 
Vijayan, 2008) 
pomca gaagaggaatccgccgaaa ccagtgggtttaaaggcatctc 60 107 (Kulkeaw et al., 
2011) 
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5.3.7 Statistical analysis 
Statistical measures were performed using the Sigmaplot software package.  Comparisons were made 
between cortisol injected and control injected embryos and between cortisol-antibody injected and 
yeast-antibody injected (control) embryos. Data are presented as mean + standard error of the mean 
(SEM). Statistical comparison of cortisol concentrations during embryogenesis (24, 48, 72 hpf) and 
after exposure to a physical stressor (0, 5, 30, 60 minutes post stressor) were assessed by two-way 
ANOVA (p<0.05) with a Bonferonni post-hoc test. All other comparisons (early cortisol for antibody 
confirmation; embryo growth metrics; qPCR analysis) were made using a student’s t-test (p<0.05). 
Where necessary, data were log-transformed to meet the assumptions of normality and equal 
variance, while non-transformed data are shown in the figures. 
5.4 Results 
5.4.1 Confirmation of antibody efficacy 
To ensure that the injected cortisol antibody was able to sequester cortisol effectively, embryo cortisol 
concentration was measured at 4 and 12 hpf via ELISA, with injected cortisol antibody acting to 
outcompete the antibody utilized in the ELISA. These results are presented in Figure 1. At both 4 hpf 
(Figure 1A) and 12 hpf (Figure1B) there was a significant reduction (86% and 64%, respectively) in 















Figure 1 - Confirmation of antibody efficacy 
Cortisol content in embryos injected with cortisol antibody (Cort AB) and the yeast-specific antibody 
(yeast AB) was measured at 4 hpf (A) and 12 hpf (B). At both timepoints, cortisol antibody injected 
embryos displayed a significant reduction in cortisol content as measured by ELISA, indicating active 
binding by the injected antibody to sequester cortisol. All data presented is mean ± SEM; * indicates 
significant differences (n=6 pools of 25 embryos, students t-test, p<0.05). 
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5.4.2 Observation and characterization of embryo phenotypes 
Embryos were observed throughout embryogenesis for gross changes in morphology, and then 
imaged for further analysis via quantification of growth metrics. Representative embryo images are 
presented in Figure 2 at 48 hpf (A) and 72 hpf (B). The controls used in the two experiments, the 
vehicle-only (for cortisol-injection) and the yeast-specific antibody (for cortisol antibody-injection), 
showed no morphological differences at any point during embryogenesis. Morphological changes 
were seen with cortisol antibody injection, including moderate tail-kinking and deformed curvature 
(see arrows). The images presented of the cortisol-injected embryos (Figure 2) are those that showed 
the previously (Nesan and Vijayan, 2012a) characterized “mild” or “unaffected” phenotypes that 
exhibited only mild cardiac edema and no other major deformations. 
 Embryo growth was measured by assessing the length from head to tail at 48 hpf (Figure 3A, 
B) and 72 hpf (Figure 3C,D). At 48 hpf, there was a significant increase in embryo length in cortisol-
injected embryos relative to controls (24% increase, Figure 3A), and this change was even more 
pronounced at 72 hpf (76% increase, Figure 3C). In cortisol-antibody injected embryos, there was a 
small decrease in embryo length at 48 hpf (19% reduction, Figure 3B), but no significant change at 72 
hpf was observed. In addition to length, the angle between the eye-ear axis and the notochord was 
measured to assess embryo extension at 72 hpf (Figure 4). There was no change observed in cortisol-
injected embryos relative to controls (Figure 4A), but cortisol antibody injected embryos had a 
significantly increased angle relative to yeast antibody treated embryos (Figure 4B), indicating a 













Figure 2 – Representative images of treated embryos 
Embryos injected with 32 pg of cortisol (CORT), vehicle control (CON), cortisol antibody (C-AB), or 
yeast-specific antibody (Y-AB), were imaged at 48 hpf (A) and 72 hpf (B). Representative images are 
presented. Cortisol-injected embryos displayed mild cardiac edema (see arrows), and cortisol 
antibody embryos displayed kinked tails and other disruptions in mesoderm formation (see arrows).  
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Figure 3 – Quantification of embryo length 
Embryo growth was measured by the length from the tip of the head to the tail at 48 hpf (A,B) and 72 
hpf (C,D) for embryos treated with 32 pg of cortisol or vehicle (A, C) to upregulate cortisol signaling 
in development, and embryos treated with cortisol antibody or yeast-specific antibody (B,D) to reduce 
available embryo cortisol content. Cortisol upregulation resulted in increased embryo length at both 
timepoints, while decreased cortisol signaling reduced embryo length only at 48 hpf. All data 
presented is mean ± SEM; * indicates significant differences (n=6-7 embryos, students t-test, p<0.05). 
  
 





















































































Figure 4 – Quantification of embryo extension 
Embryo extension was measured by determining the angle between the ear-eye axis and the 
notochord in developing embryos at 72 hpf after treatment with either 32 pg of cortisol or vehicle 
only control (A), or with cortisol or yeast-specific antibody injection (B). Cortisol injection did not 
result in any change relative to control, but cortisol antibody injected embryos were less extended 
(indicated by a higher angle which represents a curled embryo). All data presented is mean ± SEM; * 
indicates significant differences (n=6-7 embryos, students t-test, p<0.05). 
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5.4.3 Embryo cortisol concentration throughout development 
Exogenous administration of 32 pg of cortisol into the newly-fertilized egg significantly elevated 
embryo cortisol concentration at all measured developmental timepoints (Figure 5A). At 24 hpf, 
control-injected embryos had 1.35 pg/egg, compared to 4.83 pg/egg in cortisol-injected embryos. At 
48 hpf, control-injected embryos remained relatively constant, containing 1.76 pg/egg, and cortisol-
injected embryos did not show a significant increase either at 48 hpf (6.85 pg/egg). Only at 72 hpf 
was cortisol significantly elevated within each treatment group, with control-embryos containing 5.8 
pg/egg and cortisol-injected embryos containing 8.71 pg/egg.  
 Antibody treatment, which was previously shown to sequester cortisol (Figure 1), also 
reduced the available cortisol in the embryo at later developmental stages (Figure 5B). At 24 hpf, 
both the cortisol antibody injected embryos and the yeast antibody injected embryos had quite low 
cortisol concentrations (0.88 pg/egg and 1.26 pg/egg, respectively), but there was no statistical 
difference between the values. The result was the same at 48 hpf (1.22 and 1.50 pg/egg, respectively). 
Again it was only at 72 hpf that there was an observed difference both between the treatment groups 
and against the earlier timepoints. The cortisol antibody injected embryos had a significantly 
increased level of cortisol compared to earlier timepoints (3.46 pg/egg), as did the yeast antibody 
injected embryos (5.79 pg/egg; different letters in Fig. 5B indicate significance within a treatment). 
Additionally, at 72 hpf, the cortisol antibody injected embryos were significantly lower in cortisol 
concentration than the yeast antibody injected embryos (Figure 5B). 
  
 










Figure 5 – Embryo cortisol content of treated embryos during development 
ELISA was used to measure cortisol in the developing embryos was measured at 24, 48, and 72 hpf 
after treatment with either 32 pg of cortisol or vehicle only control (A), or with cortisol or yeast-
specific antibody injection (B). Cortisol injection resulted in elevated cortisol content at all times 
relative to control injection, and both treatments were only significantly elevated at 72 hpf relative to 
their respective 24 hpf concentrations. All data presented is mean ± SEM; * indicates significant 
differences (n=4 pools of 15-25 embryos, two-way ANOVA, p<0.05). 
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5.4.4 Quantifying the response to a physical stressor 
The effects of the injected treatments on the stress response were measured by quantifying embryo 
cortisol concentration during recovery from an acute physical stressor. Cortisol-injected embryos 
displayed an abrogated stress response relative to control embryos (Figure 6A). Control embryos had 
an initial cortisol of 6.28 pg/egg, and showed a significant increase at 5 minutes post stressor (11.74 
pg/egg), which remained elevated and relatively constant at 30 minutes (11.27 pg/egg) and 60 
minutes (11.33 pg/egg) post-stressor. Cortisol-injected embryos had a higher pre-stress cortisol level 
(8.36 pg/egg) and did not show a stress-induced increase in cortisol at either 5 (9.11 pg/egg) or 30 
(9.70 pg/egg) minutes post-stressor, and in fact showed a decrease in cortisol after 60 minutes (6.08 
pg/egg).  
 A reduction in available embryo cortisol, on the other hand, appears to heighten and shorten 
the stress response (Figure 6B). Yeast antibody injected embryos had an initial cortisol concentration 
of 5.04 pg/egg, which was not significantly changed at 5 minutes post stressor (6.29 pg/egg), but was 
elevated at 30 minutes (11.33 pg/egg) post stressor and that level was maintained until 60 minutes 
(10.03 pg/egg) post-stressor. Cortisol antibody injected embryos had a lower pre-stress cortisol level 
(3.77 pg/egg) than the yeast antibody injected embryos, as was shown throughout development 
(Figure 5B). After stressor, cortisol levels increased significantly by 5 minutes (16.09 pg/egg) and 
remained elevated at 30 minutes (18.14 pg/egg) post-stressor. At both of these timepoints, cortisol 
antibody injected embryos had significantly higher cortisol content than yeast antibody injected 
embryos. By 60 minutes post-stressor, the cortisol concentration in the cortisol antibody injected 
embryos had returned to pre-stress levels (2.66 pg/egg). 
  
 









Figure 6 – Cortisol response to a physical stressor in treated larvae 
ELISA was used to measure changes in cortisol content during recovery from an acute physical 
stressor in embryos injected with either 32 pg of cortisol or vehicle only control (A), or with cortisol 
or yeast-specific antibody injection (B). Cortisol injection completely abolished the stress response 
relative to control embryos, with no observable rise in cortisol concentration at any time point, while 
control embryos. Cortisol antibody injection accentuated but shortened the stress response in 
comparison to yeast-specific embryos, with higher cortisol at 5 and 30 minutes post stressor, but a 
reduced cortisol concentration after 60 minutes. All data presented is mean ± SEM; * indicates 
significant differences (n=4-6 pools of 15-25 embryos, two-way ANOVA, p<0.05). 
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5.4.5 Expression of HPI axis genes 
In order to find mechanistic linkages for the disrupted stress response in treated embryos, expression 
of key genes involved in the function of the HPI axis was measured by qPCR in 48 hpf embryos. 
These results are displayed in Figure 7, organized by gene: graphs displaying cortisol-injection effects 
(relative to control embryos) are in the left column; graphs displaying changes from cortisol antibody 
injection (relative to yeast antibody injected embryos) are on the right.  
Expression of a number of HPI genes was significantly changed in cortisol-injected embryos 
relative to controls. Transcript abundances of crh (Figure 7A), 11β-hydroxylase (Figure 7E). pomca 
(Figure 7K), and star (Figure 7M) were all significantly reduced in response to exogenous cortisol 
administration at 48 hpf. A single gene, mc2r, was significantly increased in cortisol-injected 
embryos relative to controls (Figure 7G). There was no observed change in expression of gr (Figure 
7C) or mr (Figure 7I).  
The reduction of cortisol content in the embryo had opposite effects for most of the observed 
genes. In cortisol antibody injected embryos, the expression of crh (Figure 7B), 11β-hydroxylase 
(Figure 7F). pomca (Figure 7L), and star (Figure 7N) were all significantly increased relative to yeast 
antibody injected embryos. There was also a significant decrease in the expression of mr in response 
















Figure 7 – Altered expression of HPI axis genes 
Quantitative PCR was used to measure the mRNA abundance of key genes involved in HPI axis 
function in 48 hpf embryos. Measured genes were: crh (A, B), gr (C, D), 11B-hydroxylase (E, F), 
mc2r (G, H), mr (I, J), pomca (K, L), and star (M, N). For all genes, data from embryos injected with 
either 32 pg of cortisol or vehicle only control are in the left column, and data for embryos with 
cortisol or yeast-specific antibody injection are in the right column. Expression of crh, 11B-
hydroxylase, pomca, and star were all downregulated as a result of cortisol injection (relative to 
control embryos), and upregulated after cortisol antibody injection (relative to yeast antibody injected 
embryos). Expression of gr was unchanged by either treatment. Expression of mr was downregulated 
only after cortisol antibody injection, and expression of mc2r was upregulated only after cortisol 
injection. All data presented is mean ± SEM; * indicates significant differences (n=6 pools of 25 
embryos, students t-test, p<0.05). 
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5.5 Discussion 
In this study, we describe for the first time some clear linkages between the amount of cortisol 
available to newly-fertilized zebrafish embryos and the post-larval functioning of the stress axis, and 
we identify key HPI genes that are under the control of cortisol signaling during early development.  
Together these results demonstrate that maternally deposited cortisol is functionally relevant in the 
developing zebrafish embryo and can have significant impacts on the ability to respond to a stressor 
challenge later in life. These findings point to a putative linkage between the maternal stress state and 
the offspring phenotype, which has interesting ecological and evolutionary implications for the use of 
maternally deposited cortisol as a stress-induced signal that may pattern the developing embryo as a 
preparatory measure. 
5.5.1 Characterization and validation of treatments 
To investigate the role of maternally deposited cortisol in the fertilized zebrafish embryo, we 
performed two experiments in parallel. We injected exogenous cortisol into single-cell embryos to 
mimic increased deposition, and we used a commercially available cortisol antibody to sequester 
deposited cortisol in the yolk to simulate a reduced deposition load. We have previously characterized 
and validated the addition of 32 pg of cortisol as sufficient to elevate cortisol content until hatching 
(Nesan and Vijayan, 2012a [Chapter 3]), and while it is unlikely that this level of deposition can 
occur in natural conditions, the continued use of this model allows us to further characterize cortisol-
responsive processes in development. In this previous study, we showed that 32 pg of cortisol results 
in upregulation of GR-responsive genes, indicating a functional increase in glucocorticoid signaling. 
 With the use of the cortisol and yeast-specific antibodies, we took steps to validate their use in this 
study. First, we saw clear reductions in the frequency and severity of the presented morphological 
phenotype only with cortisol but not yeast antibody (Figure 2). Furthermore, we found that the 
cortisol antibody significantly reduced the amount of measurable cortisol in early development 
(Figure 1), indicating that binding and sequestration are occurring and that it is likely that the amount 
of cortisol available to the embryo initially after fertilization is drastically different. This is of key 
importance, as previous research has shown that reduced glucocorticoid signaling (altered by 
knockdown of GR) results in an altered transcriptome after the mid-blastula transition, implicating 
cortisol signaling in the degradation of maternal mRNA (Pikulkaew et al., 2011). We also observe 
that the cortisol antibody shows interesting phenotypic consistencies with previously established GR 
morphant embryos (Pikulkaew et al., 2011; Nesan et al., 2012 [Chapter 2]), including kinked tails 
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(Figure 2), reduced growth (Figure 3), and slowed straightening of the tail (Figure 4) during 
embryogenesis. This indicates that the GR knockdown phenotype is at least partially due to a 
reduction of glucocorticoid signaling in the embryo as opposed to solely ligand-independent effects. 
As seen previously (Nesan and Vijayan, 2012a [Chapter 3]), we do not see any changes to embryo 
extension as a result of increased cortisol signaling in development, but there is a significant increase 
in growth at both 48 and 72 hpf (Figure 3). This is interesting as we see a decrease in embryo length 
both in the current study with the administration of cortisol antibody and in morphant embryos after 
knockdown of GR translation (Nesan et al., 2012 [Chapter 2]). The clear implication is that growth in 
the developing embryo is glucocorticoid responsive as both increases and decreases in cortisol 
signaling result in disrupted growth. Previous research in teleosts has shown differing relationships 
between cortisol and the somatostatic axis (van der Boon et al., 1991). In some cases there is a 
positive correlation between cortisol and growth hormone expression (Young et al., 1989; Yada et al., 
2005), whereas in other situations cortisol inhibits growth (Peterson and Small, 2005; Pierce et al., 
2011). To our knowledge, little is known about cortisol action on the growth of the early zebrafish 
embryo, and this research presents a novel relationship between embryo growth and circulating 
glucocorticoids. 
5.5.2 Developmental cortisol dynamics in our treated embryos 
As a preliminary step to assessing the effects of modulated cortisol deposition in the developing 
embryo, we quantified the basal embryo cortisol levels during development. We have assessed this 
before for the administration of 32 pg of cortisol (Nesan and Vijayan, 2012a [Chapter 3]) and our 
results are in general agreement. Our findings in this study also support our previous measurements of 
~4 pg/egg of initial cortisol deposition (Alsop and Vijayan, 2008; Nesan and Vijayan, 2012a), 
indicating that the level of cortisol deposition by unstressed zebrafish mothers appears to be relatively 
constant. It is unclear to what extent this deposition can vary, although evidence from other teleosts 
suggests that stressed mothers can deposit an increased amount of steroid (Giesing et al., 2011). 
During normal zebrafish embryogenesis, cortisol content in the embryo decreases during the pre-
hatch period from the initial deposition, with de novo synthesis and accumulation becoming 
significant only after hatching and close to feeding (Alsop and Vijayan, 2008; Nesan and Vijayan, 
2012a [Chapter 3]). This pattern was not changed in embryos injected with either the cortisol or 
yeast-specific antibody, however the cortisol antibody reduced the measured cortisol at 72 hpf. It 
should be noted that this is expected to be a decrease in the available cortisol that can be measured, 
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due to sequestration by the antibody, as opposed to a reduction in production or an increase in cortisol 
turnover. However, as there are multiple feedback levels acting on the HPA in response to cortisol 
levels (Bradford et al., 1992; Wendelaar Bonga, 1997; Mommsen et al., 1999), there may be a natural 
reduction in cortisol production or accumulation in response to reduced cortisol deposition at 
fertilization. It is unclear as to what extent decreased overall embryo cortisol concentration would be 
functionally relevant at 72 hpf, but a chronic reduction in circulating cortisol can disrupt a variety of 
functions involving metabolism and other necessary processes (Fries et al., 2005). In humans, 
hypocortisolism can occur in patients with Addison’s disease or other adrenal conditions, and has 
implications for fatigue, reduced cardiovascular health, and conditions such as fibromyalgia (Heim et 
al., 2000; Fries et al., 2005; Van Houdenhove et al., 2009). 
5.5.3 Reduced embryonic cortisol availability enhances the larval stress response 
It is particularly interesting that the sequestration of cortisol and the resulting reduced signaling seems 
to heighten and sensitize the cortisol response in zebrafish larvae. We observe a stronger, faster, 
cortisol response in embryos injected with cortisol antibody (Figure 6B).  This result coincides with 
an increased expression of multiple genes involved in HPI axis function at 48 hpf, such as CRH 
(Figure 7A) and the ACTH precursor POMCA (Figure 7L), which are both necessary for triggering a 
cortisol response (Wendelaar Bonga, 1997). Two genes involved in steroidogenesis, StAR (Figure 
7N), which is involved in initial movement of the steroid precursor cholesterol (Bauer et al., 2000), 
and 11β hydroxylase (Figure 7F), which is an enzyme involved in the cortisol synthesis pathway 
(Kawamoto et al., 1992; Alsop and Vijayan, 2008) are also increased in embryos treated with the 
cortisol antibody. The increased expression of these four genes indicates that these embryos that 
experienced lowered glucocorticoid signaling in the early embryo have an enhanced HPI signaling 
and steroid production capacity. It was also observed that mineralocorticoid receptor (MR) expression 
was decreased in the cortisol antibody treated embryos. MR can bind cortisol in vitro, but its exposure 
to the ligand in live tissues is unclear (Sturm et al., 2005; Pippal et al., 2011), and the overall role of 
MR in the zebrafish and other teleosts remains to be explored. However, it is interesting that 
decreased glucocorticoid signaling yields a reduction in MR expression, as it points to potential 
crosstalk between corticosteroid receptors. This study also reinforces our previous findings from 
knockdown of GR protein translation, which caused upregulated expression of pomca and the 
hypothalamic marker otpb (involved in dopaminergic neuron formation, (Blechman et al., 2007)) at 
both 24 and 36 hpf (Chapter 4). We observe the same change in pomca at 48 hpf and see an increase 
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in crh which would be expected in embryos with increased hypothalamic development. These 
correlations lend further support to our conclusions that the cortisol antibody administration causes a 
functional decrease in glucocorticoid signaling, and that this disrupts HPI axis development and 
function. This indicates that maternal cortisol deposition may be an important signal for patterning the 
HPI axis development of the embryo. 
5.5.4 Exogenous cortisol addition reduces HPI axis stress response capacity 
It is particularly interesting that the four genes that were upregulated in cortisol-antibody treated 
embryos show opposing changes with exogenous cortisol administration. All of the previously 
mentioned genes, crh, pomca, star, and 11β hydroxylase were significantly downregulated at 48 hpf 
in larvae with elevated pre-hatch cortisol (Figures 7A, 7K, 7G and 7M, respectively). In addition, 
these larvae displayed an abrogated cortisol response after the acute physical stressor (Figure 6A), 
with no rise in cortisol being evident at any point. This lack of cortisol response is likely to have a 
large impact on the post-hatch zebrafish, which must begin feeding and competing in environments 
that are likely to be stressful. The four genes previously mentioned are likely responsible for the 
inhibited stress response, as cortisol-antibody injected embryos with low expression of crh and pomca 
will show reduced activation of the interrenal steroidogenic cells, and the downregulation of star and 
11β hydroxylase will reduce the cortisol production capacity of the cells. Altogether, this will result in 
reduced cortisol production in response to stress in embryos that experience increased developmental 
glucocorticoid signaling. It should be noted that any effects on the feedback regulation of the HPI axis 
in our treated zebrafish do not seem to include modulation of GR expression. In other teleosts, GR 
receptors at different levels of the HPI axis act to feed back and control the axis (Mommsen et al., 
1999; Barton, 2002; Alderman et al., 2012), but that was not seen in the current study. Instead, we 
observed an alteration in expression of crh, pomca (produced by the hypothalamus and pituitary, 
respectively) in both sets of treatment and of mc2r (expressed in the interrenals) after upregulation of 
cortisol signaling, indicating that all three HPI organs may be affected by embryonic cortisol 
concentration. Together these results provide clues to a mechanistic linkage between embryonic 
cortisol deposition and HPI axis activity. We posit that glucocorticoid signaling in early development 
is necessary for proper formation of the hypothalamus, which can then cause long-term programming 
of the stress axis into maturity. 
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5.5.5 Potential disruptions to embryo fitness as a result of altered maternal cortisol 
deposition  
The implications for the disrupted HPI axis function on the larval and maturing zebrafish are 
widespread due to the numerous roles of cortisol in teleosts (Mommsen et al., 1999; Barton, 2002). In 
addition to the previously mentioned roles in energy metabolism and the implications for growth, 
cortisol is also a major osmoregulatory hormone in fish (McCormick, 2001). The changes in cortisol 
responsiveness seen in our study, with cortisol antibody treatment resulting in upregulated cortisol 
production, and increased cortisol at fertilization having the opposite effect, implies that the ability to 
respond to a physical stressor may be compromised in these fish as they mature. This may present 
problems for larvae that are exposed to physically-challenging environments or in the context of 
predator exposure. In addition, a prominent emerging field in teleost study is the understanding of fish 
behavioral dynamics. Initial studies in trout and subsequent supporting evidence from other teleost 
species has linked the magnitude of the cortisol response to stress with aggression, behavior, and the 
establishment of dominant/subordinate relationships (Pottinger and Carrick, 2001; Gilmour et al., 
2005; Barreto et al., 2009; Chang et al., 2012). Social stratification has been observed in zebrafish 
(Dahlbom et al., 2011), but correlations with stress responsiveness have not been established. 
However, if the linkage between stress-induced cortisol levels and aggression is conserved in 
zebrafish, there is interesting potential for maternal stress levels and steroid deposition to pattern the 
behavior of offspring. This concept of maternal stress hormone deposition as a phenotypic 
programming molecule for offspring has been established in birds and reptiles, where changes in yolk 
corticosterone concentration affect the post-hatch animal (De Fraipont et al., 2000; Hayward and 
Wingfield, 2004; Meylan and Clobert, 2005; Müller et al., 2007; Groothuis and Schwabl, 2008; Love 
and Williams, 2008). Clearly this is an area of zebrafish development where further exploration is 
required.  
5.5.6 Conclusions 
For the first time, our findings provide a linkage between early embryo cortisol content and the post-
hatch function of the stress-axis, with measurements altered expression of key HPI genes to provide 
assessment of HPI organ activity. We also quantify and assess the disrupted cortisol response to stress 
in embryos that have experienced differential early cortisol signaling, showing that increased cortisol 
in the embryo suppresses the cortisol response to stress, and that lack of available cortisol at 
fertilization results in a heightened larval stress response. To our knowledge this is the first instance 
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in teleosts that maternally deposited cortisol levels have been linked to altered stress axis functioning, 
but this supports findings from mammalian models. In avian and reptilian models, egg corticosteroid 
concentration is known to alter the developing phenotype. The actions of the HPI axis in teleosts are 
complex and fundamental to the survival of the adult animal, underscoring the importance of these 
novel findings. Together, this study adds further evidence to the growing consensus that 
glucocorticoid signaling in zebrafish development is critically important to a variety of developmental 
processes and can have lasting effects in the adult animal. 
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6.1 Summary of findings 
Altogether, the findings from these experiments for the first time underscore a key role for maternal 
cortisol signaling by glucocorticoid receptor (GR) activation in zebrafish development. The results 
support the primary hypothesis that maternal cortisol and GR signaling have functional relevance in 
the early zebrafish embryo. 
 The first study demonstrated that GR knockdown resulted in a series of deformations and 
developmental delays in the early embryo, affecting somitogenesis, myogenesis and expression of 
muscle specific genes, and overall embryo growth and extension, and post-hatch survival (Chapter 2). 
Perhaps most importantly, GR signaling was shown to disrupt the expression of bone morphogenetic 
proteins (BMPs), implying a much more prominent role for GR signaling in the developing embryo. 
These characterized phenotypic changes were rescued with exogenous administration of GR mRNA 
further supporting our conclusion that the observed changes were GR-specific. This was the first 
study to demonstrate the importance of GR knockdown to embryo growth and survival and 
demonstrate the GR responsive nature of specific BMP genes. 
 This study was followed by exogenous cortisol administration to the newly fertilized embryo, 
causing disrupted cardiogenesis and yielding a series of phenotypes ranging from mild cardiac edema 
to complete lack of pericardium and no functional heartbeat (Chapter 3). These changes were linked 
to altered expression of key cardiogenic genes including the heart field transcription factor nkx2.5. In 
addition to morphogenic malformations of the heart, post-hatch larvae showed a reduced resting heart 
rate and an inhibited ability to raise heart rate in response to an acute physical stressor. This study 
provided a definitive linkage between the concentration of cortisol in the developing zebrafish 
embryo and organogenesis, specifically the development of the heart, and indicated that larval 
performance will be disrupted by increased zygotic cortisol. 
 The microarray analysis yielded a wealth of knowledge regarding the effects of GR 
knockdown at 24 and 36 hpf, measuring over 1000 significantly changed genes at each time point 
(Chapter 4). These results supported the role of GR in BMP signaling, myogenesis, and cardiogenesis 
that were presented in the first two chapters, as microarray fold-changes were in agreement with 
genes measured previously by other methods and helped to explain the previously characterized 
phenotypes. In addition to this support, the microarray measurements indicated a number of novel 
pathways and genes that were unexpectedly changed in response to lowered glucocorticoid signaling, 
including neurogenesis, cell adhesion, eye formation, and hypothalamic-pituitary-interrenal (HPI) 
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axis formation and function. Together this study displayed the critical role of GR as a developmental 
regulator that modulates a variety of key pathways in embryogenesis. 
 The potential role of maternal cortisol signaling in zebrafish HPI axis formation was 
explored, both in response to increased cortisol in the zygote at fertilization (achieved via exogenous 
administration as in Chapter 2) and also by reducing cortisol content by sequestering this steroid 
using antibodies (Chapter 5). In this chapter, glucocorticoid signaling was found to pattern the HPI 
axis, with significant changes seen in the post-hatch larval ability to increase cortisol levels in 
response to a physical stressor. Embryos exposed to exogenous cortisol displayed an abrogated stress 
response, while those that experienced a reduction in available cortisol showed a heightened cortisol 
peak after a stress challenge. These changes in HPI function were correlated with changes in 
expression of signaling molecules like crh, 11B-hydroxylase, pomca, and star. This is the first study 
to link levels of cortisol in the newly fertilized embryo, which only occur through maternal 
deposition, to the development and function of the stress axis in post-hatch zebrafish larvae. This is a 
critical connection between the maternal environment prior to spawning and the resulting offspring 
phenotype. 
 Together, these findings add a great deal to the relative paucity of prior knowledge about 
glucocorticoid signaling in the early zebrafish embryo. The results from this thesis for the first time 
position GR as a major developmental regulator, acting upstream of key development factors such as 
BMPs and matrix metalloproteinases, and acting, directly or through intermediates, on a host of 
developmental events, including maternal mRNA degradation, somitogenesis and myogenesis, 
cellular migration, cardiogenesis, stress axis development, neurogenesis, eye formation, and 
craniofacial development (see Figure 1 for a summary). These early GR actions may have lasting 
effects on developmental programming as the larvae mature, influencing the ability to respond to 
stressor challenges by compromising osmoregulation or cardiac performance in a manner similar to 
the established mammalian glucocorticoid programming effects that result in hypertension or other 
cardiovascular defects.  
  
 






Figure 1 – Summary of known glucocorticoid-responsive genes and pathways in zebrafish 
development 
The glucocorticoid receptor (GR) is a developmental regulator that affects a variety of genes and 
pathways, this schematic summarizes the known processes and associated genes during early 
development in zebrafish (transcription factors are in bold). GR signaling affects myogenesis and 
modulates myogenic transcription factors and downstream muscle proteins. Specific matrix 
metalloproteinases (MMPs) have been shown to be GR-responsive which can affect numerous 
developmental processes associated with extracellular matrix remodeling, and this study has 
highlighted a variety of other ECM and cell adhesion proteins affected by GR knockdown. 
Expression of specific bone morphogenetic proteins (BMPs), receptors, and signaling molecules are 
also modulated by GR signaling and are involved with a variety of major developmental processes. A 
number of cardiogenic genes and major cardiac muscle proteins are disrupted by increased cortisol 
signaling, resulting in malformed heart structures and reduced cardiac performance. Osmoregulation 
has also been shown to be GR-mediated via the ammonia transporter rhcg1. Neurogenesis has been 
shown to be a glucocorticoid  responsive process, with a variety of neural transcription factors 
disrupted and specific hypothalamic markers affected, along with other signaling molecules in the 
HPI axis response to stress. Finally, GR signaling has been implicated in maternal mRNA 
degradation at the mid-blastula transition, retina and lens formation, and with overall embryo growth, 
extension, and survival, but no specific molecular mechanisms have been linked to these effects.  
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6.2 Perspectives and avenues for further research 
The findings presented in this thesis provide interesting starting points for research questions in a 
variety of areas of zebrafish development and physiology. The microarray study alone is likely to 
contain more novel findings than are presented in Chapter 4. However, there are also questions that 
stem from the data that have been presented in full. The novel linkages of GR knockdown to 
increased neurogenesis and di- and tel-encephalon development are an interesting finding. 
Ascertaining the extent to which these changes occur in the living animal is a critical question 
remaining in this area, and can apply to a variety of the pathways we have begun to explore in these 
studies. 
 Other questions that present themselves involve behavior and the role of maternally deposited 
cortisol in patterning the phenotype and behavior of the larva and mature animal. It is known that fish 
populations tend to subdivide into dominant and subordinate individuals that vary in their 
aggressiveness, feeding patterns, and response to stimuli (Gilmour et al., 2005). A key difference 
between these subpopulations is that dominant fish have an attenuated cortisol response to stressors 
(Pottinger and Carrick, 2001; Overli et al., 2004). Given the evidence that prenatal glucocorticoids 
can modulate the stress response later in life in mammalian (Matthews, 2002; Seckl and Meaney, 
2004), avian (Hayward and Wingfield, 2004) and zebrafish (Chapter 5) models, it begs the question 
whether maternal glucocorticoid deposition into oocytes and the associated changes in brain 
developmental programming may be playing a role in these social divisions. The zebrafish model 
provides significant advantages as a model for genetic and behavioural studies and can be used to 
effectively investigate these questions. The optically clear zebrafish embryos allow for easy 
visualization of developmental defects, and the speed with which they develop means that behavioral 
changes at various developmental stages to adulthood can be observed within a few months in this 
species.  
 The newfound developmental roles for glucocorticoid action from the zebrafish model, 
including regulation of morphogens (BMPs, MMPs), cardiogenic, myogenic, and neurogenic 
transcription factors underscore the role of this steroid in regulating embryogenesis. Understanding 
the molecular mechanisms of action is critical to unraveling the pathways modulated by cortisol 
during development. To answer questions of programming, mechanisms of action, and epigenetic 
effects, the molecular tools available to zebrafish researchers are highly valuable. Forward and 
reverse genetic techniques are well established, including mutation screens, RNA silencing and 
 
  190 
protein knockdown, microarray analysis, and transgenics, along with other molecular and imaging 
tools (Driever et al., 1994; Jowett, 1999; Rasooly et al., 2003; Teh et al., 2005; McLean and Fetcho, 
2008). Next generation sequencing techniques that are now more effective and less cost-prohibitive 
could also be used to investigate GR effects on the transcriptome at fertilization or around the mid-
blastula transition to elucidate GR actions on maternal mRNAs or possible GR-mediated epigenetic 
effects. These techniques, in combination with the wealth of knowledge of developmental processes 
that has developed over the last two decades of investigation, makes zebrafish the best possible 
animal in which to identify the precise mechanisms of cortisol signaling and its effect on 
development. Promoter characterization and identification of functional glucocorticoid response 
elements present on target genes of interest may shed light on the mechanisms of action of GR in 
regulating morphogenesis. Other techniques such as chromatin immunoprecipitation (ChIP) alone or 
in combination with microarray (ChIP on chip) will be invaluable in revealing novel GR signaling 
pathways and also assist with establishing the interactome involved in the developmental regulation 
by glucocorticoids. 
 A promising area of study is the environmental regulation of long-term phenotypic changes 
and a key player in this regard is the epigenetic modulation of gene expression during development 
(Youngson and Whitelaw, 2008; Zhang and Meaney, 2010). GR is a known target for epigenetic 
regulation (Lillycrop et al., 2007; Oberlander et al., 2008; McGowan et al., 2009), and corticosteroid 
signaling appears to modulate gene expressions via epigenome modifications (Moritz et al., 2005; 
Weaver, 2009; Krukowski et al., 2011). These relationships, along with the established effects of GR 
in the degradation of zebrafish maternal mRNAs (Pikulkaew et al., 2011) suggests that developmental 
glucocorticoid effects on organogenesis and growth may involve epigenome modifications, but this 
remains to be tested. The known effects of glucocorticoids on zebrafish organogenesis and the 
research showing that altered developmental glucocorticoid exposure can modulate the stress 
response in larval and adult animals (Matthews, 2002; Hayward and Wingfield, 2004; Seckl and 
Meaney, 2004; Nesan and Vijayan, 2012[Chapter 2]) also leads us to hypothesize that regulation of 
embryo cortisol levels may be necessary for proper development of the stress axis. The similarity 
between zebrafish and human GR variants suggest that findings on the functional role of this receptor 
in zebrafish may provide important clues to the developmental risks and phenotypes associated with 
fetal stress and/or abnormal prenatal glucocorticoid exposure in humans.  
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6.3 Conclusions 
Stress axis organ ontogeny patterns and the endocrine stress response itself are well conserved 
throughout vertebrates. Our newfound evidence from zebrafish has identified the primary circulating 
glucocorticoid, cortisol, and its receptor as a developmental regulator that is critical for 
embryogenesis, acting upstream of several different developmental processes and pathways. These 
findings dovetail with established effects of glucocorticoids on mammalian organogenesis and other 
models. The similarities in vertebrate corticosteroid physiology indicate that the glucocorticoid 
actions during development may be conserved, providing a mechanistic link between maternal or 
prenatal stress and developmental abnormalities leading to reduced fitness and survival. The 
techniques and methodologies that have been developed for use in zebrafish provide an excellent 
model for understanding the role of fetal glucocorticoid signaling on developmental-endocrine 
interactions in humans, with important biomedical applications. For the first time, this dissertation 
presents maternally deposited cortisol and glucocorticoid receptor content as a major developmental 
morphogen, acting independently of their classically-studied actions in the physiological response to 
stress. Altogether, this research has spawned a host of novel findings which position glucocorticoid 
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Figure A1 – Glucocorticoid receptor-green fluorescent protein (GR-GFP) reporter construct.  
Schematic display of the construct is presented detailing binding sites and regions of interest within 
the GR promoter including primer and other putative binding sites (GR2-FR, GR-RV), glucocorticoid 
response element (GRE), activator protein 1 binding site (AP-1), splicing factor 1 binding site (SP-1), 
estrogen response element (ERE), and transcription start site (TSS).  
  
 




























Figure A2 – Putative GR promoter sequence 
Sequence of putative GR promoter region, complete with specific locations of each putative binding 
site: glucocorticoid response element (GRE), activator protein 1 binding site (AP-1), splicing factor 1 
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Figure A3 – Fluorescence images of GR promoter activation in developing embryos. 
A GR-GFP construct consisting of zebrafish GR promoter region coupled to the GFP coding 
sequence was injected into embryos (n=9 groups of 40-60 embryos). No fluorescence was detected at 
12 hpf (I), but fluorescence was observed at 15 hpf (II) and 18 hpf (III), while a negative control 
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Figure A4 – Putative non-functional glucocorticoid response elements in MyoD and IGF 
promoter regions. 
Schematics of putative glucocorticoid response elements (GREs; numbered by starting base pair) 
upstream of MyoD, IGF1, and IGF2. 
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Appendix B 
Expanded Methods and Protocols 
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This appendix contains more detailed protocols for specific methods that are commonly used in this 
dissertation. As these chapters were written for submission to primary journals, attempts were made 
to limit the length of each chapter and to refer to published methods where applicable. However, to 
provide benefit to anyone attempting to repeat or carry on from these studies, this appendix provides 
more information on specific methods 
 
Zebrafish care and breeding 
Adult zebrafish were maintained in an AHAB recirculating system (Aquatic Habitats, Apopka, FL), 
on a 14h:10h light-dark cycle at ~28 C. For initial studies (Chapter 2), the system was filled with well 
water from the University of Waterloo main campus supply, however for all remaining studies, the 
water was made from the addition of 60 mg/L Instant Ocean marine salts (Spectrum Brands), to 
deionized distilled water. Fish were maintained in 10L tanks at an approximate stocking density of 35 
fish per tank. Water in the system was changed at a rate of ~15% per week (40-50L replaced). 
Ammonia, nitrite, and nitrate concentrations were measured weekly in the system, and pH and 
temperature were routinely monitored. Fish were fed at least 2 times per day during studies. 
During breeding attempts, fish were fed 3 times per day. Breeding was performed by 
placement of breeding traps (Aquatic Habitats) into the system to minimize handling or transfer 
stress. Subsets of the fish population were bred randomly 1-2 times per week during each study. 
Traps were put into the tanks within 60 minutes of the end of the daily light cycle, left overnight, and 
then removed 30-45 minutes after the start of the subsequent day’s light cycle. Eggs were rinsed in 
system water and cleaned, then transferred to a beaker of embryo medium (Westerfield, 2007) for 
microinjection and/or incubation. Traps would be returned to the tanks to collect eggs from any 
subsequent rounds of breeding. 
 
Microinjection protocol 
 In all experiments in this thesis, we utilize a nitrogen gas powered microinjector (Narishige, Japan) 
that is able to control the length of time of the injection event and the injection pressure. These 
measurements, in combination with the use of a microcapillary tube of known internal 
volume/diameter and an initial quantification of the volume dispensed in a known number of 
injections, allows us to closely control the amount of treatment injected into the zebrafish embryo. 
This allows for repeatability and reliability in the presented experiments, which take advantage of the 
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unique characteristics of the zebrafish embryo that are particularly beneficial when using this 
technique. 
 Microinjection needles were made with a PC-10 Dual Stage Micropipette Puller (Narishige), 
which heated and separated a single microcapillary tube (10uM internal diameter, Sutter Instruments, 
Novota, CA) into two pieces each with a sealed fine-pointed end. Fine forceps or a sterile razor blade 
were used to open the sealed end of the needle prior to use. Needle calibration was performed by 
measuring the injection volume produced by 50-100 injections, by collection in a 1uL capillary tube 
(Fisher Scientific, Ottawa, ON) and then calculating the volume of a single injection. Injection 
volume was easily adjusted by varying either the injection pressure or the injection duration on the 
microinjector to maintain a precise volume. Prior to injection, the cleaned embryos were placed in an 
injection mold to streamline the procedure. The injection mold was made of 4% agarose in embryo 
medium, and had grooves to align embryos for speedy injection. On average, hundreds of embryos 
could be injected within the 30-45 minutes between fertilization and first cleavage. Eggs beyond the 
two-cell stage were not injected in any study. All injections were carried out at the same time of day. 
After injection, eggs were transferred to 10 cm petri dishes in embryo medium,  and incubated at 28.5 
C on a 14h:10h light-dark cycle. 
 
RNA extraction and quantification 
Quantification of gene expression is a frequently-used endpoint in this dissertation. In most studies 
(Chapters 2, 3, 4) RNA was extracted by use of the RNeasy RNA extraction mini-kit with the Qiazol 
lysis reagent (both from Qiagen, Mississauga, ON), using their protocol for fatty tissues to account 
for the embryo yolk. In chapter 5, this process was replaced by the use of the Ribozol reagent 
(Amresco, Soton, OH) and extraction without the use of a kit. Both are very similar processes, based 
on variations of the phenol-chloroform extraction process, with centrifugation to separate the layers 
and manual removal of the RNA fraction. Care was taken not to remove any of the thin middle DNA 
layer, but DNAse treatment was always performed after extraction during or just prior to cDNA 
synthesis, to prevent genomic contamination. RNA was always quantified by calculation of optical 
density with a Nanodrop spectrophotometer, measuring 1.5 uL of extracted RNA. RNA was eluted or 
resolubilized in 20-25 uL of sterile, nuclease-free water in order to maintain high concentrations 
wherever possible. The absorbance ratios at 260nm/280nm and 230nm/260nm were always observed 
to ensure a high RNA purity, with 260nm/280nm ratios required to be over 1.8.  
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Appendix C 
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Data presented in this appendix include the results of statistical testing of microarray analysis fold-
changes, as described in Chapter 4, after false discovery correction. Table C1 is all significantly 
changed genes at 24 hpf, Table C2 is all significantly changed genes at 36 hpf. Calculated fold-
changes and p-values are included in the table. Colored text represents a gene that was significantly 
changed at both 24 and 36 hpf, with the color change indicating that the gene was upregulated at both 
time points (green text), downregulated (red text), or differentially altered (blue text).  
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Table C1 – Significantly changed genes at 24 hpf in response to GR knockdown 
Gene Fold Change P-value 
a2bp1 2.235 0.018918 
aanat1 0.467 0.017915 
aatf 0.602 0.038489 
abca1a 0.684 0.041834 
abcc9 2.666 0.025931 
abcg4b 0.425 0.015937 
abhd2b 2.571 0.025968 
acad8 1.322 0.021660 
acadl 2.257 0.031177 
acat1 1.716 0.029248 
acat2 1.260 0.019803 
accn1 2.148 0.050513 
aco2 1.553 0.029248 
acot7 1.499 0.011111 
acsf2 1.450 0.039732 
acta1 1.629 0.030990 
actn3a 2.854 0.037196 
adcyap1b 2.318 0.014138 
add1 1.382 0.041987 
adh5 1.240 0.045863 
adh8b 1.318 0.049430 
adipor1b 0.788 0.046797 
adora2aa 0.498 0.034921 
adora2ab 0.259 0.030320 
adsl 1.303 0.018469 
adss 1.795 0.049716 
afmid 2.022 0.043103 
agr2 2.506 0.047798 
agt 0.318 0.050117 
ahcy 1.813 0.014456 
ahr2 1.499 0.034176 
aig1 2.233 0.036903 
akap12 0.526 0.031960 
alas2 2.161 0.017711 
alcam 0.604 0.014755 
aldh16a1 1.798 0.027035 
aldh18a1 2.273 0.019816 
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Gene Fold Change P-value 
aldh7a1 1.724 0.024016 
alkbh5 0.401 0.046771 
alp 1.987 0.017711 
alpi 0.541 0.014138 
alx4 1.474 0.036390 
amdhd1 3.884 0.016384 
amph 2.147 0.027478 
angptl2 0.652 0.023632 
ank1 2.951 0.017283 
ankrd37 0.425 0.035557 
anxa11a 0.689 0.037831 
anxa13 0.669 0.027768 
anxa4 0.207 0.044936 
anxa5b 1.925 0.021651 
aox1 1.695 0.027537 
apc 1.342 0.037465 
aph1b 1.707 0.026439 
apln 1.637 0.036614 
aplnrb 0.466 0.014138 
aplp 1.990 0.015977 
apoa1 0.348 0.029973 
apoea 3.537 0.037436 
apoeb 0.587 0.030558 
apol1 1.717 0.023632 
appb 1.602 0.009609 
aqp11 1.681 0.015406 
aqp3 5.461 0.025641 
arhgef3l 3.657 0.023541 
arid3b 0.420 0.046797 
arih1l 0.570 0.023632 
arl11 1.450 0.026102 
arl13b 1.960 0.038572 
arl4a 0.623 0.016384 
arl4cb 0.784 0.043047 
arl4l 0.623 0.023380 
arnt2 0.511 0.050264 
arntl2 0.360 0.021660 
arpc1b 2.663 0.048096 
arrb1 1.863 0.040530 
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Gene Fold Change P-value 
arrdc2 0.432 0.036472 
asb12a 1.428 0.046610 
asb5 5.168 0.045683 
asb8 1.436 0.041446 
ascl1a 2.009 0.017296 
ascl1b 3.182 0.013268 
asf1b 1.532 0.043752 
aspdh 1.868 0.046610 
asph 0.589 0.019803 
aspn 2.052 0.043731 
atad4a 1.850 0.034606 
atl1 1.446 0.038905 
atl3 0.548 0.047394 
atoh2a 2.706 0.049189 
atoh2b 4.936 0.014755 
atp1a1 0.646 0.023541 
atp1a1a.2 2.785 0.017081 
atp1a1a.4 0.521 0.027478 
atp1a1b 2.021 0.027478 
atp1a3a 1.877 0.045960 
atp1b1b 2.712 0.009574 
atp1b3b 1.623 0.047798 
atp2a1 1.764 0.014755 
atp2a2a 0.211 0.043599 
atp2b1a 0.521 0.039732 
atp2b1b 0.414 0.033794 
atp5f1 1.383 0.014755 
atp5i 1.460 0.037831 
atp5j 2.520 0.031549 
atp5o 1.235 0.025693 
atp6v1b2 1.708 0.038572 
atp6v1e1 1.269 0.023541 
atp6v1h 1.349 0.039732 
avpl 1.847 0.029321 
b3gnt5 2.468 0.027300 
b3gnt7 0.226 0.043599 
barhl1.1 2.874 0.012309 
bbox1 0.199 0.017296 
bcam 0.342 0.049141 
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Gene Fold Change P-value 
bcl11a 2.704 0.019803 
bcl2l 0.395 0.009320 
bcl9l 0.516 0.049863 
bhmt 0.374 0.031834 
bik 0.509 0.034173 
bin1 2.174 0.015977 
bin2a 1.903 0.044019 
birc2 0.810 0.030990 
birc5a 1.542 0.035436 
blvrb 2.335 0.049570 
bmp4 0.563 0.015821 
bmp6 0.440 0.015406 
bmp7a 0.288 0.025641 
bmpr1ab 0.374 0.041871 
bmpr1b 0.454 0.035855 
bnip3l 0.510 0.043733 
boka 0.740 0.038489 
bpnt1 3.784 0.027300 
brn1.2 1.440 0.030901 
brunol5 2.122 0.017915 
bsg 0.612 0.033951 
btbd2 1.853 0.019803 
btbd6 1.671 0.027664 
bxdc1 0.541 0.039949 
bzw1b 0.704 0.030914 
c1qtnf5 2.257 0.021660 
c6orf115 1.921 0.043103 
c8g 1.990 0.046371 
ca15a 2.449 0.040993 
ca2 1.579 0.039949 
ca8 0.538 0.033951 
cacna1s 2.654 0.020489 
cacnb2b 0.563 0.049769 
cacnb4b 2.303 0.050237 
cacng2 2.512 0.021660 
cacng2b 2.979 0.014755 
cadm2a 2.690 0.026439 
cadm4 1.458 0.039918 
calb2l 2.325 0.014755 
 
  211 
Gene Fold Change P-value 
calca 6.711 0.040419 
calhm2 2.660 0.020880 
calm3a 2.465 0.014755 
camk2a 3.702 0.025610 
camk2d2 2.462 0.027478 
camkv 2.156 0.049812 
capg 2.033 0.009609 
capn9 0.728 0.030758 
caprin1b 0.728 0.013925 
casp2 1.301 0.043265 
cast 0.562 0.041159 
casz1 2.020 0.038054 
cat 2.082 0.027478 
cav3 2.348 0.026439 
cbln1 2.223 0.021014 
cbln4 2.235 0.021651 
cbx3b 1.753 0.011111 
ccl1 0.491 0.029248 
ccng2 0.468 0.014755 
ccnt2 0.525 0.043407 
cd2apl 0.718 0.047859 
cdc40 0.720 0.039082 
cdca8 1.404 0.031578 
cdh1 0.606 0.036472 
cdh2 0.502 0.038572 
cdh4 4.957 0.014755 
cdk2 1.843 0.014138 
cdk5 1.457 0.014755 
cdk5r2 3.196 0.015720 
ch25h 0.093 0.038489 
cha 0.047 0.026439 
chad 20.346 0.016033 
chaf1b 1.995 0.021660 
chat 1.391 0.049430 
chchd3 1.796 0.048096 
chchd7 1.833 0.012827 
chka 0.500 0.050239 
chmp4b 1.225 0.049863 
chrm2a 2.543 0.009609 
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Gene Fold Change P-value 
chrne 2.980 0.014755 
chst1 1.968 0.034652 
ciita 0.254 0.048096 
cited3 0.550 0.023878 
cki 0.646 0.035882 
ckmb 3.034 0.050281 
ckmt1 0.363 0.046610 
cldnc 0.275 0.015406 
cldne 0.541 0.042824 
cldnf 0.686 0.050249 
clgn 1.468 0.034606 
clstn1 1.943 0.017711 
cltcb 1.496 0.025693 
clu 1.432 0.038211 
cmya5l 4.043 0.013226 
cnot10 1.379 0.032414 
cnot6 0.706 0.040970 
cog8 2.061 0.030901 
col15a1 0.299 0.009320 
col18a1 0.610 0.040023 
col1a1 2.196 0.026588 
col1a2 1.960 0.017843 
col1a3 3.180 0.018797 
col28a1a 1.750 0.026439 
col4a4 1.584 0.027300 
col6a1 2.146 0.048096 
col6a2 2.720 0.033311 
col7a1l 0.564 0.036157 
col9a2 1.323 0.049812 
colm 1.551 0.049770 
copg2 0.738 0.049222 
coro1a 2.615 0.050403 
coro1b 1.450 0.047161 
cox17 1.972 0.042150 
cox7a2 1.297 0.029961 
cplx2 2.732 0.021634 
cpn1 0.679 0.030501 
cpox 0.627 0.045331 
cpsf5 0.923 0.043047 
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Gene Fold Change P-value 
cpt1b 6.290 0.009320 
cpt2 1.846 0.025610 
crabp2b 0.412 0.014755 
crfb8 0.569 0.027300 
crispld1 4.249 0.009414 
crsp6 0.679 0.030501 
crtap 0.694 0.011111 
cry1b 0.546 0.029248 
cry3 0.562 0.040958 
cry4 0.589 0.023541 
cryba1b 13.454 0.014138 
cryba2a 9.402 0.013226 
cryba4 7.075 0.049812 
crygn1 0.362 0.038572 
cs 1.563 0.046610 
csdc2 1.894 0.026300 
csf1b 4.339 0.045683 
csnk1e 1.982 0.021660 
cspg5 1.593 0.015805 
ctgf 0.651 0.035952 
ctnnb1 0.799 0.030901 
ctsc 0.117 0.009320 
ctsh 0.419 0.017915 
ctssb.1 0.321 0.017711 
ctsz 1.598 0.033873 
cugbp2 1.901 0.013925 
cul4a 0.734 0.032879 
cul5 1.457 0.032723 
cwf19l2 0.742 0.050403 
cx23 4.160 0.017711 
cx33.8 2.005 0.014755 
cx36.7 0.429 0.014755 
cx39.9 3.262 0.021660 
cx44.1 9.961 0.014878 
cxcr4a 0.567 0.032723 
cxcr4b 0.570 0.030901 
cyb5r2 0.616 0.015821 
cyb5r3 1.403 0.026439 
cygb1 2.064 0.033244 
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Gene Fold Change P-value 
cyp11a1 0.125 0.048167 
cyp17a1 1.873 0.019739 
cyp24a1l 0.122 0.009609 
cyp2j27 1.599 0.046610 
cyp51 0.561 0.046771 
cyth1 0.660 0.021014 
d2hgdh 0.740 0.046977 
dab1 1.533 0.027300 
dao.2 1.702 0.028164 
daxx 0.848 0.026632 
dbx1a 1.525 0.038572 
dci 1.627 0.030030 
dct 4.506 0.025951 
dctn2 1.366 0.031683 
ddx54 0.513 0.029105 
defbl1 6.171 0.014755 
depdc6 1.636 0.031563 
desm 1.461 0.050232 
dgat1 2.284 0.046610 
dhfr 1.646 0.046681 
dhrs3a 0.527 0.034176 
dhrs3a 0.525 0.032414 
dia1 1.351 0.023541 
diras1 2.465 0.038266 
dlc 0.628 0.035665 
dldh 1.228 0.045286 
dlg1 0.679 0.043954 
dlg2 1.527 0.031056 
dlx5a 0.856 0.037831 
dmrt2a 0.317 0.018469 
dmrt3a 2.450 0.045226 
dnaja1l 2.079 0.044064 
dnase1l3l 0.407 0.045760 
dnm1l 2.131 0.038572 
dpyd 2.546 0.009320 
dpysl3 1.799 0.016847 
dpysl5a 1.734 0.029852 
dpysl5b 1.924 0.023676 
drd2a 1.473 0.042304 
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Gene Fold Change P-value 
dtna 1.930 0.025727 
duox1 1.728 0.025538 
dusp5 0.425 0.027478 
dync1li1 1.970 0.015720 
ebi3 3.220 0.049716 
echs1 2.037 0.014755 
ecm2 2.270 0.046807 
ef1 0.637 0.022269 
efcab4a 0.465 0.034176 
efemp2 0.360 0.030758 
efna3b 1.582 0.040526 
efna5a 0.670 0.014755 
efnb2b 0.580 0.048596 
egfl7 0.594 0.043445 
egfr 0.519 0.021660 
egln3 0.081 0.017863 
egr2b 0.176 0.009320 
ehd2 1.625 0.046797 
ehhadh 2.140 0.019960 
ehmt1a 1.426 0.027300 
eif3ea 0.626 0.046610 
eif3m 0.667 0.045863 
eif3s2 0.845 0.037831 
eif6 0.667 0.049448 
ek1 1.873 0.030501 
elavl4 2.188 0.044973 
elmod2 1.842 0.039082 
elovl7a 0.578 0.025136 
emx3 0.759 0.039171 
eng1a 3.308 0.023632 
eng1b 2.010 0.038572 
enkur 0.745 0.021660 
eno1 0.674 0.027478 
eno2 2.166 0.022408 
enpp6 1.545 0.029105 
entpd2a.1 2.408 0.047394 
eomesa 2.157 0.013451 
eomesb 1.389 0.046771 
epas1 2.561 0.037465 
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Gene Fold Change P-value 
erf 0.610 0.027599 
esr2b 0.426 0.046797 
esrp1 0.545 0.037430 
esrrd 49.326 0.036903 
etfa 1.377 0.038905 
evlb 2.107 0.014755 
eya4 1.880 0.011735 
f 2.506 0.014138 
f3a 0.500 0.014755 
f5 3.559 0.019925 
f7i 2.462 0.014755 
faah2a 2.305 0.013602 
fabp2 0.615 0.026036 
fabp3 1.581 0.015982 
fabp7b 3.272 0.010347 
fah 2.558 0.044480 
fam134a 0.765 0.020559 
fam46b 0.126 0.030990 
fam91a1 1.517 0.033944 
farp2 0.653 0.020422 
fbln1 0.378 0.034945 
fbln4 0.306 0.017763 
fbp2 3.103 0.019602 
fbxl2 0.627 0.043047 
fbxo25 1.415 0.048478 
fbxo3 1.506 0.023541 
fev 2.317 0.033216 
fez1 2.607 0.014755 
fga 4.825 0.003518 
fgb 3.628 0.022269 
fgd 1.323 0.034173 
fgf13 2.325 0.031553 
fgf13l 1.788 0.027970 
fgf17 0.183 0.011111 
fgf2 0.463 0.045032 
fgf24 0.461 0.019803 
fgf8a 0.414 0.020153 
fgfr1a 0.609 0.011111 
fgfr1b 0.348 0.028980 
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fgfrl1a 0.458 0.037436 
fgg 3.612 0.046610 
fhl3 0.598 0.025136 
fhla 0.447 0.038198 
fibin 0.581 0.041590 
figf 1.668 0.046610 
figla 0.247 0.019960 
fign 0.669 0.050403 
fkbp11 0.413 0.037465 
fkbp3 1.401 0.037900 
fkbp4 1.673 0.027792 
flt4 0.669 0.029248 
fn1b 0.178 0.046524 
foxa1 0.706 0.021660 
foxa3 0.568 0.038352 
foxb1.1 0.598 0.024681 
foxc1b 0.452 0.018986 
foxd5 0.235 0.027300 
foxg1 1.326 0.014755 
foxk1 0.611 0.022269 
foxl2 0.401 0.027478 
foxn4 2.572 0.014755 
foxp1a 0.312 0.020665 
fstb 2.270 0.021660 
ftr67 0.484 0.041590 
ftr78 0.399 0.039909 
ftr79 0.293 0.050239 
furina 0.401 0.042024 
fut9 0.453 0.022799 
fyna 1.500 0.047537 
fzd3l 0.640 0.027300 
g12 0.335 0.036903 
gad1 5.437 0.009609 
gad2 2.071 0.020829 
gadd45b 0.221 0.017542 
gata1 0.504 0.045372 
gata2b 2.502 0.039949 
gata4 0.366 0.029105 
gata6 0.356 0.014755 
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gats 0.479 0.033164 
gba2 0.739 0.044557 
gbp 0.355 0.037006 
gbx2 0.621 0.044932 
gc3 2.691 0.013226 
gch2 3.940 0.014755 
gchfr 1.631 0.038905 
gdf11 1.343 0.049292 
gem 0.648 0.031722 
gfi1.1 0.067 0.028718 
gfpt1 0.438 0.045683 
ghrb 1.399 0.038054 
glb1l 1.781 0.015977 
glcea 2.421 0.029248 
gle1l 2.419 0.030501 
glod4 1.609 0.028846 
glra4a 2.072 0.049716 
glula 0.550 0.031960 
gmpr 1.606 0.015223 
gmps 1.906 0.046610 
gnai2l 0.759 0.033951 
gnai3 0.739 0.043047 
gnao1b 1.697 0.043663 
gnat2 1.845 0.030990 
gnav1 0.519 0.023068 
gngt1 3.268 0.038605 
gnsb 0.480 0.032870 
golga5 0.556 0.015173 
gopc 0.705 0.046610 
gorasp2 0.859 0.050239 
got1 1.574 0.027300 
gpd1 0.522 0.030320 
gpd1b 1.750 0.049086 
gpib 5.472 0.033311 
gpm6aa 2.579 0.009320 
gpm6ab 1.804 0.050513 
gpr133 0.494 0.023803 
gpr143 1.570 0.036903 
gpr177 0.556 0.045918 
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gpr27 1.540 0.023781 
gprc5c 0.563 0.046695 
gpsm2 1.724 0.011111 
gpx1a 1.429 0.038572 
gpx4a 0.555 0.047798 
grb10 0.531 0.040023 
grem2 1.931 0.029574 
grhl1 0.405 0.050594 
gria2a 2.111 0.029105 
gria2b 3.904 0.029248 
gria4b 1.446 0.027478 
grin1a 3.514 0.046797 
grna 1.991 0.026187 
grnas 1.243 0.030501 
grtp1a 2.079 0.044936 
gspt1 1.911 0.025136 
gstt1a 2.164 0.009320 
gtpbp4 0.596 0.038572 
gygl 2.254 0.027478 
h1fx 0.390 0.032713 
hadhb 1.691 0.050911 
hand2 0.557 0.040166 
hao1 3.186 0.043690 
hapln1a 2.040 0.036921 
hapln1b 0.314 0.027478 
hbae1 2.178 0.026632 
hbae3 2.306 0.009609 
hbbe3 1.703 0.025136 
hcrt 4.575 0.030758 
heatr1 0.624 0.027478 
her1 0.140 0.009609 
her12 1.129 0.043599 
her13 2.105 0.014138 
her2 1.800 0.015178 
her3 0.560 0.049156 
her5 0.340 0.017711 
her6 0.483 0.018469 
hey1 0.528 0.023781 
heyl 2.180 0.049430 
 
  220 
Gene Fold Change P-value 
hhatla 3.099 0.014138 
hhatlb 2.175 0.011111 
hhex 0.370 0.043954 
hhip 0.777 0.033951 
hibadhb 1.546 0.026439 
hif1al2 4.268 0.025641 
hint2 1.349 0.049812 
hirip5 0.725 0.044932 
hkdc1 0.373 0.048596 
hlx1 2.241 0.023322 
hmbsb 1.488 0.039909 
hmox1 0.445 0.030758 
hmx4 1.618 0.039560 
hn1 2.189 0.030501 
hnf1a 0.485 0.026439 
hnf4a 0.317 0.036614 
homer1 3.619 0.011492 
hoxa10b 0.542 0.013186 
hoxa11a 0.444 0.035079 
hoxa13b 0.368 0.011111 
hoxa2b 0.771 0.042304 
hoxa9a 0.680 0.014755 
hoxa9b 0.492 0.012913 
hoxb10a 0.549 0.030758 
hoxb1a 0.282 0.011111 
hoxb7a 0.398 0.018918 
hoxb9a 0.602 0.048385 
hoxc10a 0.595 0.013226 
hoxc3a 0.428 0.032870 
hoxc6a 0.533 0.017081 
hoxc6b 0.740 0.014755 
hoxc8a 0.589 0.033216 
hoxd10a 0.659 0.038947 
hoxd12a 0.339 0.013186 
hprt1l 1.744 0.015465 
hsd17b10 1.716 0.025693 
hsd17b2 0.305 0.014755 
hsf2 0.802 0.026439 
hsp90ab1 0.834 0.046274 
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hspa12b 1.823 0.011111 
hspb6 2.053 0.041501 
hspb9 1.848 0.041590 
htatip2 2.234 0.009609 
hyou1 0.681 0.050638 
icn 1.607 0.032981 
idh2 1.336 0.019960 
idh3g 0.571 0.030491 
ift46 2.272 0.011111 
igf2bp2a 1.367 0.047394 
igfbp1a 0.358 0.025136 
igfbp2a 1.884 0.031598 
igfbp3 1.638 0.049189 
igfbp5b 3.473 0.014755 
ighm 4.828 0.027478 
igsf21a 2.008 0.019960 
il15l 0.590 0.049905 
il17c 0.490 0.030901 
il17d 1.406 0.038352 
il17rd 0.317 0.014138 
il1rapl1a 2.067 0.017081 
ilk 0.836 0.038905 
inadl 0.610 0.030501 
ing5a 0.680 0.049696 
inhbaa 0.443 0.030758 
ins 2.256 0.044936 
insb 0.329 0.047394 
insig1 0.286 0.029469 
invs 0.446 0.025641 
ip6k2 1.797 0.021357 
irak3 0.520 0.044480 
irx2a 2.248 0.041829 
irx4a 2.758 0.014138 
irx6a 2.413 0.030262 
irx7 0.218 0.019651 
isl2a 0.526 0.014755 
islr2 2.904 0.023068 
isoc1 0.675 0.031834 
isoc2 2.398 0.049770 
 
  222 
Gene Fold Change P-value 
itgb1b.2 3.151 0.017843 
itgb4 1.818 0.033601 
itih2 0.457 0.014755 
itm2bb 0.515 0.045918 
itpk1 0.406 0.027478 
ivd 1.796 0.023803 
ivns1abpa 0.604 0.013602 
jag2 0.591 0.039431 
jagn1b 0.742 0.045331 
jmjd6 0.231 0.025753 
jph2 2.163 0.036614 
junbl 0.389 0.014755 
kbtbd8 1.525 0.049448 
kcnd3 1.512 0.046681 
kcnip3 0.433 0.017081 
kcnip3l 3.320 0.029852 
kcnip3l 1.961 0.043663 
kctd6 1.340 0.043047 
kctd7 1.778 0.000083 
kdm6b 1.733 0.031183 
kdr 0.410 0.032723 
keap1a 1.680 0.017081 
kif3c 2.537 0.043599 
kif5a 2.130 0.042038 
klf13l 1.624 0.041046 
klf2b 1.522 0.032881 
klf4 0.422 0.037913 
klf7 1.367 0.035293 
klhdc6 5.852 0.016413 
klhl31 2.011 0.026439 
kpna2 1.526 0.030758 
krcp 1.269 0.035344 
krt1-19d 2.178 0.011449 
krt8 0.679 0.027478 
lama5 0.474 0.038947 
lamb1 0.330 0.016556 
lamb2 2.251 0.046797 
lamb4 2.357 0.015977 
ldb3a 2.200 0.030758 
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Gene Fold Change P-value 
ldb3b 2.864 0.014755 
ldhb 1.348 0.023632 
ldhd 1.879 0.019960 
ldlrap1a 1.663 0.041348 
ldlrap1b 0.415 0.026439 
lect2l 0.057 0.044019 
lef1 0.374 0.031183 
lgals1l2 1.802 0.027478 
lhx1b 1.614 0.042024 
lhx6 3.309 0.049350 
lim2.4 13.737 0.041070 
lingo1b 3.036 0.026632 
lipf 1.354 0.025752 
lman1 0.683 0.015582 
lmf2 1.640 0.025727 
lmo1 1.432 0.011111 
lmo2 0.369 0.024306 
lmx1b.2 0.611 0.014755 
lnx2a 2.144 0.021660 
loxl5b 0.311 0.026187 
lratb 0.580 0.020047 
lrrc4a 2.559 0.046977 
lrrc50 0.629 0.046610 
lrrc8a 0.739 0.043642 
lrrn1 2.587 0.027300 
lrrtm1 2.080 0.009728 
lrrtm2 2.205 0.038054 
lsrl 0.753 0.027664 
lyricl 0.633 0.049349 
mab21l1 2.989 0.014755 
maf 1.926 0.019970 
mafba 0.491 0.030491 
mafg2 1.714 0.039225 
man2a1 0.458 0.021357 
map1b 2.224 0.029248 
map1lc3b 0.615 0.030901 
map3k5 0.686 0.029105 
mapk14a 0.567 0.050856 
mapk3 0.531 0.024864 
 
  224 
Gene Fold Change P-value 
mapk4 1.519 0.043599 
mark1 2.440 0.031699 
marveld2b 0.443 0.027478 
matn3a 2.064 0.020422 
matn4 2.767 0.015977 
mc5ra 4.606 0.009320 
mcl1b 0.231 0.021660 
mdh1a 1.607 0.046681 
mdh1b 2.942 0.009320 
mdka 1.394 0.027478 
mdm2 0.319 0.031183 
me1 1.478 0.037831 
me2 1.845 0.014138 
me3 2.194 0.036903 
mecr 1.363 0.027035 
meox1 0.276 0.027478 
mespb 0.173 0.045657 
metap2l 1.718 0.037373 
mfap1 0.845 0.049189 
mfng 2.444 0.014755 
mfsd2b 1.615 0.025968 
mgll 0.631 0.037903 
mhc1uba 0.296 0.049189 
mif 1.728 0.030262 
mip1 19.248 0.032881 
mitfa 2.741 0.025727 
mkln1 1.642 0.023999 
mknk2b 0.178 0.014755 
mkrn1 1.325 0.049430 
mllt3 0.288 0.036614 
mlphb 3.028 0.019970 
mmp23a 2.423 0.050560 
mobkl1a 1.287 0.033216 
mogat2 0.515 0.043773 
moxd1 1.323 0.041501 
mpeg1 3.179 0.030841 
mpp1 0.549 0.026632 
mpp5a 0.639 0.014755 
mpzl2 0.702 0.021357 
 
  225 
Gene Fold Change P-value 
mpzl3 0.511 0.023632 
mrps18c 1.276 0.046681 
mrps31 2.308 0.048167 
msi2a 0.667 0.049375 
msn 7.040 0.015805 
msxb 0.492 0.015977 
mtch2 1.239 0.042849 
mterfd1 0.513 0.043773 
mtf2 0.502 0.042038 
mthfsd 1.501 0.015406 
mtmr8 0.678 0.026102 
murc 3.260 0.011492 
mut 1.208 0.046610 
mxa 0.308 0.014138 
mxd3 1.554 0.036921 
mxra8a 1.807 0.041590 
mybl2 1.318 0.019803 
mybpc3 3.584 0.015406 
myf5 0.150 0.035004 
myf6 2.390 0.019970 
myh11 0.273 0.014755 
myh6 1.913 0.038181 
mylk3 2.706 0.035079 
mylz2 3.930 0.014138 
mylz3 3.789 0.014755 
myo15l1 0.279 0.014755 
myoc 0.477 0.026439 
myog 0.534 0.038605 
myom1a 3.206 0.048905 
myoz2 2.344 0.025610 
mypt2 0.751 0.046775 
nadk 0.686 0.044936 
nae1 1.501 0.028212 
nalcn 2.041 0.037961 
napgl 0.520 0.030501 
narf 0.623 0.038572 
nbas 1.389 0.038572 
nccrp1 1.752 0.049430 
ncoa3 0.606 0.049812 
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Gene Fold Change P-value 
ND5 1.825 0.023541 
ndel1a 1.788 0.038905 
ndrg1 0.282 0.013065 
ndrg4 2.068 0.046722 
ndufa10 1.433 0.035785 
ndufab1 1.397 0.025968 
ndufb5 1.311 0.038489 
nefl 3.201 0.020422 
nefm 2.974 0.020422 
negr1 1.457 0.031329 
net1 0.642 0.017863 
neurod4 2.279 0.017081 
nf2a 0.676 0.015937 
nfe2l3 1.600 0.030030 
ngf 0.559 0.027478 
nipsnap1 0.302 0.043954 
nitr3a 3.417 0.028846 
nkx1.2la 0.513 0.032190 
nkx1.2lb 4.125 0.039082 
nkx2.5 0.542 0.021660 
nlcam 0.537 0.016033 
nme2l 0.247 0.031183 
nmnat2 1.780 0.030501 
nog1 0.477 0.036614 
nola1 0.699 0.039954 
nom1 0.667 0.035595 
nop10 0.600 0.025727 
nos2b 2.314 0.019697 
notch1a 0.544 0.023781 
notch2 0.696 0.025641 
nots 0.736 0.017843 
nox1 0.099 0.044737 
npb 2.131 0.011735 
nphs2 0.808 0.043047 
npl 0.557 0.043861 
npsnl 2.241 0.037831 
npy1r 2.541 0.045991 
nr1h5 1.563 0.044737 
nr2f1a 1.937 0.039175 
 
  227 
Gene Fold Change P-value 
nr2f1b 2.322 0.027904 
nr4a2a 1.394 0.043165 
nr5a1b 3.181 0.046139 
nr6a1a 0.233 0.034021 
nrarpb 2.415 0.043047 
nrg1 0.439 0.043731 
nrp1a 0.538 0.015982 
nrp2b 0.522 0.049189 
nrxn1b 2.882 0.037196 
nrxn3b 2.412 0.040154 
nsf 2.940 0.014755 
ntd5 0.518 0.031863 
nubpl 0.875 0.048527 
nudt15 0.440 0.025693 
nudt4 1.299 0.015406 
numbl 0.400 0.018972 
nup133 1.270 0.044936 
nvl 0.705 0.048679 
nxph1 1.909 0.040146 
oat 4.751 0.010347 
oclna 0.683 0.041496 
oep 0.335 0.014138 
ogt.2 1.369 0.023376 
olfm1b 3.003 0.013925 
olfml3 1.653 0.036903 
onecut1 2.481 0.019803 
opa3 1.464 0.049939 
or125-2 1.257 0.031856 
os9 1.399 0.041590 
osbpl9 0.743 0.023781 
otpb 2.726 0.050911 
otx1 0.684 0.030841 
otx1l 0.526 0.035344 
oxsr1b 0.527 0.014755 
p2rx3b 1.813 0.029264 
p2rx5 2.328 0.043676 
p4ha1 0.241 0.029720 
p4ha2 0.235 0.027478 
pabpc1b 1.570 0.028846 
 
  228 
Gene Fold Change P-value 
paics 0.454 0.023541 
pak1 0.647 0.017711 
paqr3b 1.511 0.034176 
paqr8 0.657 0.028320 
pard3 0.729 0.039889 
park7 2.212 0.042160 
parp12b 1.300 0.014755 
parvb 1.600 0.050667 
pax2a 0.641 0.029574 
pax9 1.697 0.033873 
pbk 1.374 0.046555 
pbp 1.666 0.012299 
pbx1a 1.614 0.027599 
pcbd1 1.371 0.037196 
pcdh17 2.182 0.023541 
pcdh1a4 2.405 0.031140 
pcdh1g18 2.061 0.030518 
pcdh1gb2 2.031 0.035947 
pcdh2ac 1.930 0.013451 
pcdh8 0.104 0.044533 
pcm1 1.669 0.049769 
pcmt 2.271 0.018972 
pcsk1nl 3.268 0.014138 
pcyt1bb 0.530 0.015977 
pdcd6ip 1.324 0.009609 
pde5a 1.736 0.014983 
pdgfra 0.715 0.021756 
pdlim7 2.694 0.014138 
pdzk1ip1l 2.521 0.030030 
pea3 0.451 0.034276 
peli2 0.532 0.019486 
penkl 2.930 0.016384 
per1b 0.389 0.030501 
pex12 1.480 0.031863 
pfkfb1 0.604 0.021014 
pfkfb2 2.009 0.027300 
pfkfb3 0.137 0.012839 
pfkfb4 0.566 0.013451 
pfkfb4l 0.639 0.017711 
 
  229 
Gene Fold Change P-value 
pfkma 5.920 0.047859 
pfn2 1.274 0.030171 
pgam1a 0.403 0.025582 
pgam1b 1.501 0.029264 
pgd 1.559 0.043954 
pglyrp2 0.657 0.009703 
phactr2 1.337 0.038351 
phax 1.574 0.014755 
phlda3 0.318 0.048478 
pigp 3.020 0.017843 
pik3c3 1.628 0.049189 
pik3r3 1.726 0.046344 
pim1 0.097 0.025136 
piwil1 0.528 0.027922 
pla2g12b 0.692 0.025538 
pla2g15 0.753 0.032723 
plcd1b 0.773 0.016384 
plcxd3 2.014 0.025136 
plekha8 1.592 0.044341 
plk2 0.548 0.014755 
plod1a 0.507 0.009609 
plp1a 2.821 0.030901 
plxna4 1.592 0.049430 
plxnd1 0.652 0.043599 
pno1 0.688 0.028857 
pnpo 3.410 0.042820 
pnx 0.266 0.048096 
pola1 1.470 0.027300 
pold2 1.496 0.027300 
polr1e 0.707 0.039175 
polr2c 1.669 0.013925 
pomgnt1 1.251 0.043773 
popdc1 2.494 0.029248 
popdc3 4.245 0.046695 
pou12 1.427 0.019370 
pou3f3b 1.725 0.028718 
pp 0.488 0.050577 
ppa1 1.712 0.039162 
ppcdc 1.735 0.046274 
 
  230 
Gene Fold Change P-value 
ppib 1.142 0.031183 
ppm1k 1.304 0.045331 
ppp1cc 1.485 0.050856 
ppp2r4 1.283 0.050239 
prcp 2.240 0.029973 
prdm1a 0.450 0.019388 
prdm1b 0.208 0.047394 
prdx6 2.909 0.032881 
prickle1a 0.152 0.037831 
prickle1b 0.518 0.014755 
prim1 1.648 0.036903 
prkar2ab 1.967 0.042786 
prkch 0.399 0.044064 
prl 3.767 0.042677 
prlrb 0.358 0.014755 
prnprs3 1.848 0.014755 
prox1 1.491 0.038947 
prph 2.007 0.013226 
prss35 3.970 0.049086 
prtga 0.660 0.046610 
psap 0.701 0.030501 
pskh1 1.574 0.018972 
psmb9b 0.197 0.016384 
psme1 0.084 0.040023 
ptgisl 0.553 0.022563 
ptgs1 0.370 0.033996 
ptgs2b 0.104 0.014755 
pth2 5.652 0.013925 
ptpn4 0.661 0.033996 
ptprk 0.469 0.021660 
ptpru 0.630 0.042431 
ptrf 2.043 0.027478 
purb 2.028 0.041446 
pvalb1 5.177 0.027478 
pvalb2 4.830 0.038905 
pvalb4 4.403 0.023781 
pvalb5 6.742 0.038489 
pvrl2l 0.478 0.049716 
pxk 0.645 0.013925 
 
  231 
Gene Fold Change P-value 
pyya 6.151 0.042958 
qdpra 2.161 0.041774 
rab14 1.750 0.015821 
rab24 0.877 0.047798 
rab38 2.826 0.009320 
rab39b 2.022 0.014138 
rab3c 1.574 0.038489 
rab3d 1.380 0.014755 
rab6b 1.949 0.021014 
rac2 1.522 0.025693 
racgap1 0.764 0.043047 
rad23b 0.430 0.038905 
rarga 0.469 0.014755 
rb1 1.335 0.042842 
rbb4 1.407 0.044973 
rbks 1.842 0.015406 
rbp1a 1.519 0.025727 
rbp4 4.338 0.036614 
rbpms2 0.505 0.021660 
rchy1 0.759 0.037066 
rcl1 0.583 0.022563 
rcv1 0.358 0.027792 
rd3 1.396 0.042024 
rdh5 3.266 0.043165 
rel 0.404 0.034176 
rfx2 0.476 0.025641 
rfx4 0.379 0.038905 
rgl1 0.511 0.027734 
rgs17 2.506 0.014138 
rgs20 1.845 0.039137 
rgs4 0.250 0.011111 
rgs7bpb 1.623 0.047321 
rhag 3.123 0.003761 
rhbg 0.350 0.015406 
rhogc 1.204 0.039280 
rhoub 0.496 0.043645 
ripply1 0.151 0.042038 
ripply2 0.122 0.041590 
rnaseka 0.802 0.046371 
 
  232 
Gene Fold Change P-value 
rnd1l 0.495 0.014138 
rnd3a 0.622 0.025693 
rnf11 0.636 0.032623 
rnf14 1.279 0.025727 
rnf17 0.740 0.029248 
rnf24 0.439 0.015406 
rnls 1.514 0.030841 
rorab 2.240 0.047981 
rpl10a 0.770 0.047798 
rpl28l 0.804 0.050203 
rpl4 0.787 0.025641 
rpl8 0.759 0.039732 
rprm 0.258 0.033996 
rps24 1.512 0.035028 
rqcd1 2.080 0.025727 
rrbp1 0.771 0.030901 
rrm1 1.415 0.048096 
rtf1 1.499 0.049769 
rtn1a 1.861 0.014755 
rtn1b 2.252 0.040600 
rtn2b 3.292 0.034652 
rtn4a 1.590 0.043861 
rtn4rl1 1.468 0.032779 
rundc3b 0.282 0.027599 
runx1 0.343 0.023312 
runx3 0.343 0.047798 
rxraa 0.614 0.042615 
ryr1a 1.370 0.036222 
s100a10a 0.442 0.035004 
s100a10b 1.636 0.041921 
s100u 0.683 0.017915 
s1pr1 1.978 0.017296 
sall1a 1.960 0.027404 
sall4 0.393 0.035806 
sap30l 1.155 0.045598 
sat1 1.792 0.036157 
scn4ab 3.359 0.029248 
scn4ba 2.827 0.015406 
scpp8 0.620 0.043676 
 
  233 
Gene Fold Change P-value 
sdad1 0.637 0.040043 
sdcbp 0.624 0.031863 
sdha 1.527 0.021660 
sdr16c5 2.091 0.014755 
sec14l1 0.686 0.049189 
sec61al2 0.547 0.023541 
sec61b 0.541 0.045321 
sema3fb 0.525 0.014755 
sepn1 0.717 0.046977 
sept4b 0.392 0.019917 
sept9a 0.659 0.050577 
serac1 1.803 0.035028 
serf2 1.242 0.034208 
serhl 2.840 0.023878 
serinc1 0.716 0.036157 
sesn1 0.532 0.021651 
setd3 1.474 0.024006 
setd8a 0.865 0.023541 
setmar 2.357 0.030758 
sfrs7 1.817 0.046977 
sgcd 2.631 0.023541 
sgce 1.771 0.046771 
sgcg 2.572 0.043191 
sgk1 0.502 0.038572 
sh3bp5 0.657 0.024941 
sh3gl2 1.481 0.044064 
shd 0.572 0.025727 
shmt1 0.518 0.038489 
shox 2.075 0.043773 
shox2 2.892 0.027300 
silva 2.744 0.012650 
silvb 4.092 0.014138 
six4.2 0.681 0.043191 
six6b 2.540 0.038544 
skap1 0.554 0.041590 
slc10a1 2.837 0.049863 
slc10a4 2.396 0.046797 
slc12a2 1.516 0.030320 
slc16a12b 1.433 0.039606 
 
  234 
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slc17a6l 3.073 0.021014 
slc1a2 2.014 0.023165 
slc1a3 1.323 0.038198 
slc20a1a 1.625 0.050207 
slc25a22 1.945 0.028402 
slc25a25 2.030 0.030901 
slc25a28 1.426 0.038947 
slc25a3 0.670 0.048096 
slc25a36b 0.440 0.027379 
slc25a4 5.194 0.033573 
slc25a46 1.646 0.030501 
slc25a5 0.751 0.017542 
slc26a5 0.614 0.038947 
slc2a15a 4.284 0.009320 
slc2a15b 2.744 0.012309 
slc31a1 0.379 0.014755 
slc34a2aas 1.528 0.040096 
slc34a2b 0.527 0.031863 
slc37a4 0.568 0.036390 
slc38a3 0.527 0.017542 
slc38a4 2.039 0.045321 
slc38a7 0.557 0.031799 
slc39a6 0.791 0.043047 
slc39a7 1.355 0.039338 
slc40a1 3.283 0.050513 
slc46a1 0.712 0.025727 
slc4a1 2.800 0.017711 
slc4a1b 1.658 0.029264 
slc4a4b 1.574 0.047798 
slc5a11 1.708 0.027478 
slc5a9 2.076 0.017863 
slc6a5 3.471 0.015982 
slc7a7 1.666 0.046681 
slc8a3 1.566 0.046797 
slc9a3r2 0.767 0.036390 
smad2 0.606 0.040600 
smad3b 2.601 0.014755 
smad7 0.550 0.014755 
smo 0.701 0.016384 
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Gene Fold Change P-value 
smpx 1.528 0.049769 
smyd1a 2.814 0.014755 
smyd2b 1.936 0.030501 
smyd3 0.714 0.036614 
snai1a 0.340 0.042677 
snai1b 0.172 0.049423 
snap25a 2.380 0.030990 
snap25b 3.535 0.019960 
sncb 1.909 0.027478 
sncga 2.162 0.033601 
sncgb 2.203 0.009320 
snd1 0.431 0.011111 
snx5 1.292 0.035693 
sod2 2.760 0.012299 
sox11a 1.454 0.037831 
sox21b 1.645 0.046435 
sox4a 1.674 0.050390 
sox7 0.408 0.027537 
sox9b 0.388 0.030320 
sp5 0.631 0.017711 
sp5l 0.312 0.020422 
sp7 0.327 0.043668 
sp8 0.584 0.021660 
sp8l 0.801 0.038947 
sp9 0.575 0.013268 
spam1 3.967 0.046610 
sparcl 2.482 0.044064 
spata6 1.384 0.038528 
spcs3 0.745 0.045331 
spi1 0.546 0.036908 
spon1a 2.368 0.046681 
sprn 4.612 0.015223 
spry2 0.674 0.028846 
spry4 0.514 0.009320 
spsb4a 0.607 0.036529 
sptb 2.449 0.036614 
src 0.533 0.014755 
srl 1.800 0.015545 
srp68 0.747 0.042820 
 
  236 
Gene Fold Change P-value 
ssbp3 0.555 0.046899 
ssr1 0.413 0.046610 
ssr2 0.582 0.028980 
st13 1.343 0.039247 
st6galnac5 1.918 0.037831 
st8sia1 1.539 0.044936 
st8sia7.1 0.355 0.030990 
stac3 2.688 0.014755 
stap2b 0.261 0.043663 
stard10 0.554 0.043599 
stat1a 0.495 0.021660 
stm 0.456 0.021651 
stmn1b 2.799 0.049189 
stmn2a 2.003 0.031863 
stmn2b 1.839 0.014138 
stnnc 2.090 0.028846 
stom 0.700 0.043047 
strada 1.514 0.021660 
stx11b.1 0.516 0.046888 
stxbp1 2.178 0.014755 
sub1 1.405 0.044019 
sucla2 1.697 0.019970 
suclg1 1.367 0.023781 
sulf1 0.654 0.033164 
sulf2 1.738 0.030758 
sult1st4 3.736 0.031203 
sult1st6 2.605 0.027875 
sult2st1 0.677 0.037831 
suv39h1a 1.425 0.036921 
syn2a 2.136 0.017711 
syn2b 2.589 0.025641 
syngr3 1.906 0.017296 
syntaxin1b 1.953 0.031863 
syt1 1.572 0.011111 
syt11a 1.777 0.028320 
syt12 2.177 0.047798 
syt4 1.951 0.014138 
tac1 2.125 0.015977 
taf1b 0.660 0.027300 
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tagln2 0.533 0.023068 
tal1 0.402 0.035028 
tal2 2.335 0.023541 
tbc1d7 0.664 0.035028 
tbr1 2.291 0.023084 
tbx15 1.764 0.009320 
tbx16 0.066 0.024006 
tbx24 0.096 0.027478 
tbx2a 0.605 0.023781 
tbx3b 0.463 0.003518 
tbx6 0.098 0.036614 
tcf7l1a 0.558 0.013925 
tcf7l2 1.510 0.046797 
tead1 0.242 0.029973 
tekt2 1.758 0.048096 
tfa 0.596 0.043047 
tfap2a 0.718 0.026588 
tfap2b 1.766 0.041590 
tfap2c 0.655 0.045331 
tfap2e 3.459 0.009320 
tfcp2l1 1.620 0.042849 
tfdp1 0.748 0.023541 
tfdp2 1.717 0.019033 
tfip11 0.794 0.015982 
tgm2 3.054 0.015406 
thbs1 2.271 0.027537 
thbs3b 0.534 0.049793 
thbs4b 0.683 0.040267 
them2 1.790 0.004320 
thoc5 0.591 0.025641 
tie1 0.669 0.033316 
tigarb 0.622 0.049169 
tjp2b 0.768 0.029973 
tm9sf3 0.794 0.039175 
tmbim1 0.392 0.042155 
tmem110l 0.736 0.014755 
tmem115 0.714 0.039082 
tmem150 0.551 0.030990 
tmem178 2.229 0.020047 
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tmem57a 1.367 0.045260 
tmem59l 1.923 0.031863 
tmod4 2.466 0.026187 
tmprss13a 1.855 0.019960 
tmprss4a 0.629 0.038605 
tmsb 2.396 0.013925 
tmtc3 0.652 0.043047 
tmtc4 1.775 0.030501 
tnc 1.976 0.043047 
tnfsf10l2 1.926 0.036207 
tnks 0.607 0.014755 
tnnc 2.129 0.021081 
tnnt1 1.842 0.050177 
tnnt3a 4.749 0.028320 
tnnt3b 6.382 0.047350 
tnr 1.607 0.028846 
tnrc5 1.643 0.025529 
tnw 3.710 0.011785 
tomm20 0.641 0.025968 
tor2a 0.782 0.026632 
tp53bp2 0.693 0.040023 
tp63 0.495 0.031183 
tp73 0.693 0.030501 
tph2 1.606 0.049430 
tpm3 1.698 0.046681 
tpm4 0.725 0.027728 
traf3 0.217 0.049716 
traf4b 1.493 0.038489 
tram1 0.616 0.036614 
trim71 0.397 0.028846 
trpc4apa 0.807 0.028320 
trpc5 1.468 0.035947 
trpn1 2.188 0.038947 
trpv6 2.149 0.023659 
tsc22d2 0.467 0.011735 
tspan15 0.491 0.043477 
tspan7b 1.904 0.031553 
ttc25 0.683 0.034909 
ttna 3.607 0.015720 
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ttnb 1.804 0.046835 
ttpa 0.760 0.035344 
tuba1 3.065 0.025968 
tuba2 2.350 0.017081 
twf2 3.363 0.012753 
twistnb 0.457 0.024016 
txnip 0.424 0.011111 
txnrd1 2.027 0.027038 
tyms 1.521 0.029105 
tyrp1b 6.180 0.018469 
tyw3 0.734 0.046797 
uap1 0.669 0.043540 
ube2r2 1.502 0.027173 
ube2w 0.672 0.024306 
ubn2 0.740 0.022269 
ubtf 1.520 0.030758 
ubtfl 1.917 0.046610 
uchl3 1.719 0.027478 
ulk1 2.334 0.014138 
unc119.1 0.745 0.014755 
unc119.2 1.575 0.049863 
unc5b 0.539 0.046771 
uncx4.1 0.373 0.038572 
unk 0.431 0.020223 
upk3l 1.951 0.015406 
uso1 0.623 0.040419 
usp16 0.833 0.037436 
usp25 0.786 0.049863 
uvrag 0.616 0.027191 
vamp3 0.796 0.050048 
vat1 2.140 0.027537 
vcanb 1.976 0.024681 
vcl 1.803 0.013268 
vdac3 1.664 0.050594 
vegfab 1.761 0.038834 
vgll2b 0.547 0.015173 
vhl 0.434 0.027300 
vmhc 0.729 0.013065 
vsx1 1.901 0.014755 
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vtnb 5.096 0.033601 
wdsof1 0.630 0.014755 
wif1 0.680 0.042150 
wnt16 0.650 0.044936 
wnt2b 0.276 0.011324 
wnt4a 0.597 0.015406 
wnt5b 0.495 0.016384 
xdh 2.761 0.029248 
xirp2 2.470 0.014339 
xirp2l 8.025 0.038211 
xpo7 0.819 0.030758 
ypel1 0.250 0.040170 
ypel3 0.469 0.049442 
ywhae2 0.600 0.040043 
ywhag1 1.874 0.020422 
ywhah 1.154 0.047659 
ywhaqa 0.631 0.037831 
zbtb33 1.750 0.044936 
zc3h15 1.624 0.046797 
zcchc9 0.711 0.038874 
zfand1 1.425 0.041446 
zfand5a 0.540 0.023781 
zfhx1 0.528 0.049812 
zfyve21 0.696 0.014755 
znf503 0.555 0.046775 
znf536 2.069 0.009320 
znf598 1.313 0.045244 
znf703 0.621 0.039732 
znfl1 0.376 0.043663 
znrd1 0.728 0.041442 
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Table C2 – Significantly changed genes at 36 hpf in response to GR knockdown 
Gene Fold Change P-value 
a2bp1 1.904 0.020380 
aanat2 0.601 0.040592 
aatf 0.590 0.038630 
abat 0.786 0.040365 
abcc9 3.522 0.049154 
abcd3b 0.645 0.044795 
abhd2a 0.762 0.043023 
acadl 2.723 0.041818 
acat1 1.983 0.041292 
accn2a 2.385 0.041795 
accn2c 1.809 0.044245 
ache 2.211 0.049497 
acsl4a 0.607 0.035106 
acsl4l 0.461 0.040956 
acss1 0.549 0.032396 
acta1b 3.130 0.032631 
actn3a 2.852 0.034461 
ada 2.820 0.041377 
adam10b 1.279 0.044997 
adam17a 0.880 0.045768 
adcyap1b 2.551 0.028907 
adi1 0.688 0.047397 
adipor1b 0.785 0.046466 
adssl1 2.639 0.043463 
agpat4 0.737 0.050355 
agr2 2.127 0.045159 
agxtl 1.837 0.044997 
ahr2 1.654 0.041795 
ahrrb 2.616 0.044795 
aig1 2.750 0.043387 
alas1 0.569 0.031970 
aldh2b 1.926 0.045514 
aldh3d1 0.615 0.046829 
allc 4.029 0.044121 
amph 2.053 0.044004 
amt 0.696 0.048422 
ank1 2.872 0.035106 
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aox1 2.182 0.039477 
apba1 1.410 0.044795 
aplp 2.797 0.032396 
apoea 3.179 0.032396 
appb 1.756 0.032974 
arhgef7b 1.253 0.048823 
arl15b 1.336 0.028477 
arl6ip4 0.561 0.050828 
arl6ip5 0.439 0.048823 
arpc1b 2.436 0.039705 
asb16 2.225 0.041050 
asb8 1.653 0.045514 
ascl1a 2.276 0.044245 
ascl1b 2.843 0.046598 
aspdh 2.778 0.040365 
atad4b 0.483 0.046320 
atl1 1.790 0.048598 
atoh2a 3.744 0.034461 
atoh2b 3.008 0.048598 
atp2a1 2.591 0.041818 
atp2a1l 25.433 0.044997 
atp2a2a 0.693 0.035106 
atp2b3a 2.537 0.034461 
atp6v1b2 2.247 0.032396 
avpl 2.752 0.050266 
b3gat2 1.751 0.046083 
bach2 1.806 0.035106 
barhl1.1 2.819 0.035106 
barx1 3.155 0.044795 
bcl11a 5.987 0.044121 
bdnf 2.006 0.041795 
bhlhb3l 0.576 0.045159 
bmpr2b 1.756 0.032396 
bod1 1.165 0.050828 
brpf1 1.355 0.044936 
brunol5 2.403 0.050266 
c1d 0.690 0.035106 
c1qtnf4 2.422 0.032396 
c6 0.526 0.046751 
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ca14 8.968 0.049517 
ca2 2.205 0.046751 
cabp1 2.744 0.034163 
cacna1s 2.172 0.045133 
cacna2d1a 1.770 0.045514 
cacnb2b 0.425 0.039705 
cacnb4b 2.798 0.047676 
cacng2 2.316 0.032396 
cacng2b 2.116 0.040296 
cad 0.663 0.044245 
cadm2a 2.735 0.045761 
cadm3 2.241 0.046822 
cadm4 1.685 0.032919 
calb2 2.560 0.041795 
calb2l 3.645 0.024975 
calca 2.496 0.050346 
calhm2 2.596 0.044245 
calm1b 1.537 0.047563 
calrl 0.726 0.043387 
camk2a 2.368 0.046235 
camk2d2 3.115 0.031433 
camkv 2.579 0.044245 
camsap1 1.951 0.039705 
cant1b 0.546 0.035106 
caprin1a 1.237 0.043800 
caspb 6.239 0.039669 
cblb 1.837 0.035106 
cbln1 3.338 0.033095 
cbln2b 1.798 0.049186 
cbln4 2.006 0.024975 
cbx1b 2.351 0.034163 
cbx4 1.189 0.048823 
ccbl1 1.765 0.034163 
ccdc85al 2.494 0.031970 
ccl-c11b 2.133 0.044997 
ccng1 0.566 0.049154 
cd9 1.250 0.040832 
cdc14aa 0.732 0.032396 
cdc37 0.810 0.047397 
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cdh10 1.806 0.047397 
cdk5r2 3.220 0.039477 
cdkn1b 1.213 0.045159 
chad 9.655 0.050206 
chchd3 1.762 0.049236 
chordc1 0.716 0.032974 
chrna4 1.839 0.047920 
chst1 2.146 0.049154 
cirh1a 0.549 0.044004 
ciz1 1.170 0.049154 
ckma 3.325 0.040832 
ckmb 2.923 0.041795 
clasp2 1.576 0.035106 
clcn7 0.794 0.047397 
cldn19 2.540 0.037957 
cldnb 0.493 0.041795 
cldne 0.499 0.044245 
cldnf 1.614 0.047563 
clstn1 1.614 0.047563 
cmlc1 0.523 0.040832 
cnih2 4.204 0.021690 
cntn1b 4.417 0.035106 
col1a1 2.684 0.043905 
col1a2 2.127 0.044083 
col1a2 1.501 0.048422 
col1a3 3.105 0.048598 
col1a3 3.105 0.048598 
col6a1 3.053 0.034461 
col6a1 3.053 0.034461 
col6a2 2.988 0.044795 
col6a2 2.988 0.044795 
colm 3.557 0.034461 
colm 3.557 0.034461 
coro1b 1.875 0.038630 
coro1b 1.875 0.038630 
cplx2 2.472 0.040832 
cpt1b 3.835 0.044245 
cpt1b 4.143 0.045159 
cpvl 0.783 0.049691 
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crabp1a 2.007 0.048823 
crabp1b 2.232 0.034461 
crfb1 1.749 0.045159 
crhbp 1.434 0.039477 
crip2 0.418 0.044900 
crispld1 3.028 0.047563 
crlf1a 0.665 0.037484 
cry3 0.611 0.046320 
cryaba 0.353 0.037660 
cryba1b 7.381 0.024975 
cryba2a 8.994 0.040296 
cryba4 9.623 0.020380 
crybb1 13.092 0.042308 
crybb3 0.818 0.050266 
crygm2a 29.380 0.035106 
crygm2b 45.889 0.048823 
crygm3 19.986 0.049517 
crygmx 10.219 0.020380 
crygn2 8.704 0.039477 
csdc2 2.792 0.039705 
csf1b 3.004 0.046822 
csmd2 2.013 0.024975 
csnk1e 1.834 0.048294 
cspg5 1.702 0.044245 
ctnna2 3.090 0.047887 
ctsba 0.577 0.045003 
ctssa 4.286 0.032396 
cugbp1 0.685 0.048422 
cugbp2 2.212 0.045003 
cul3 1.186 0.048598 
cx23 3.177 0.043800 
cx43.4 0.519 0.047920 
cx44.1 2.787 0.050126 
cygb1 0.415 0.041818 
cygb2 2.360 0.039705 
cyp19a1b 1.504 0.048598 
cyp1b1 3.484 0.041795 
cyp2j27 2.084 0.040956 
cyp2x12 1.813 0.048823 
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cyp4v2 2.609 0.039750 
dab1 2.363 0.047563 
dbx1a 1.988 0.045768 
dck 1.738 0.045133 
dclk1 1.974 0.040956 
dclk2 1.677 0.040331 
dcp1a 1.358 0.050525 
dct 3.512 0.039705 
ddb2 0.360 0.041795 
ddc 2.840 0.040296 
ddx18 0.570 0.046320 
ddx51 0.410 0.044083 
ddx55 0.700 0.050870 
ddx56 0.593 0.048528 
def 0.658 0.048823 
defbl1 6.124 0.039477 
dennd4a 0.869 0.047397 
dgat1 2.544 0.040365 
dhdhl 0.637 0.049497 
dhrs11a 0.735 0.039681 
dhx16 0.756 0.044245 
dhx37 0.590 0.048422 
dio2 2.788 0.044795 
diras1 3.251 0.037660 
dixdc1 1.713 0.046320 
dkc1 0.561 0.044795 
dla 2.062 0.037952 
dlb 2.108 0.044245 
dlc 1.451 0.050355 
dld 1.857 0.020380 
dlx4a 2.657 0.044795 
dlx6a 1.649 0.048422 
dnase1l3l 12.346 0.050266 
dnmt4 0.623 0.044245 
dnttip2 0.622 0.041779 
dpp6b 2.220 0.022280 
dpyd 1.516 0.049038 
dpysl2 1.680 0.040296 
dpysl4 1.810 0.049517 
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dpysl5b 1.778 0.047887 
drd2a 1.610 0.022397 
drd4a 1.590 0.021690 
dtnb 1.791 0.039669 
dusp5 0.459 0.045133 
dynlt3 1.378 0.046215 
eaf1 1.306 0.034163 
eapp 0.762 0.041795 
ebna1bp2l 0.536 0.040296 
edf1 0.673 0.046751 
edn1 0.798 0.049038 
ednrb1 2.170 0.045159 
efcab7 1.294 0.045514 
eif2b3 0.571 0.044083 
eif6 0.686 0.043800 
ek1 1.885 0.044795 
elavl4 2.587 0.050355 
elmo1 1.501 0.040832 
elovl4 1.452 0.048598 
elovl6 2.029 0.041795 
emilin1a 1.451 0.032396 
eno2 1.603 0.042308 
eno3 2.000 0.031433 
enpp6 2.229 0.041292 
eomesa 1.661 0.049154 
epyc 5.508 0.024975 
ercc2 0.755 0.044795 
etv1 1.786 0.047233 
evi1 1.679 0.044900 
evla 1.518 0.040956 
evlb 2.565 0.039705 
evx1 1.976 0.037957 
exoc6 2.022 0.049154 
exosc8 0.613 0.032974 
eya4 1.582 0.034163 
f5 2.728 0.049691 
f7i 2.167 0.042787 
fabp11b 10.868 0.049517 
fabp7a 4.000 0.046235 
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fah 2.312 0.043967 
fam70a 6.040 0.035106 
fancd2 0.840 0.040832 
fancl 0.755 0.032396 
fbl 0.655 0.037957 
fbln1 0.486 0.049517 
fbp1a 1.462 0.046829 
fbp2 4.126 0.020380 
fdps 0.790 0.043463 
fech 0.392 0.039692 
fez1 3.566 0.036240 
fgf13l 2.427 0.020380 
fgf6a 2.432 0.049154 
fgl2 1.184 0.049517 
fhl 1.674 0.044795 
fkbp1b 1.883 0.032396 
flncb 0.337 0.048823 
foxf1 2.268 0.045768 
foxn4 4.716 0.044245 
foxq1 0.659 0.048422 
frem3 0.748 0.049038 
fstb 0.657 0.050266 
ftr29 0.706 0.044795 
ftr79 0.658 0.050355 
fxyd6 5.856 0.032396 
fyna 2.188 0.039705 
gabra1 3.145 0.039477 
gabrb2 2.521 0.039705 
gad1 3.826 0.046320 
gad2 4.133 0.039477 
gadd45a 0.550 0.037957 
gadd45bl 0.256 0.020380 
gapdh 1.737 0.035106 
gart 0.553 0.035106 
gbgt1l3 2.374 0.050243 
gcga 2.149 0.039669 
gck 1.624 0.040956 
gcm2 0.651 0.044795 
gdf11 2.584 0.050870 
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gefiltin 2.587 0.035106 
gfap 1.390 0.041795 
ggt1 3.559 0.032396 
glra1 9.846 0.039705 
glra3 2.274 0.050243 
glud1b 2.060 0.048963 
glula 0.421 0.040956 
gmfb 0.620 0.045842 
gnai3 0.671 0.040592 
gnao1a 1.852 0.037957 
gnb5 2.204 0.046829 
gng12 0.802 0.044245 
gng2 1.619 0.040296 
gng3 2.254 0.040592 
gng7 1.555 0.049855 
gnrh2 0.299 0.040832 
gpc3 1.603 0.040467 
gpib 2.732 0.043463 
gpm6aa 3.168 0.040296 
gpm6ab 2.210 0.035106 
gpr177 0.642 0.043463 
gpr27 2.518 0.040832 
gpx4a 0.339 0.045003 
grhl1 0.509 0.035106 
gria2a 3.666 0.048422 
gria2b 3.247 0.035106 
grifin 13.894 0.032396 
grin1b 8.644 0.044795 
gtf2f1 0.850 0.024975 
gtf3aa 0.542 0.034461 
guca1e 0.617 0.045768 
gys1 2.626 0.046744 
hccsa 0.618 0.029813 
hdac9b 0.531 0.044795 
hdr 0.363 0.046320 
heca 1.965 0.040592 
helt 2.507 0.041377 
her13 2.887 0.031433 
her3 0.686 0.050159 
 
  250 
Gene Fold Change P-value 
her4.2 2.180 0.044121 
her5 2.766 0.045514 
her8.2 4.583 0.032974 
hes5 1.487 0.039477 
hhatla 3.008 0.032396 
hlx1 3.008 0.032396 
hlxb9la 1.570 0.048988 
hmx3 1.732 0.049691 
hnrnpa0 0.712 0.020380 
hnrnpa3 1.430 0.049038 
hnrnpm 1.338 0.042308 
homer1 2.222 0.050870 
hpca 1.741 0.047299 
hs6st2 0.621 0.046822 
hsd17b3 0.770 0.044083 
hspb3 5.547 0.034163 
ier5 1.147 0.041818 
ifng1-2 0.519 0.025317 
igfbp3 1.862 0.046761 
igsf21a 2.015 0.040296 
ihha 0.628 0.041795 
il15 1.636 0.046829 
ing5b 0.610 0.039813 
insl5b 1.988 0.044245 
insm1a 2.846 0.034163 
irge4 0.706 0.034163 
irgf3 0.547 0.047858 
irx1a 1.536 0.039669 
irx2a 2.773 0.035995 
irx4a 3.478 0.050870 
isl1 1.783 0.038292 
islr2 3.392 0.039477 
isoc2 2.165 0.041795 
itgb1b.2 2.999 0.042261 
itgb3b 2.395 0.039477 
itm1 1.234 0.045443 
itm2ca 1.983 0.046320 
jph2 3.784 0.047233 
kal1a 1.831 0.046235 
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kat2b 3.014 0.024975 
kcnd3 1.896 0.020380 
kcnip3 2.521 0.022236 
kcnip3l 2.310 0.020380 
kdm6b 1.796 0.044245 
kidins220b 1.610 0.039553 
kif23 2.063 0.048823 
kif3c 4.195 0.037957 
kif5a 2.361 0.032974 
klf13l 1.969 0.044245 
klf2b 1.187 0.024975 
klhdc6 5.948 0.039705 
klhl6 2.053 0.042542 
kmo 2.080 0.042308 
kpna4 0.890 0.048823 
kri1l 0.618 0.040832 
krt15 3.340 0.045514 
ktn1 1.183 0.035106 
lbx1b 2.645 0.035106 
ldb3a 3.224 0.032396 
ldb3b 3.184 0.046822 
lect2l 0.218 0.046215 
lhx1b 2.642 0.046744 
lhx6 6.826 0.050346 
lhx9 2.559 0.036776 
lim2.3 10.201 0.044245 
lim2.4 9.430 0.050206 
lin37 0.761 0.041795 
lin7a 3.198 0.041779 
lingo1b 2.714 0.035106 
lmbr1l 0.639 0.034145 
lmbrd2b 1.993 0.035106 
lmo1 2.009 0.035106 
lmo3 2.495 0.040832 
lnx2a 2.830 0.039705 
lonp2 0.603 0.050266 
lox 1.861 0.047397 
lrit1 2.437 0.040721 
lrrc4a 2.466 0.044245 
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lrrc4c 2.373 0.044121 
lrrc50 0.670 0.041292 
lrrn1 1.938 0.049154 
lrrtm1 2.447 0.043463 
lrrtm2 2.518 0.024063 
lyricl 0.532 0.035106 
lyz 3.283 0.041795 
mab21l1 1.587 0.046456 
magi1 1.333 0.048598 
mak16 0.461 0.039705 
map1b 1.427 0.044795 
mapk10 2.487 0.020380 
mapk14a 0.729 0.046320 
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nbr1 1.536 0.020380 
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nkx1.2lb 3.887 0.031083 
nkx2.2a 1.440 0.034461 
nkx6.3 2.915 0.032396 
nlgn4b 1.786 0.040956 
nmbr 0.560 0.041795 
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nop14 0.686 0.050355 
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npm1 0.448 0.040832 
nppa 6.808 0.020380 
npsnl 3.493 0.032396 
nptn 2.120 0.043800 
npy 0.509 0.041818 
npy1r 2.905 0.050035 
nr2f1a 1.974 0.050702 
nr3c1 3.851 0.035106 
nr5a1b 3.606 0.044795 
nrarpb 1.607 0.032396 
nrxn1b 4.848 0.048528 
nrxn2a 2.551 0.041818 
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nrxn3b 2.699 0.032974 
nsf 2.502 0.044795 
nsun2 0.601 0.049154 
nupr1 1.874 0.045003 
nxph1 2.857 0.040832 
oc90 0.308 0.039477 
oca2 2.326 0.034461 
ociad2 1.289 0.049154 
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olfm1b 2.505 0.035106 
olfm3 2.766 0.020380 
olfml3 2.708 0.032974 
olig2 1.509 0.047563 
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omp 2.322 0.035106 
onecut1 2.290 0.037952 
oprl 2.899 0.048766 
optc 0.372 0.047397 
or120-1 2.151 0.039705 
or130-1 2.779 0.043463 
otpb 2.646 0.046320 
p2rx3a 0.524 0.048422 
pax3a 1.523 0.044795 
pax6a 1.323 0.044368 
pbx3b 2.923 0.034461 
pcdh17 1.968 0.044795 
pcdh1a4 2.846 0.028477 
pcdh1g18 1.689 0.053460 
pcdh1g3 1.629 0.038670 
pcdh1gb2 1.838 0.044795 
pcdh2ac 2.351 0.020380 
pcolce2b 0.485 0.046822 
pcp4a 2.838 0.037957 
pcp4b 3.882 0.040956 
pcp4l1 1.819 0.050738 
pcsk1nl 2.046 0.048823 
pdcd11 0.571 0.041795 
pdcd4b 1.862 0.043463 
pde6c 0.485 0.020380 
pde6g 5.530 0.032631 
pdgfrl 3.642 0.049363 
pdlim5 2.288 0.050355 
pdlim7 2.700 0.032396 
penk 2.742 0.034504 
pes 0.535 0.044083 
pfkfb2 2.292 0.035106 
pfkma 10.841 0.041795 
pgam1b 2.018 0.040832 
phkg2 1.348 0.035106 
pion 0.579 0.050870 
pisd 1.197 0.049154 
pla1a 1.185 0.044245 
plekhf1 0.348 0.046751 
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plp1a 2.545 0.044083 
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pou3f3b 1.737 0.033081 
pou47 1.483 0.044245 
pou4f1 1.814 0.044245 
ppan 0.527 0.032396 
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ppig 0.599 0.041795 
ppox 0.580 0.043967 
ppp2r4 1.447 0.041104 
pppde2a 2.003 0.030693 
prg4 0.498 0.044855 
prkcsh 1.301 0.050870 
prph 2.647 0.040956 
prss35 2.393 0.041377 
ptf1a 4.169 0.035106 
ptgds 0.242 0.022236 
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pycrl 0.878 0.039477 
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rbm41 1.236 0.044663 
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rogdi 1.740 0.032396 
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tnw 3.810 0.031083 
tpi1a 2.633 0.048963 
tpm3 0.809 0.036889 
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tsr1 0.683 0.045443 
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ttnb 2.403 0.050176 
tuba2 3.147 0.036240 
tuba7l 1.908 0.044997 
tyrp1b 3.786 0.041795 
ube2q1 1.153 0.049691 
uhrf1bp1l 1.343 0.041377 
urod 0.455 0.048316 
utp6 0.590 0.046315 
vamp1 3.215 0.031433 
vamp2 2.364 0.020380 
vax1 1.215 0.045555 
vegfab 1.843 0.050188 
vldlr 1.900 0.049691 
vps4a 1.268 0.034461 
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wdr12 0.634 0.044795 
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wnt4b 2.506 0.039692 
wrb 1.410 0.045761 
xdh 3.207 0.040832 
xirp2l 5.246 0.048823 
xk 1.832 0.048785 
xkr6 2.153 0.040721 
xrn2 0.664 0.043877 
yes1 0.684 0.048422 
yipf1 0.583 0.040721 
ywhag2 1.697 0.041292 
zbtb2b 0.795 0.046751 
zcchc17 0.695 0.043967 
zcchc24 0.804 0.046822 
zfpm2a 1.423 0.047563 
zfpm2b 2.173 0.048422 
zmiz1 1.741 0.049517 
znf259 0.630 0.044795 
znf277 0.733 0.039705 
znf326 2.215 0.041795 
znf593 0.573 0.020380 
znrd1 0.623 0.039477 
znrf1 2.431 0.039669 
zranb2 1.334 0.040956 
zswim6 2.214 0.044121 
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